













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
i 
Quest for early hematopoietic stem cell precursors 
Kateryna Bilotkach 
Thesis submitted in satisfaction of the requirements 
for the degree of 
Doctor of Philosophy 
Scottish Centre for Regenerative Medicine, School of Biological Sciences, 





В пам‘ять про тих, що живуть в моєму серці i про 
тих, що надихнули мене на цей шлях. З любов‘ю і вдячністю 
моїй родині: Володі, Ярославі, Руслану, які прокрокували зі 
мною цю дорогу від самого її початку до кінця. Для мого 
маленького дива, Зоряна, який прийшов розставити всі 
крапки над "і". З подякою всім щедрим душею людям, що 





First, I would like to thank my PhD adviser Professor Alexander Medvisnky who gave me the wonderful 
opportunity to engage in the captivating world of developmental biology and stem cell research. I am thankful for 
him to trust in me to establish the new direction for our group research studies of chick embryo haematopoiesis; 
and being patient in waiting for the results. I am also grateful for the inspiring and stimulating discussions we had 
about the research results and his suggestions. 
I would like to thank my “comrade” Dr Stanislav Rybtsov who was always next to me in the laboratory 
“trenches” in the days and nights we spent at SCRM. I am obliged to Stanislav for his invaluable advice on my 
research and technical suggestions and for his compassion during desperate times. 
I am indebted for Professor Helen Sang and Dr Adam Balik for advising and technical help on chicken 
haematopoiesis project and Debiao Zhao for teaching to work with chicken embryos. I am beholden for Dr Katie 
Long for helping with establishment of chick embryo culture in SCRM. Special thanks to Dr Manli Chuai for 
advising on early chick embryos culture protocol. 
I am grateful to Dr Valerie Wilson for advice on early embryo development and technical support in 
work with early mouse embryos. I also would like to thank Dr Wilson’s lab members Dr Ronald Wilkie, Dr Filip 
Wymeersch and Dr Yali Huang for technical help with histology and early mouse embryo work. I am thankful 
for my PhD committee members Dr Lesley Forrester and Dr Sally Lowell for advising on the results and next 
steps of my research project. 
I would like to thank all my fantastic former and current lab members, who not only assisted on multiple 
technical and theoretical issues, but most importantly spent their spare time with me to support me through the 
challenges of a PhD student: Anahi, Andrey, Anna, Antoniana, Boni, Ceine, Dasha, David, Edie, Fiona, Heather, 
Javi, Jenny, Jordi, Niamh, Sabrina, Sara, Stas, Suling, Vincent, Yiding and a special thanks to my friend Natalia 
who also gave me shelter when I performed my night experiments. 
I thank supporting staff: Dr Bertrand Vernay and Dr Valeria Berno for assisting with imaging; Dr Fiona 
Rossi, Dr Claire Cryer, Dr Olivia Rodrigues - for helping with flow cytometry; John Verth and Carol Manson for 
chick eggs supply. 
Many thanks for Kelly Duglas – our postgraduate secretary, - for the unstopping help in managing my 
progression as a PhD student. 
Finally, I would like to thank the University of Edinburgh for providing a rich personal and academic 
development environment that allowed me to broaden my perspectives on higher education and to realize my role 
as a student, researcher and a teacher for my younger student fellows. I am thankful, Institute of Academic 
Development for enrolling me in Postgraduate Certificate of Academic Practice programme and so making me a 





The first transplantable hematopoietic stem cells (HSC) arise in the aorta-gonad 
mesonephros region (AGM) during early stages of embryo development. Specifically, ventral 
aspect of embryonic dorsal aorta (DA) contains HSC that upon transplantation into irradiated 
recipients can reconstitute all lineages of the haematopoietic system [Medvinsky et al. 1993; 
Muller and Medvinsky, 1994; Medvinsky and Dzierzak, 1996; Cumano et al., 1996; Tavian et 
al., 1996; Peault and Tavian, 2003; Taoudi and Medvinsky, 2007; Ivanovs et al., 2011, 2014]. 
The ventral aspect of DA bears so-called intra-aortic cell clusters (IAC), the appearance of 
which coincides with the emergence of HSC [Babovic and Eaves, 2014; Bhatia, 2007; Boisset 
et al., 2010, 2011; Bollerot et al., 2005; de Bruijin et al., 2002; Bertrand et al., 2010]. According 
to recent reports, HSC are a heterogeneous population of cells [Dykstra et al., 2007; Seita and 
Weissman, 2010; Muller-Sieburg et al., 2012]. It is unclear whether all HSC precursors 
originate from the same location, for example, DA lining, IAC or sub-aortic tissues; or HSC 
precursors migrate into DA lining from other parts of the embryo [Tavian et al., 1999; Yoder 
et al., 1997; Oberlin et al., 2002; Peault and Tavian, 2003; Dzierzak, 2003; Samokhvalov et al., 
2007; Medvinsky et al., 2011]. 
To elucidate ontogeny of early HSC precursors (pro-HSC), two approaches were 
applied in this PhD project. First, we mapped potential pro-HSC in pre-circulation mouse 
embryos (embryonic day 6-8.5, E6-E8.5). We defined potential pro-HSC as cells co-expressing 
the transcription factor Runx1, endothelial markers (VE-Cad or CD31) and/or haematopoietic 
markers (CD45, CD41) [Oberlin et al., 2002; de Bruijn and Dzierzak, 2012; Liakhovitskaia et 
al., 2009, 2014]. In E6-E8 mouse embryo, prospective pro-HSC were found to be located in 
chorionic plate, yolk sac and in allantoic core domain. In early somitic mouse embryo (E8-8.5) 
cells with pro-HSC phenotype (Runx1+CD31+CD41+) were found to be in cell clusters in 
forming vessel of confluence and in nascent dorsal aortae lining. 
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Pro-HSC are not directly transplantable [Cumano et al., 1996., 2001; Godin et al., 1993; 
1995; Batta et al., 2016; Matsuoka et al., 2001; Nishikawa et al., 1998]. Therefore, cells and 
tissues containing prospective pro-HSC were initially matured using several in-vitro culture 
systems. According to our results, E8 mouse embryo pro-HSC are only preserved in explant 
cultures, but not in co-aggregate cultures with stroma cells. After culture, cells were 
transplanted into sub-lethally irradiated recipients. Six weeks after transplantation 19 out of 82 
transplanted recipients had donor derived blood cells’ chimerism at the level of 0.1-0.3%. Forty 
six percent of these grafts were derived from rostral part of the embryo tissues (head, heart, 
upper somites). Only one out of 82 recipients had donor cells contribution above 1% (1.2 %). 
This recipient was engrafted with cells derived from the E8 mouse embryo head and heart 
region. 
Recipients having blood chimerism at the range of 0.1-0.3% had mainly lymphoid 
donor derived cells in their peripheral blood. The only recipient showing the high donor cells 
contribution (1.2%) had contribution mainly to myeloid lineage. Recorded low levels of blood 
chimersims are in line with those reported by Rybtsov et al. (2014) for early E9 mouse embryos. 
Donor derived cells formed clearly distinguishable populations on cytometry plots. This 
population of cells were absent from control engraftment experiments with carrier cells only. 
Previously, lymphoid potential was detected in paraaortic spnanchnopleura (P-Sp) of E8.5-9 
mouse embryos, but not in E8 mouse embryos (0-5 somites, pre-circulation) and later in yolk 
sac [Cumano et al., 1996; Nishikawa et al., 1998; Fraser et al., 2002; Yokota et al., 2006]. 
However, prior works used different criteria to establish recipient reconstitution. Therefore, it 
is possible that recipients repopulated with E8 derived cells at the level of 0.1% were not 
considered as repopulated and hence, presence of lymphoid lineage precursors was overlooked 
in early somitic mouse embryos. The only recipient showing substantial myeloid cells 
contribution (73% Mac1+Gr1+ cells of donor derived cells) received engrafted cells from an 
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older (6-13 sp) embryo and therefore potentially has yolk sac derived myeloid cells. Yolk sac 
cell contribution to myeloid lineage, specifically to the brain microglia was reported in prior 
works [Samokhvalov et al., 2007]. 
Our data show that early E8 AGM cells do not expand in in vitro conditions. While in 
AGM, cells from E9 mouse embryo expand in culture [Rybtsov et al., 2014]. We have analysed 
Runx1 expression pattern and dorsal aorta morphology at the time when E9 HSC precursors 
acquire ability to expand in in vitro culture. Runx1 expression becomes clearly polarised at the 
time point (22-26 sp), when paired dorsal aortae fusion is initiated. We envision that intimate 
connection between DA fusion events and induction of pro-HSC maturation exists. According 
to prior reports, Bmp, Shh and VEGF signalling regulate DA fusion [Garriock et al., 2010]. 
Thereofore, to enhance in vitro HSC maturation system, DA fusion triggers (for example, 
Bmp4) might be added to culture. 
Since, pro-HSC maturation methods established to date are not efficient to expand and 
differentiate E8 pro-HSC into potent HSC, another approach had to be implemented to study 
HSC ontogeny. The second approach we utilized was to trace the origin of HSC in chicken 
embryo, starting from the very beginning of cell fate specification, i.e. from gastrulation stages. 
Chick embryo haematopoiesis is similar in both human and mouse: precursors of HSC arise in 
the embryo proper in AGM, and IAC are formed in DA ventral aspect [Dieterlen-Lièvre, 1975; 
Dieterlen-Lièvre and Martin, 1981; Dieterlen-Lièvre and Jaffredo, 2009; Jaffredo et al., 2000; 
Le Douarin and Dieterlen-Lièvre, 2013]. In contrast to mammals, chick embryo develops ex 
vivo, making direct labelling and cell tracing possible. We aimed to identify cells giving rise to 
regions of DA that produce IAC. Therefore, segments of primitive streak (PS) were labelled 
with lipophilic dyes or by substituting segments of host PS with PS sections derived from 
transgenic (GFP+) stage matched chicken embryos. 
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Our results show that in an 18-25h chicken embryo (Hamburger and Hamilton 
developmental stage 4-6, HH4-6) cells giving rise to DA ingress through the wide region of PS 
(35-60% of its length) [Hamburger and Hamilton, 1951]. We identified that the section of DA 
producing HSC is formed by cells ingressing through PS in region of 40-55% of its length at 
18-25h of chick embryo development. Regardless of the embryo development stage (HH4-6), 
in chimeras grafted at 40-55% of PS length, GFP+ cells contributed to DA and to the IAC. 
Within GFP+ labelled areas, we observed clusters consisting entirely of GFP+ and clusters 
having a mixture of GFP+ and GFP- cells. Entirely GFP+ clusters were found in the stretch of 
DA that had the entire aortic endothelial lining labelled. Clusters formed on the mosaic 
(GFP+/GFP-) aortic endothelium also had mosaic nature. According to our data, multiple 
descendants of PS contribute to the same stretch of dorsal aorta. This explains mosaicity of 
dorsal aorta lining and IAC labelling. Since we encountered clusters with mixture of GFP+ and 
GFP- cells, we conclude that IAC are not clonal formations. Mosaicity of IAC also does not 
exclude a scenario when cells migrate in and out of a cluster. Further tracing experiments are 





Haematopoietic stem cells (HSC) are the cells that can produce all blood cells (red and 
white blood cells and platelets) throughout one’s lifetime [Urso and Congdo, 1957; Till and 
McCulloch, 1961; Becker et al., 1963; Seita and Weissman, 2010]. Nowadays transplantation 
of HSC is widely used in treatments of blood and bone marrow cancers (for example, 
leukaemia, lymphoma, multiple myeloma etc.) [Schwaber et al., 2016]. Recently, HSC 
transplantation was also successfully used in treatment of multiple sclerosis and has shown 
promise in clearing a patient’s blood from human immunodeficiency virus (HIV) [Hardy and 
Ikpeazu, 1989; Eaves et al., 2015; Schwaber et al., 2016]. 
For transplantations, HSC are obtained from bone marrow, peripheral blood, or 
umbilical cord blood [Turpen et al., 1981; Querol et al., 1998; Ramsfjell et al., 1999; Batta et 
al., 2016]. The immune system can recognise molecules on the surface of foreign cells that 
distinguish them from one’s own cells. Therefore, for transplantations, clinicians will try to 
find a donor with the best possible “match” to the patient [Scott F. Gilbert, 2003]. This 
requirement significantly reduces the number of suitable HSC donors for certain patient groups. 
Therefore, there is a shortage of HSC donors [Heike and Nakahata, 2002; Sauvageau et al., 
2004; Celebi et al., 2011]. To overcome this shortage, researchers are exploring methods of 
HSC maturation from various potential sources, for example from embryonic stem cells or 
induced pluripotent stem cells, which can make any cell type in the body [Qiu et al., 1999; 
Bhatia, 2007; Pick et al., 2007; Doulatov et al., 2013; Batta et al., 2016]. The main obstacle in 
producing HSC in the laboratory, however, is the lack of knowledge of where HSC mature 
(HSC niche) and what growth factors control this process. The best way to address this gap in 
knowledge is to look at how HSC first emerge in vivo. It may then be possible to recreate HSC 
maturation in the laboratory. 
x 
 
During embryo development, HSC first appear in the largest embryonic vessel, the 
dorsal aorta [Bertrand et al., 2010; Pardanaud et al., 1996; Zovein et al., 2008; Jaffredo et al., 
1998]. They later migrate to the fetal liver and finally to the bone marrow [Hardy and Ikpeazu, 
1989; Medvisnky et al., 2011; Rybtsov et al., 2011; Schwaber et al., 2016]. It is still unclear 
where HSC arise from before they appear in the dorsal aorta. This PhD project is aimed to 
identify where the very first HSC come from. We used several approaches: (1) various parts of 
early mouse embryos were transplanted into recipient mice to check which parts contain HSC 
or their precursors. To detect precursors of HSC, cells were cultured before transplantation. 
We found that current culture methods were not efficient at maturing these early precursors 
and therefore (2) we tried a second approach to trace the origin of HSC: we used chicken 
embryos to identify cells that contribute to the embryonic aorta. Chicken development can be 
easily tracked since they develop in eggs rather than inside the body. By grafting labelled cells 
into recipient embryos, we were to show that in chicks, the dorsal aorta is built from 
descendants of an earlier tissue called the primitive streak (PS) [Downs et al., 1993; Garcia-
Martinez and Schoenwolf, 1992; Lawson et al., 1991]. Not all sections of dorsal aorta produce 
HSC. We identified the specific part of the PS that contributes to the region of the DA that is 
implicated in production of HSC. This work lays a foundation that will allow the establishment 






7-AAD 7 -amino-actinomycin; 
Ac-LDL Acetylated low-density lipoprotein; 
ACD Allantoic core domain; 
AGM Aorta-gonad-mesonephros region; 
AlP Alkaline phosphatase; 
AO Area opaca; 
AP Area pellucida; 
A-P Anterior-Posterior 
BFU-E Burst-forming unit erythroid; 
CD Cluster of differentiation (or classification determinant) is the nomenclature 
used for identification of cell surface markers; 
CD41 Integrin alpha-IIb. Membrane bound molecule. Receptor for fibronectin, 
fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. 
Also known as CD41; 
CFU-C Colony-forming unit-culture; 
CFU-GM Colony forming unit - granulocyte-macrophage; 
CFU-M Colony forming unit -macrophage; 
CFU-S Colony forming unit - spleen; 
C-R Caudal-Rostral; 
DA Dorsal aorta; 
DAPI 4',6-diamidino-2-phenylindole, dihydrochloride; 
HSC Definitive hematopoietic cells; 
DPBS Dulbecco's phosphate buffer saline; 
D-V Dorsal-Ventral; 
E or ED Embryonic day of development (E for mouse, ED for chick); 
EDTA Ethylene-diamine-tetra acetic acid; 
FACS Fluorescence-activated cell sorting; 
FCS Fetal calf serum; 
GEMM Granulocyte, erythroid, macrophage, megakaryocyte CFU; 
GFP Green fluorescent protein; 
HH Hamburger and Hamilton stage of chick embryo development; 
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HN Hensen’s node; 
HSC Hematopoietic Stem Cells; 
Ht Heart; 
IAC Intra aortic clusters; 
KO Knockout. A mouse animal model with a disrupted gene; 
LacZ Beta-galactosidase; 
Lin- Population of cells lacking committed hematopoietic progenitors’ markers: 
Ter119, Mac-1, Gr-1, B220, CD3ε, CD4 and CD8; 
LPM Lateral plate mesoderm; 
LSK Population of cells that are lineage negative (Lin−), Sca-1+, c-kit+ 
LTR Long term repopulation; 
Nc Notochord; 
NT Neural tube; 
PBS Phosphate buffer saline; 
PECAM-1 Platelet endothelial cell adhesion molecule – 1 (synonym – CD31); 
PFA Paraformaldehyde; 
PS Primitive streak; 
Som Somite; 
STR Short term repopulation; 
Tris-HCL Tris(hydroxymethyl) aminomethametane- hydrochloric acid; 
UGR Urogenital ridges; 
VE-Cad Vascular endothelial cadherin, cadherin 5; 
VOC Vessel of confluence; 
VV Vitelline vessels; 
WT Wild type; 
X-gal 5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside; 
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1.1. Glossary of the key terms and definitions 
 
Hematopoietic stem cell (HSC) – a cell that self-renews and can give rise to all elements of a 
hematopoietic system; 
Self-renewal – is a process of stem cell division with maintenance of stem cell undifferentiated 
state;  
Precursor of hematopoietic stem cells (pre-HSC and pro-HSC) – immature embryonic cell 
that eventually will become a HSC. Pre-HSC – HSC precursors apprearing in embryos with 
established blood circulation, but before appearance of HSC in fetal liver. Pro-HSC – HSC 
precursors appearing in embryo tissues before establishment of blood circulation. 
Aorta-gonad mesonephros region – consists of the dorsal and embryonic rudiments of kidney 
and mesonephros (urogenital ridges); 
Intra-aortic clusters – clusters of cells appearing on the internal endothelial lining of the dorsal 
aorta; 
Primitive haematopoiesis – process of generation of immature (fetal type) hematopoietic stem 
cells in the yolk sac; 
Extra-embryonic tissues  - yolk sac and its vessels, allantois, chorion, placenta; 
Hematopoeitc system reconstitution (or repopulation) – a process when donor cells injected 
into a lethally irradiated recipient give rise to hematopoietic cells that compliment the 
recipient’s hematopoietc system; 
Blood chimerism - percentage of donor-derived blood cells appearing in recipient’s peripheral 








1.2.  On hematopoietic stem cell 
In the 1950s, it was discovered that bone marrow injections into lethally irradiated 
recipients allow complete reconstitution of the recipient’s hematopoietic system [Urso and 
Congdon, 1957; Lorenz et al., 1952; Hardy and Ikpeazu, 1989; Seita and Weissman, 2010]. 
McCulloch and Till, experimenting with bone marrow injections in mice, observed that in 8-
14 days cell colonies appear within mice spleens. These colonies later were termed – “colony 
forming unit-spleen” (or CFU-S) [Till and McCulloch, 1961; Becker et al., 1963; Siminovitch 
et al., 1963]. When these colonies were analysed it was concluded that each colony was derived 
from one transplanted bone marrow cell [Becker et al., 1963; 2014]. Moreover, when cells 
isolated from CFU-S were injected into secondary irradiated recipients, the complete 
reconstitution of the host hematopoietic system was also observed. Therefore, it was concluded 
that cells in one CFU-S colony are descendants of one bone marrow cell that gives rise to all 
lineages of committed hematopoietic progenitors and are also able to self-renew [McCulloch 
and Till, 2005]. Later, McCulloch and Till proposed to term cells giving rise to CFU-S - “stem 
cells” [Becker et al., 1963, 2014; Wolf and Trentin, 1968]. 
According to the given above stem cell definition, adult hematopoietic stem cells are 
the cells that can provide lifelong reconstitution of all lineages of the hematopoietic system in 
an irradiated recipient. Under normal conditions these cells reside in the bone marrow of adults 
[Hopman and DiPersio, 2014; Schwaber et al., 2016]. HSC are responsible for keeping the 
hematopoietic system of an adult in homeostasis, e.g., maintaining numbers of terminally 
differentiated blood cells constant, the timely rise to multipotent hematopoietic progenitors (for 
example, during injury) and keeping the pool of hematopoietic stem cells under control 
[Babovic and Eaves, 2014; Mendelson and Frenette, 2014; Seita and Weissman, 2010]. The 




some blood malignancies can result from proliferation of a hematopoietic stem cell that has a 
genetic lesion dysregulating stem cell’s control of self-renewal [Carlesso and Cardoso, 2010; 
Babovic and Eaves, 2014]. 
Initially bone marrow transplants in humans were challenging, but after blood cell 
allotypes were discovered, bone marrow transplantation became one of the methods of choice 
in treatment of blood malignancies (leukaemia, lymphoma, multiple myeloma) and some 
immunodeficient conditions [Thomas et al., 1970; 1971; Hardy and Ikpeazu, 1989; Schwaber 
et al., 2016]. For today, HSC are isolated from bone marrow, new-born umbilical cord blood 
and adult peripheral blood [Hopman and DiPersio, 2014]. Due to the need to match blood 
allotypes of the donor to the recipient, there are still shortages in bone marrow donors [Hardy 
and Ikpeazu, 1989; Hopman and DiPersio, 2014; Schwaber et al., 2016]. Therefore, delineation 
of the ontogeny and the process of hematopoietic stem cells maturation is of great interest in 
the field of regenerative medicine [Rowe et al., 2016]. 
 
1.3. Hierarchical organization of the adult hematopoietic system in mammals 
A hematopoietic stem cell (HSC) is positioned at the top of the hematopoietic system 
hierarchy [Babovic and Eaves, 2014; Seita and Weissman, 2010]. HSC represent a very small 
pool of bone marrow cells. According to Szilvassy et al. in the whole mouse bone marrow there 
is just 1 in 10 000 cells with the ability to engraft and completely reconstitute the hematopoietic 
system [Szilvassy et al., 1990]. HSC mainly remain in the G0 phase (quiesce) of the cell cycle 
[Passegué et al., 2005; Wilson et al., 2008; Pietras et al., 2011]. HSC slowly cycle, which slows 
down the cell’s metabolic rate, reduces oxidative stress and prevents HSC from accumulation 




From the very beginning of stem cell discovery McCulloch and Till recognized that the 
pool of HSC is not homogeneous. The authors observed that propensity of CFU-S to support 
further colonies’ expansions broadly varies between them [Siminovitch et al., 1963; McCulloch 
and Till, 2005]. Over the last decade, new insights were obtained for the heterogeneity of HSC 
pool in mice [Copley et al., 2012; Muller-Sieburg et al., 2012; Crisan and Dzierzak, 2016; 
Weissman, 2015; Bush et al., 2015]. Dykstra et al., proposed to distinguish 4 types of HSC: α, 
β, γ and δ [Dykstra et al., 2007]. According to the authors, α and β HSC both support self-
renewal, but provide quite a different spectrum of hematopoietic progenitors. For example, α-
HSC mainly produce myeloid lineage progenitors, while β-HSC produce both myeloid and 
lymphoid progenitors. Upon secondary transplantations α-HSC can give rise to β-HSC, 
indicating that α-HSC are not devoid of the ability to give rise to both myeloid and lymphoid 
lineages, but require special conditions to trigger this process. The abundancy of α and β-HSC 
is approximately 30% of all bone marrow HSC. Both α and β HSC provide so-called “long 
term” or “life-long” engraftment [Seita and Weissman, 2010]. In animal models, long term 
engraftment is accepted when HSC support hematopoietic system reconstitution for 4 months. 
This kind of HSC are also called long-term repopulating HSC or LTR-HSC [Seita and 
Weissman, 2010; Liu et al., 2012]. 
There are also short-term repopulating cells, the cells that provide complete 
hematopoietic system reconstitution for a period shorter than 4 months (short-term 
repopulating cells or STR-HSC) [Liu et al., 2012; Fibbe et al., 1997]. As self-renewal property 
is lost by these cells, they cannot be seen as “true” HSC, even though they give rise to both 
myeloid and lymphoid lineages. As McCulloch and Till noticed, the initial stem cell goes 
through a pivotal point when a decision is made to differentiate or to self-renew [McCulloch 




there is no way to distinguish this stem cell from a hematopoietic progenitor. Therefore, 
establishing if a cell is a HSC or a progenitor remains a controversial issue. 
Other components of bone marrow HSC pool are γ and δ cells. These cells support 
multilineage life-long engraftment but are not able to repopulate secondary recipients, which 
indicates limits of their self-renewal ability [Seita and Weissman, 2010]. Moreover, while the 
level of blood chimerism (percentage of donor derived cells) in mice transplanted with α and 
β HSC stays at a high level, percentage of donor derived cells in mice engrafted with γ and δ 
HSC drops (though remains above 1%) [Dykstra et al., 2007]. γ and δ HSC provide low levels 
of myeloid engraftment with a particularly diminishing number of donor derived myeloid cells 
(derived from δ HSC). In mice, γ and δ types represent 12 and 22% of all HSC accordingly. γ 
and δ HSC can be derived from α and β HSC in vivo and in vitro. Interestingly, in vitro culture 
of bone marrow cells reduces numbers of α and β HCS and expands γ and δ types. Longer 
culture (10 days) eliminates α and β HSC, but expands δ HSC % [Dykstra et al., 2007]. 
HSC gives rise to multi-potent hematopoietic progenitors (MPP), which are different 
from HSC in that they have lost their self-renewal property [Babovic and Eaves, 2014; Seita 
and Weissman, 2010]. MPP can generate all types of more differentiated oligopotent 
progenitors [Kawamoto et al., 2010; Eaves, 2015; Snoeck, 2013; Muller-Sieburg et al., 2012]. 
In particular, common myeloid, common lymphoid and common megakaryocyte-erythrocyte 
progenitors (Figure 1.). Even though the lifespan of committed hematopoietic progenitors is 
much shorter than that of HSC, they are available at higher quantities, have fast proliferation 
rates and are widely used in clinic for reconstitution of the lymphoid compartment in some 
immunodeficient patients [Hardy and Ikpeazu, 1989; Hopman and DiPersio, 2014; Schwaber 
et al., 2016]. Common myeloid progenitors give rise to restricted megakaryocyte-erythrocyte 




to pre-B; -T and -normal killer cells [Babovic and Eaves, 2014; Kawamoto et al., 2010; Eaves, 
2015]. Dendritic cells represent a separate group of hematopoietic cells and can be derived 
from both lymphoid and myeloid progenitors [Watowich and Liu, 2010; Merad et al., 2013]. 
















Marker Function Reference 
Leucocytes CD45/Ly-5 
Cellular differentiation/ 
activation, tyrosine phosphatase 
pan-leukocyte marker 
Komuro et al., 1974; 
Scheid, M.P. and 
Triglia, 1979 
Erythroid lineage 
Late stage erythroid 
cells Ter119 
TER-119 antigen is a molecule 
associated with cell-surface 
glycophorin A but not with 
glycophorin A itself 
Kina et al., 2000 
Erythroid precursors CD71 Transferring receptor-1 
Dong et al., 2011; 





TCR coreceptor, MHC class II 
receptor, signal transduction. 
Single chain transmembrane 
glycoprotein 
Lai et al., 1998; 
Dialynas et., al, 1993 
CD8α 
TCR coreceptor, MHC class I 
receptor, signal transduction. 
Surface glycoprotein 





pan-B-cell-specific isoform of 
CD45. Protein Tyrosine 
Phosphatase, Receptor Type C 
Blessing et al., 2003; 
Lai et al., 1998 
CD19 BCR co-receptor, signal 
transduction, pan-B-marker Rolink et al., 1996 
Natural killer cells NK1.1 Killer cell lectin-like receptor 
subfamily B, member 1 
Vicari AP and  
Zlotnik A, 1996 
Myeloid lineage 
Macrophages CD11b/Mac-1α Integrin alpha M Stewart et al., 1995 





1.4. Fetal haematopoiesis in mammals 
 
1.4.1. Definitive hematopoietic potential 
While in adults, hematopoietic stem cells (HSC) reside in the bone marrow. In an 
embryo, hematopoietic stem cells (HSC) and their precursors (pro- and pre-HSC) migrate from 
one tissue niche to another until they reach their final destination – the bone marrow. HSC, pro- 
and pre-HSC migrate from the tissue of their origin (which is still under investigation) to the 
aortic floor, fetal liver, spleen and thymus (or para-aortic foci and bursa in avians). In mouse 
and human, HSC expand and further differentiate in the fetal liver. In avian embryo para-aortic 
foci might play the role of fetal liver. Timeline of HSC migration between niches is different 
for each particular specie [Müller at al.,1994; Medvinsky et al. 1996; Babovic and Eaves 2014; 
Eaves, 2015; Rybtsov et al., 2016]. The comparison of HSC migration between human, chick 
and mouse is given on Figure 2.  
In this work, to describe hematopoietic stem cells of embryonic origin we use the term 
“definitive hematopoietic stem cells” (dHSC) [Medvinsky et al., 2011]. dHSC are embryonic 
cells that can provide complete and lifelong reconstitution of all hematopoietic cell lineages in 
an adult irradiated recipient. 
 
1.4.2. Timeline of hematopoietic stem cells and their precursors appearance in a 
mouse embryo 
In a mouse embryo, cells with hematopoietic potential reside in various locations (yolk 
sac, allantois, placenta, dorsal aorta, fetal liver, main hematopoietic organs) starting from 
embryonic (E) day 7 [Melchers, 1979; Godin et al., 1995; Yoder et al., 1997; Palis et al., 1999; 




Dzierzak, 2005; McGrath and Palis, 2005; Zeigler et al., 2006; Corbel et al., 2007; Rhodes et 
al., 2008; Lux et al., 2008;  Dieterlen-Lièvre et al., 2010; Yoshimoto et al., 2012; Arora and 
Papaioannou, 2012]. This hematopoietic potential was elucidated either in vivo assay by 
transplantations or in vitro in hematopoietic colony-forming cell assays* (*- glossary of terms 
and definitions). 
First hematopoietic cells (primitive erythroblasts and some macrophages) appear in the 
yolk sac around embryonic day (E) 7-8 in so-called blood islands (Figure 2) [Moore and 
Metcalf, 1970; Cumano et al., 1996; Yoder et al., 1997; Lichanska and Hume, 2000; Cumano 
et al., 2001; Lux et al., 2008]. These cells in contrast to mature erythrocytes are nucleated and 
express an embryonic type of haemoglobin [McGrath and Palis, 2005]. Cells with lymphoid 
and myeloid potential were identified in E8.5 mouse embryos in the placenta labyrinth and 
allantois [Zeigler et al., 2006; Alvarez-Silva et al., 2003; Ottersbach and Dzierzak, 2005; 
Melchers, 1979]. In mouse embryos blood circulation starts around E8.5 when embryo 
develops 5-8 somite pairs (sp) [McGrath et al., 2003]. Released with blood flow primitive 
hematopoietic cells migrate from yolk sac into the embryo proper. These primitive blood cells 
are not able to reconstitute the hematopoietic system of myeoablated recipients and therefore 
are not dHSC [Medvisnky et al., 1996; 2011; Seita and Weissman 2010;  McGrath and Palis, 
2005]. 
The first cells supporting lifelong multilineage engraftment can be detected in mouse 
embryo at late embryonic day 11.5 (E11.5) in the so-called aorta-gonad mesonephros region 
(AGM) [Medvinsky et al. 1993; Muller et al., 1994; Medvinsky and Dzierzak, 1996; de Bruijn 
et al., 2000;  Taoudi and Medvinsky, 2007]. By series of works of in vitro culture of E9-E10 
AGM derived cells it was demonstrated that dHSC originate in AGM autonomously [Taudi and 
Medvinsky, 2007; Rybtsov et al. 2011, 2014; Ivanovs et al., 2014]. dHSC and their precursors 




Bruijn et al., 2002; Taudi and Medvinsky, 2007; Rybtsov et al., 2011] and in human [Péault et 
al., 2002; Ivanovs et al., 2011]. Emergence of dHSC and their precursors in AGM coincides 
with appearance in the ventral aspect of dorsal aorta (DA) so-called intra-aortic cell clusters 
(IAC) [Yokomizo and Dzierzak, 2010; Yokomizo et al., 2011; Mizuochi et al., 2012; Boisset et 
al., 2011]. Today, it is broadly accepted that dHSC mature in hemogenic endothelium and give 
rise to intra-aortic clusters (IAC) [Jaffredo et al., 1998, 2005; Zovein et al., 2008; Boisset et al., 
2010; Bertrand et al., 2010; Kissa and Herbomel, 2010; Swiers et al., 2010]. After dHSC 
potential is detected in AGM, other vascularized organs (placenta, allantois, yolk sac 
vasculature, embryonic head) acquire dHSC potential [Ottersbach and Dzierzak, 2005; Rhodes 
et al., 2008; Alvarez-Silva et al. 2003; Dieterlen-Lièvre et al., 2010; Gordon-Keylock et al., 
2013; Kumaravelu et al., 2002; Gekas et al., 2005]. At embryonic day 12 (E12) dHSC and their 
precursors (pre-HSC) migrate into the fetal liver, where they expand and mature [Kumaravelu 
et al., 2002; Zovein et al., 2008; Rybtsov et al., 2011; 2014; 2016]. 
Even though today it is known that maturation of dHSC precursors takes place in the 
ventral aspect of dorsal aorta, it is still not known where early dHSC precursors come from in 
the E8 mouse embryo. Since blood flow effectively disseminates cells from one embryonic 
compartment to another, after E8.5 (initiation of blood circulation) it is difficult to 
unequivocally determine where precursors of dHSC come from. Therefore, the best strategies 
to answer this question would be the lineage tracing of descendants of selectively labelled 






Figure 2. Timeline of hematopoietic stem cells and their precursors migration during 
gestation. Chronology of hematopoietic stem cells and their precursors migration between 
tissues is shown. Numbers indicate day of embryonic development. Coloured rectangles 







Figure 3. Timeline of hematopoietic stem cells and their precursors appearance in 
mouse embryo. First primitive hematopoietic cells appear in mouse embryo at E7-8 in yolk 
sac blood islands. At around E8-8.5, hematopoietic cells autonomously appear in placenta 
and allantois [Alvarez-Silva et al., 2003; Ottersbach and Dzierzak, 2005; Corbel et al., 2007; 
Dieterlen-Lièvre et al., 2010]. First transplantable dHSC appear in E11.5 mouse embryo. 
They first appear in aorta-gonad mesonephros region (AGM). Simultaneously inta-aortic 
clusters (IAC) appear in the lumen of the dorsal aorta. Shortly after that dHSC can be 
identified in the yolk sac (YS), future umbilical cord and placenta. At E12.5 dHSC migrate 
into the fetal liver and at E16.5 colonise the fetal thymus, spleen and bone marrow. A – 







1.4.3. Early mouse embryo tissues definitive hematopoietic potential 
Prior reports demonstrate that several tissues in early mouse embryos (placenta, allantois, 
yolk sac vasculature, head, heart) possess hematopoietic potential [Godin et al., 1995; Yoder et 
al., 1997; Palis et al., 1999; Gekas et al., 2005; Ottersbach and Dzierzak, 2005; Lux et al., 2008; 
Dieterlen-Lièvre et al., 2010; Yoshimoto et al., 2012]. Hematopoietic cells isolated from these 
tissues cannot directly engraft irradiated recipients and hence are not mature dHSC. According 
to Cumano et al., these immature dHSC lack expression of MHC1, and after injection into 
immunocompetent recipients are eradicated by normal killer cells (NK) [Cumano et al., 1996, 
2001; Kieusseian et al., 2012; Rybtsov et al., 2011, 2014]. To prove early mouse embryo tissues 
have definitive hematopoietic potential, cells must be pre-cultured iv vitro in the presence of 
stromal cells and/or growth factors (thrombopoietin, stem cell factor, Flt3 ligands, some 
interleukins).  Kieusseian et al., (2012) demonstrated that dHSC precursors upregulate MHC1 
expression during culture. Before recent, cells isolated from mouse embryos younger than E10 
after in vitro culture step could engraft only NK deficient mice (Ragℽc-/- recipients), but not 
adult or Rag2-/- mutant mouse recipients (Rag2-/- has no mature T or B lymphocytes). However, 
in Rybtsov at al. (2014) work, we demonstrated that E9 pro-HSC could mature into 
transplantable cells if co-cultured in 3D co-aggregates with OP9 stromal cells and in the 
presence of stem cell factor (SCF). 
Majority of published works to date indicate the presence of pro-HSC in early mouse 
embryos (starting from E8). In these works, definitive hematopoietic potential was shown in 
immuno-deficient animal models or with utilization of not existing for today components 
(some stromal cell lines). Also, the level of blood chimersim (% of donor derived blood cells) 
was not clearly reported [Cumano et al., 2001; Godin et al., 1993; 1995; Fraser et al., 2002; 




was the definitive one: providing high level and complete lifelong reconstitution of the 
hematopoietic system with the ability to engraft secondary recipients [Custer et al., 1995; 
Mombaerts et al., 1992]. Below we will review details of works reporting definitive 
hematopoietic potential in E8 mouse embryos. 
Cumano et al. (2001) reported that mice lacking normal killer cells (Ragℽc-/-) were 
repopulated after injection of 10-12 ee (embryo equivalents) of cells derived from the caudal 
parts of 0-10 sp mouse embryos (E8-E8.5) after 4 days of the explant culture. Although, the 
extent of repopulation is not mentioned, it is much lower than that of control experiments in 
which a suspension from 3 pooled AGMs was injected. The authors show that only 
splanchnopleura-explants (P-Sp) provided multilineage engraftment. Authors also showed 
dose-dependent engraftment, e.g., 8 ee did not provide long term repopulation while 10-12 ee 
did. Although it is difficult to judge what was the percentage of recipient blood chimerism, 
authors reported that there were no lower than 0.5% of donor derived cells in the bone marrow. 
Long term repopulation was not achieved. Yolk sac (YS) tissues provided only transient 
myeloid repopulation [Cumano et al., 2001]. 
With utilization of the co-culture with S17 stromal cell line, Godin et al. (1995) showed 
that multipotent hematopoietic progenitors appear around 10 sp simultaneously in YS and 
splanchnopleura (P-Sp) [Godin et al., 1995]. Godin et al. (1993) grafted P-Sp cells from early 
mouse embryos under the kidney’s capsule of the recipient mice and found that only P-Sp (but 
not YS) from embryos older than 5 sp could reconstitute recipients [Godin et al., 1995]. Most 
generated cells were B1a cells. B1a cells are the cells mainly functioning in infants. There are 
several points of view on B cell development, according to one of them B1 and B2 cells appear 
from different progenitors, therefore it is not clear whether hematopoietic potential reported 




Fraser et al., were studying hematopoietic potential of Flk1+VE-Cad+ cells. E9 derived 
Vec_cad+Cd45+ cell from YS and caudal parts (CP) were injected intrahepatically into 
newborn SCID (Severe Combined Immunodeficiency) recipients. Donor cells contributed to 
the lymphoid compartment and had a weak contribution to the myeloid compartment. This 
repopulating activity was limited to E9 cells or older. E8.5 cells were unable to repopulate 
SCID recipients even when increased doses of cells were used (13 ee for YS and 22 ee for CP) 
[Fraser et al., 2002]. However, level of blood chimerism was not described and hence, it is 
difficult to judge whether that was definitive HSC engraftment or not. 
Matsuoka et al., co-cultured cells derived from E8 embryos with AGM-S3 stromal cell 
line. Preconditioned cells were injected into recipients and reconstitution for all hematopoietic 
system components was achieved. However, levels of blood chimersim were not reported 
[Matsuoka et al., 2001]. 
When P-Sp and YS tissues derived from 0-15 sp mouse embryos were pre-cultured with 
S17 stromal cells line, both P-Sp and YS cells could generate myeloid cells. Lymphoid cells 
could be only generated by P-Sp tissues [Cumano et al., 1996]. Nishikawa et al. (1998) showed 
that Flk1+VE-Cad+ fraction, but not CD45-Ter119+ fraction of cells from E8.5 mouse embryos 
after co-culture with OP9 stromal cell line exhibited myeloid potential. Both myeloid and 
lymphoid potentials could only be detected in embryonic tissues starting from E9. 
To summarise, in mouse embryos, early dHSC precursors are most probably localized 
to splanchnopleuric mesoderm, in particular, to the caudal portion of the embryo. This zone is 
situated in close proximity to the allantoic core domain, which was earlier proposed to be a 
stem cell zone [Downs et al., 2009]. Yet, proving that cells expressing markers of maturing 
HSC are true dHSC precursors remains challenging as direct methods of grafting do not allow 
repopulation of recipients’ hematopoietic system. In vitro methods of early embryonic tissues 




are injected in immunodeficient recipients. Yet, in the majority of cases this kind of donor cell 
engraftment was a short term one and published reports are not detailed in levels of donor cells 
engraftment. Therefore, the presence of committed dHSC precursors in early mouse embryo 
tissues remains a controversial issue. 
 
1.4.4. Localization of early HSC precursors in mouse embryo 
Localization of the very early (pro-HSC) precursors is currently under debate. Even 
though, hematopoietic activity is detected in early somitic mouse embryo (E8) in allantois, 
chorion, and in the yolk sac, definitive hematopoietic potential cannot be established directly. 
Immuno-fluorescent and histochemical studies of early mouse embryo tissues revealed 
multiple sites of vascularised tissues containing clusters of Runx1+ cells, resembling cell 
clusters found in the dorsal aorta. These clusters of cells were detected in extraembryonic 
arteries, allantois, placenta and head – all sites of definitive haematopoiesis identified in E11 
embryos [Palis et al., 1999; Sugiyama et al., 2007; Yoshimoto et al., 2012; Zovein et al., 2010; 
Mizuochi et al., 2012; Vodyanik et al., 2005; de Bruijn et al., 2000; Gordon-Keylock et al.,2012; 
Zovein et al., 2010; Gekas et al., 2005; Inman et al., 2007; Zeigler et al., 2006]. 
For instance, Zovein et al., (2010) observed Runx1+ cell clusters during ventral vascular 
beds remodelling. At embryonic day 9 (E9) at the vitelline artery (VA), the dorsal aorta and 
umbilical artery are connected by the vessel of confluence (VOC) [Zeigler et al., 2006; Daane 
et al., 2011]. VA and VOC connection is gradually lost, and VA moves by "walking" on 
temporary vascular beds towards the fetal liver and the umbilical artery (UA). Together with 
VA, clusters of Runx1+ cells travel along the vasculature in the direction of the fetal liver – the 
future site of intra-embryonic dHSC expansion. Zovein et al. proposed that observed Runx1+ 




et al., did not detect dHSC potential in the ventral vasculature of E9 mouse embryos, but only 
in the caudal part of future AGM [Zovein et al., 2006; Rybtsov et al., 2013]. 
Rhodes et al., (2008) reported presence of Runx1+ clusters in the early placenta 
[Rhodes et al., 2008]. According to Gekas et al., (2005) definitive hematopoietic potential will 
only be detected starting from E11.5. Identified in the placenta, definitive hematopoietic cells 
behaved in the same way as dHSC from AGM, e.g. they disappeared from placenta vasculature 
at E12 – when dHSC migrate to the fetal liver to expand [Gekas et al., 2005]. 
As blood circulation is established in mouse embryos from early somitic stages (5 sp), 
it is difficult to delineate innate dHSC activity from activity brought by the blood flow. For 
example, Kulkeaw et al. demonstrated that cells from yolk sac migrate to the embryonic caudal 
parts at E10.5. Yet, these cells did not possess dHSC potential [Kulkeaw et al., 2009]. An 
interesting approach was demonstrated by Rhodes et al. (2008) with application of the heartbeat 
lacking the Ncx-/- mutant. In this experiment, the placenta was demonstrated to develop 
multilineage hematopoietic potential in the absence of blood circulation [Rhodes et l., 2008]. 
One of the solutions would be to conduct experiments with pre-circulation mouse 
embryo tissues cultured in an HSC maturation system. In mouse embryos, younger than 
embryonic day 11 (E 11) dHSC are not mature, and hence they cannot be directly detected in 
a transplantation assay [Kieusseian et al., 2012; Rybtsov et al., 2011; 2016].  However, if cells 
isolated from AGMs of E9-E10 mouse conceptus are cultured in the right conditions, pre-HSC 
are able to mature into functional dHSC [Rybtsov et al., 2014, 2016; Sheridan et al., 2009]. In 
our group, an air-liquid interface 3D co-aggregate method of pro-HSC was developed. The 







1.4.5. Molecular phenotypes of maturing mouse HSC precursors 
Hierarchy of maturing HSC precursors is partially elucidated. After the culture step, 
HSC precursors were detected in cell suspensions derived from caudal parts of mouse embryos, 
starting from embryonic (E) day 9 [Taudi and Medvinsky, 2007; Rybtsov et al., 2011; 2014; 
2016]. All early dHSC precursors express endothelial markers: vascular endothelial cadherin 
(CD144 or VE-Cad); endothelial marker CD31 (platelet endothelial cell adhesion molecule), 
and vascular endothelial cell growth factor receptor 2 VEGFR2 (or kinase insert domain 
receptor, fetal liver kinase-1, Flk1, CD309) [Garcia-Porrero et al., 1998; Fraser et al., 2002; 
Rybtsov et al., 2011; 2016]. Early dHSC precursors express low levels of integrin alpha IIb (or 
platelet fibrinogen receptor, CD41) and are negative for protein tyrosine phosphatase, receptor 
type C (CD45) and major sialoglycoprotein (CD43) [Ferkowicz et al., 2003]. In general, 
molecular phenotype of dHSC precursors found in E9.5 (pro-HSC) mouse embryos can be 
described as: VE-Cad+ CD41low/+CD45−CD43− [Rybtsov et al., 2011; 2014; 2016]. 
dHSC gradually upregulate their expression of CD41 and CD43 markers when 
becoming pre-HSC type I with molecular phenotype of VE-Cad+ CD41+ CD45−CD43+ at 
E10.5 [Rybtsov et al., 2014; 2016; Mikkola et al., 2003; Hashimoto et al., 2007]. According to 
Kieusseian et al., (2012), the MHC1 antigen starts to be expressed at E10.5, just before 
upregulation of CD45 antigen expression. Finally, the CD45 marker starts to be expressed at 
E11.5 and dHSC transit to pro-HSC type 2 cells with phenotype VE-Cad+ CD41+ 
CD45+CD43+. After culture step with OP9 stromal cell line, pre-HSC type II become 
transplantable into adult irradiated recipients [Rybtsov et al., 2011; 2014; 2016]. Upregulation 
of CD41, CD43 and CD45 markers during pro-HSC maturation closely correlates with the 
expression of these markers in intra-aortic clusters and in the dorsal aorta endothelium [Taudi 
and Medvinsky, 2007; Yokomizo and Dzierzak, 2010; Yokomizo et al., 2011; Boisset et al., 




Other markers that have been found to distinguish intra-aortic clusters in the dorsal 
aorta are: VEGFR2 (Flk1); mast/stem cell growth factor receptor (or tyrosine-protein kinase 
Kit, CD 117 or c-kit); adhesion molecule CD34; and stem cell antigen-1 (phosphatidylinositol-
anchored protein that is a member of the lymphocyte antigen 6 (Ly-6) family or Sca-1) 
[Spangrude et al., 1989; Wood et al., 1997; Mikkola et al., 2003; Lux eta l., 2008; Hashimoto 
et al., 2007; Ding et al., 2012]. 
One of the most promising markers for early HSC precursors identification is 
transcription factor Runx1 [Yokomizo and Dzierzak, 2010; Lam et al., 2010; Liakhovitskaia et 
al., 2014].  
 
1.4.6. Regulation of HSC emergence in dorsal aorta 
Based on recent works done on signalling pathways regulating HSC maturation, today 
it is recognised that HSC specification starts before intraembryonic vasculogenesis takes place 
[Kobayashi at al., 2014; Ciau-Uitz et al., 2010]. HSC specification is initiated in the unspecified 
lateral plate mesoderm cells that migrate towards the embryonic midline to contribute to the 
forming dorsal aorta [Butko et al., 2016; Leung et al., 2013].  Mesoderm “lateralization”, that 
results in a generation of DA precursors, is regulated by Bone Morphogenic Protein (BMP, 
expressed in ventral embryonic part) and Wnt (Wingless-related integration site or WNT 
protein, expressed in dorsal part) signalling [Gilbert, 2003; Hohan, 1996]. Hedgehog (Hh) is 
expressed in the neural floor plate and the notochord and specifies dorsal cell fate [Wilkinson 
et al., 2009]. 
HSC potential is not detectable before paired dorsal aortae are fused (in mouse, chick 
and human) or a single luminised DA is formed. BMP antagonists Chordin and Noggin prevent 
premature dorsal aortae fusion [Resse et al., 2004; Garriock et al., 2010]. Garriock et al., (2010) 




(VEGF) and Sonic hedgehog (Shh) are necessary for DA fusion [Garriock et al., 2010; Nagase 
et al., 2006]. Notably, VEGF and Shh also regulate the Notch signalling cascade that leads to 
vessel arterialization and HSC specification [Leung et al., 2013; Lawson et al., 2002]. 
Several signalling pathways (BMP, Wnt, Shh, RA and Notch) were found to be 
involved in the regulation of angioblasts migration, vessels arterialization and formation of 
hematogenic endothelium in dorsal aorta [Lee at al., 2014; Clements and Traver, 2013]. 
Regulation of HSC specification is orchestrated by molecular queues that are either secreted 
from surrounding dorsal aorta tissues (somites, notochord, neural tube floor plate, or by 
urogenital ridges) or presented to HSC on ventral side of somites or dorsal aorta endothelium. 
[Lawson et al., 2002; Lee at al., 2014; Clements and Traver, 2013]. Below we will briefly 
review regulation of HSC specification by Runx1, Gata2 and BMP, Shh and Notch signalling 
cascades.  
 
1.4.6.1. Runx1 role in HSC maturation 
Runx1 (Runt Related Transcription Factor 1, also known as acute myeloid leukaemia 1 
protein, AML1) is an alpha DNA binding subunit of core binding factor (CBF). CBF binds to 
multiple enhancers and promoters of the genes implicated in haematopoiesis development [Bee 
et al., 2009; Swiers et al., 2010(b); Cai et al., 2011; Chen et al., 2011]. In adults, Runx1 is 
mainly expressed in differentiated myeloid and lymphoid cells [North et al., 1999; Richard et 
al., 2013]. With application of recent high throughout sequencing techniques, Runx1 
expression in adults was also identified in the lung, gastrointestinal tract, kidney and urinary 
bladder, the ovaries and in multiple tumour tissues 
[http://www.proteinatlas.org/ENSG00000159216-RUNX1/tissue]. Runx1 gene disruption in 
adults has been associated with the development of several types of leukaemia [Look, 1997; 




Embryonic Runx1 knock-out is lethal [Okuda et al., 1996; Wang et al., 1996]. Mouse 
embryos die prematurely around embryonic day (E) E11-E12 due to anaemia and widespread 
haemorrhaging. Runx1-/- embryos have normal primitive haematopoiesis, but do not develop 
any dHSC precursors and present signs of an anaemic fetal liver [Samokhvalov et al., 2006; 
2014; Tanaka et al., 2012; Liakhovitskaia et al., 2014]. Runx1 null embryos lack cell 
populations identified to give engraftment in myeloablated recipients (CD41+Vec+CD45+) 
and pre-HSC precursors (CD41+/lowVec+CD45-) [Okuda et al., 1996; Liakhovitskaia et al., 
2014]. Runx1 KO embryos also lack specific intra-aortic clusters (IAC) that are believed to 
contain developing dHSC [Samokhvalov et al., 2006; 2014]. 
Intra-aortic clusters are CD31+Runx1+c-kit+ and were observed to bud into the blood 
vessel during dHSC maturation [Mizuochi et al., 2012; Jaffredo et al., 2000]. In wild type 
embryos, these clusters of cells were detected in the dorsal aorta of E10 mouse embryos and in 
the vitelline vessel of E9 embryos. These clusters were found to be absent in Runx1 knockouts 
[North et al., 1999; Okuda et al., 1996; Samokhvalov et al., 2006; Tanaka et al., 2012].  
Strikingly, for all other tissues except AGM, for which dHSC potential was reported at E11.5 
(placenta, allantois, yolk sac arteries) Runx1+ clusters of cells were identified at E8-10 [Godin 
et al., 1995; Palis et al., 1999; Kumaravelu et al., 2003; Gekas et al., 2005; Ottersbach and 
Dzierzak, 2005; McGrath and Palis, 2005; Yoshimoto et al., 2012]. 
Runx1 gene dosage affects spatial and temporal distribution of dHSC in mouse 
embryos. For instance, dHSC are released earlier and are already detectable in AGM and YS 
of E10.5 Runx1 haploinsufficient embryos [Cai et al., 2002; Lacaud et al., 2003]. According to 
Sun and Downing (2004), loss of one Runx1 allele leads to a 50% reduction in the number of 
LT-HSC. Yet, Runx1+/- HSC acquire accelerated propensity to generate multilineage 




During embryogenesis, Runx1 is widely expressed in all sites of haematopoiesis (yolk 
sac, placenta, allantois, dorsal aorta), in hematopoietic cells, and (in particular) in hemogenic 
endothelium of the dorsal aorta floor and intra-aortic clusters [Lam et al., 2010; Swiers et al., 
2010; Chen et al., 2011; Samokhvalov et al., 2014]. After endothelium-hematopoietic transition 
is initiated (E9-E11), Runx1 expression becomes detectable in the embryonic nervous system, 
sternum and hair follicle, but for the hematopoietic system development, Runx1 becomes 
dispensable [Zagami and Stifani, 2010; Kimuraet al., 2010; Liakhovitskaia et al., 2010; 2014; 
Osorio et al., 2011 Cai et al., 2011; Kobayashi et al., 2012]. 
Runx1 gene has two alternative promoters (distal P1 and proximal P2 promoters). In 
mice, Runx1 pre-mRNA can be spliced in several different ways resulting in at least three 
different Runx1 isoforms: Runx1a, Runx1b and Runx1c [Pozner et al., 2007; Bee et al., 2009; 
Sroczynska et al., 2009]. The Runx1c isoform is expressed from distal promoter P1and is the 
longest one. The other 2 isoforms (Runx1a and Runx1b) are expressed from the proximal P2 
promoter and are shorter versions of the Runx1 protein. All three isoforms contain DNA 
binding Runt homology domain (exons 3-5). Isoforms b and c contain transcription regulatory 
domain while isoform c misses it. Runx1b is the most abundant isoform found in sites of 
embryonic haematopoiesis at midgestation. Runx1c is the rarest isoform [Challen and Goodell, 
2010; Bee et al., 2009]. 
In Runx1 gene 531-bp enhancer is located at position +23.5 in the first Runx1 intron - 
in between promoters P1 and P2 [Nottingham et la., 2007; Bee at al., 2009]. In the central part 
of the +23 enhancer, there are at least four conservative DNA sequences – binding sites for 
families of transcription factors previously shown to be implicated in dHSC maturation: Myb, 
Gata, Ets Runx. SCL also binds to this region, most probably via mediation of the Gata2 protein 




region is critical for Runx1 function. Mutations in Runx or Gata binding motifs abolishes all 
Runx1 in vitro activity [Nottingham et la., 2007; Bee at al., 2009].  
Histochemical staining of embryos expressing the Runx1 gene mutated in one of the 
sites binding transcription factors (Runx1, Gata2 or Ets1) showed that spatial distribution and 
density of Runx1+ expression is different from that in wild type (WT) embryo. Runx1+ cells 
were found in WT embryos in YS’s blood islands and nascent DA; absence of Runx1 binding 
motif leads to expansion of Runx1 expression in YS up to embryo proper. Absence of Gata2 
motif almost exterminated Runx1 expression in YS, indicating that Gata2 is upstream of Runx1 
and positively regulates Runx1 expression. Absence of Ets1 narrowed down Runx1 expression 
in YS. Interestingly, in all mutants (disrupted Runx1, Gata2 or Ets1 binding sites in +23 
enhancer region), intra-aortic clusters were still formed, but they lacked Runx1 expression 
[Nottingham et la., 2007; Bee at al., 2009; Pozner et al., 2007; Sroczynska et al., 2009]. Hence, 
the function of master regulator of HSC maturation, Runx1, is critically dependent on 
expression of Gata2 and Ets. Runx1 expression by itself regulates spatial distribution of 
Runx1+ cells in the early mouse embryo. 
Multiple works were devoted to the identification of differences in Runx1 isoforms’ 
expression and their functional effect on dHSC development, yet, all isoforms were found to 
be expressed simultaneously in the same hematopoietic sites with no specific functional effect 
on maturing dHSC. All adult hematopoietic cells were found to be descendants of cells 
expressed +23 Runx1 region [Sroczynska et al., 2009; Bee et al., 2009; 2010; Challen et al., 
2010]. 
 
1.4.6.2. Gata2 role in dHSC maturation 
Gata2 is a member of zinc-finger transcription factors that are named for the consensus 




multiple tissues. Gata1, 2 and 3 are mainly expressed in hematopoietic cells. Gata1 and 3 are 
lineage specific effectors responsible for hematopoietic cells differentiation and expansion 
[Shivdasani et al., 1997; Pandolfi et al., 1995]. In contrast to Gata1 and 3, Gata2 is 
predominantly expressed in hematopoietic stem cells in adult and in embryo [Tsai and Orkin, 
1994; Tsai et al., 1997; Rodrigues et al., 1995]. Gata2 knock out (KO) is embryonic lethal, 
embryos die around E10-11. Gata2 KO exhibit severe anaemia with loss of all hematopoietic 
lineages. Anaemia becomes apparent early in embryonic development, at E9.5. Primitive 
haematopoiesis (erythroid cells maturation) is not affected in Gata2 KO, but the number of 
cells in the yolk sac is sufficiently lower than in wild type embryos [Tsai et al., 1997]. This 
implies Gata2’s central role in embryonic haematopoietic cells proliferation and in HSC 
maintenance and expansion in particular. 
Gata2 gene dosage has biological effect on HSC numbers and localization. For instance, 
in heterozygous Gata2+/- mice, number of phenotypically defined HSC in DA decreases while 
HSC expand and are maintained in the E11-12 yolk sac (YS). Therefore, YS in Gata2 
haploinsufficient animals plays a role of a compensatory HSC generator [Ling et al., 2004]. 
According to Yoder et al., the YS has the ability to generate HSC autonomously, however, in a 
normal situation, major embryonic arteries are the main source of HSC [Yoder et al., 1997; de 
Bruijn et al., 2004]. 
Gao et al., (2013) showed that Gata2 +9.5 cys regulatory element (which contains 
enhancer, spacer and GATA motif) controls Runx1 expression in hemogenic endothelium and 
it is specifically required for emergence of c-kit+ IAC and HSC generation. In YS, + 9.5 cys 
regulatory element affects vascular integrity, but not haematopoiesis. [Gao et al., 2013]. Gata2 
deletion in endothelium (VE-Cad+ cells) leads to haemorrhages and loss of functional HSC [de 
Pater et a., 2013]. Gata2 is activated by Notch1 receptor and its transcriptional factor RBKjk. 




endothelium. In Gata2b KO, Runx1 expression is reduced in the dorsal aorta [Bee et al., 2009; 
Nottingham et al., 2007; Butko et al., 2016]. Therefore, Gata2 is an indispensable regulator of 
Runx1 expression and is critically required for vasculogenesis and HSC specification. 
 
 
1.4.6.3. Role of BMP and Hh signalling in dHSC emergence in the dorsal aorta 
Bone morphogenic protein 4 (BMP4) is a member of transforming growth factor beta 
(TGF-β) superfamily of proteins.  Secreted TGF-β ligands form homo- or heterodimers with 
similar TGF-β proteins (e.g. BMP7) and bind to TGFR-β receptors. Activation of TGFR-β 
leads to activation of SMAD family transcription factors [Kawabata et al., 1998; Nohe et al., 
2004; Dunn et al., 1997]. 
Hedgehog (Hh) signalling plays a critical role in embryo patterning and regulates 
morphogenesis of the number of embryonic tissues and organs. Hh acts as a ventralizing 
morphogen during neural tube patterning and limb bid. In mammals, there are three ligands Hh 
homologs: Sonic hedgehog (Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh). Hh 
signalling is activated by Hh ligands binding to canonical Hh receptor Patched 1 (PTCH1) 
leading to de-repression of membrane-associated protein Smothered (SMO). SMO gets 
phosphorylated on its intracellular tails and transmit the transduction signal downstream via 
several intracellular Hh pathway effectors (GLI, Kif7, SUFU). Hh targets genes regulating 
expression of the components of Hh signalling pathway and the genes responsible for cell 
proliferation and definition [Pepinsky et al., 2000; Rohatgi et al., 2007; Beachy et al., 2010]. 
During early embryo development BMP4 (which is expressed in the neural tube roof 
plate) and Shh (expressed in the notochord and neural tube floor plate) establish the neural tube 
dorsal-ventral axis [Gilbert, 2003; Hohan, 1996]. Clearly demonstrated in chicken embryos, 




forming DA [Yoshino et al., 2016]. Before paired DA appear, BMP4 is expressed in an entire 
lateral plate mesoderm. When DA precursors start to form primordial DA, BMP4 expression 
becomes restricted to splanchnopleuric mesoderm. At the same time, Shh expression is 
upregulated in the endoderm. When primordial dorsal aorta lumen is first visible, BMP4+ 
mesoderm underlines that part of the DA endothelium where Runx1+ cells will appear. 
Similarly, Shh+ endoderm is situated strictly underneath the position of future Runx1+ 
endothelium [Yoshino et al., 2016]. 
Marshall et al., showed that in human embryos that developed to the stage of intra-
aortic cluster appearances, Bmp4 expression is polarised. BMP4 is expressed in ventral 
mesoderm and not expressed above the dorsal aorta and under the neural tube [Marchall et al., 
2000]. Similarly, Durand et al. (2007) show that BMP4 is expressed in a polarized fashion 
around mouse dorsal aorta at E11 [Durand et al., 2007]. Therefore, Bmp4 and Shh expressing 
cells are strategically localized within tissues predispositioned to give rise to hemogenic 
endothelium and HSC, implying their essential function in HSC specification. 
 In zebrafish embryos, Wilkinson et al. (2009) demonstrated that BMP signalling is 
required for the initiation and maintenance of Runx1 expression in the ventral wall of the DA. 
With use of zebrafish temperature sensitive mutants expressing truncated Bmp receptor 
(inhibits BMP signalling), Wilkinson et al. demonstrated that BMP signalling initiates and 
maintains Runx1 expression in hemogenic endothelium. When these zebrafish mutants were 
heat shocked before hemogenic endothelium appearance, Runx1 expression was not 
upregulated in the DA. After Runx1 has already been expressed in the DA, inhibition of BMP 
signalling leads to reduction Runx1 expression.  Notably, Bmp4 morphants lost Runx1 
expression completely within the DA while neural Runx1 expression was not affected, 




Gering and Patient (2005) demonstrated that Hedgehog signalling (Hh) is required for 
Flk1+angioblasts migration and for aortic specification in zebrafish embryos. Ihh KO (Ihh is 
expressed in visceral endoderm) causes defective YS vasculature. One of Ihh mesodermal 
targets is Foxf1. Bmp4 was shown to be downstream of Foxf1. Therefore, Hh signalling might 
act via Foxf1 mediator on Bmp4. If Bmp4 is added to Foxf1-/- explants, normal vasculogenesis 
is observed (Byrd et al., 2002). In early somitic embryos Hh signalling induces the expression 
of arterial marker ephrinb2a and hematopoietic markers Vegf, Notch and Runx1 [Gering and 
Patient, 2005].  
Mouse embryonic stem cells treatment with exogeneous BMP4 leads to mesoderm 
induction and appearance of cells with myeloid markers [Johansson and Wiles, 1995]. AGM 
explants culture with exogeneous BMP4 results in HSC expansion revealed via increase in 
numbers of myeloablated recipients repopulated with donor AGM cells. AGM explants 
treatment with Bmp4 decreases pool of CD45-CD34+Flk1+ cells, but expand numbers of 
CD45+CD34lowc-kit+ cells. Hence, Bmp4 might accelerate endothelium to hematopoietic 
transition which is reflected in decrease of cells with endothelial phenotype (Flk1+) and 
expansion of population of cells with preHSC phenotype (CD45+CD34lowc-kit+). BMP4 action 
is specific, as treatment with gremlin (Bmp4 antagonist) abolishes HSC expansion in AGM 
explants [Johansson and Wiles, 1995]. 
In mouse, notochord, neural tube and gut tissues express Shh. Co-culture of AGM 
explants with Shh expressing tissues or addition of exogeneous Shh or Indian hedgehog (Ihh) 
expands pool of HSC (evaluated by CFU-S or by transplantations). This HSC expansion can 
be abolished with addition of Hedgehof signalling pathway inhibitors [Dyer et al., 2001; 
Peeters et al., 2009]. Using reporter mouse for Gli1 (one of Hh signalling target) Gli1 
expression was found to be around E9 mouse aorta, indicating activation of Hh signalling 




AGM explants with addition of SHH or BMP4 (in serum free medium) led to expansion 
of HSC detected by high level of donor blood chimerism in myeloablated recipients (2/6). Yet, 
treatment of AGM explants with both BMP4 and SHH revealed synergistic action of these 
proteins (increase in number of repopulated mice to 5/6) [Crisan et al., 2016]. 
Crisan et al., (2016) found that AGM contains two populations of cells: BMP- activated 
and non-BMP-activated HSC. Using the mouse model with GFP reporter for BMP signalling, 
authors showed that both E11 GFP+ and GFP- populations of cells are true HSC, which support 
a high level of engraftment in primary and secondary transplantations.  When AGM explants 
were treated with cyclopamine (Hh pathway inhibitor) it had no effect on GFP+ (HSC with 
active BMP signalling) but eliminated HSC in the GFP- fraction of cells. Treatment of GFP- 
cells with exogeneous VEGF allowed rescue of HSC maturation and the obtainment of 
engraftable cells. The observed level of engraftment was lower than in transplantations carried 
out within cells not treated with cyclopamine. Hence, Crisan et al., proposed HSC 
heterogeneity is already initiated at this stage of development. E11 AGM contains at least 2 
different HSC populations: Hh signalling dependent and Hh independent, but with active BMP 
signalling [Crisan et al., 2016]. 
There are other mechanisms that might induce BMP signalling in the dorsal aorta. For 
example, blood circulation causes shear stress on dorsal aorta endothelium cells. Kim et al. 
(2015) demonstrated that VE-Cad+ cells in response to shear stress secrete BMP ligands, 
inducing HSC maturation in autocrine-paracrine mode. One of the BMP targets is shear-stress 
response pathway mediated by protein kinase A (PKA)-cAMP response element binding 
protein (PKA-CREB) [Kim et al., 2015].  
BMP and Shh signalling is responsible for HSC maturation during a narrow window of 
time. At the time when the DA is forming or is still paired, anti-BMP signalling molecules 




Shortly before HSC emergence, genes supporting BMP signalling (Bmpr2, Smad5, Tolloid 
(cleaves chordin) start to be expressed and the dorsal aorta is able to fuse [Huber et al., 1999; 
Wilkinson et al., 2009].  Fusion of the DA requires presence of Shh [Garriock et al., 2010]. 




1.4.6.4. Notch signalling in HSC specification 
Series of works done in zebrafish and Xenopus embryos allowed light to be shed on the 
complex process of HSC specification. Notch signalling was identified to take place in multiple 
steps of HSC specification: controlling pre-HSC migration, dorsal aorta assembly, emergence 
of hemogenic endothelium and HSC maturation. Different Notch receptors and ligands 
dynamically regulate HSC specification. The united picture of the whole mechanism of HSC 
maturation by Notch signalling is yet to be constructed, however some steps are already 
described.  
 
Notch signalling. Notch pathway ligands and receptors 
Higley evolutionary conserved Notch signalling pathway serves for cell-to-cell 
communication during cell fate determination. During development, Notch was found to be 
implicated in maintenance and differentiation of multiple types of stem cells (epithelia 
hematopoietic system specification, neurogenesis and myogenesis, and other) [Liu et al., 2010]. 
In particular, Notch is known for the regulation of cell-fate decision of neighbouring cells with 
the same differentiation potential (also known as lateral inhibition or lateral specification) 




“default program” and cells expressing predominantly Notch receptors, will differentiate by 
“an alternative route” [Chen and Streit, 2013; Bray, 1998] 
Notch receptors and their ligands (in case of canonical Notch signalling) are single pass 
transmembrane proteins with extracellular domains composed of a different number of tandem 
epidermal growth factor (EGF)-like repeats. In vertebrates, there are four Notch receptors 
(Notch1-Notch4) and five Notch ligands Delta-like1, Delta-like3, Delta-like4 and Jagged1, 
Jagged 2) [Kopan and Ilagan, 2009; Hori et al., 2013]. Before the Notch receptor is presented 
on the surface of a cell, it undergoes enzymatic cleavage inside cell's Golgi apparatus (so called 
S1 furine-dependent cleavage). On the surface of the cell upon binding to one of the Notch 
ligands (Delta-like: DLL1, DLL3, DLL4 or the Jagged: JAG1, JAG2), second (S2) and third 
(S3) cleavage of the Notch receptor takes place [Hori et al., 2013]. S1 is mediated by A 
disintegrin and metalloproteinase domain (ADAM) and S3 takes place inside the membrane of 
a Notch receptor bearing cell by multimeric gamma-secretase. After these series of cleavages, 
a Notch receptor is released from the membrane, undergoes endocytosis and triggers activation 
of Notch target genes [Hori et al., 2013]. Activated intracellular Notch receptor domain localize 
to the nucleus where it binds to stem cell leukaemia (SCL, also known as T-Cell Acute 
Lymphocytic Leukaemia, TAL1) transcription factor. CSL is implicated in haematopoietic 
malignancies and hemopoietic differentiation.  SCL binds to specific DNA sequences on 
promoters of Notch target genes (Hairy and Enhancer of Split, HES-1) [Tun et al., 1994]; and 
genes implicated in haematopoiesis: Hes1, Hes5, Hey2 and Gata2 [Iso et al., 2003; Guiu et al., 
2012; Davis and Turner, 2002]. 
Notch signalling is regulated on multiple levels. Notch receptor extracellular domain is 
glycosylated in multiple ways, which affects its recognition [Xu et al., 2007]. Notch receptor 
endocytosis could result not only in Notch signalling activation, but also in receptor recycling 




depends on the type of  ligand that binds to its receptor and also on ligand endocytosis-recycling 
by signal-sending cells [Shergill et al., 2012]. The Notch receptor can be also activated by 
soluble ligands in non-canonical way or in the absence of a ligand. In modern day, the latter 
process is not entirely understood [Kopan and Ilagan, 2009]. 
Notch role in adult haematopoiesis 
In human CD34+, hematopoietic precursors expression of Notch1 and Notch2 was 
identified - on bone marrow derived myeloid cells, but not on erythroid cells (Ter119+ cells). 
Notch ligand expression was also identified on the surface of bone marrow stromal cells. When 
Sca-1+c-kit+lin− bone marrow cells were transduced with viral construct to overexpress 
Notch1, HSC become immortalized and were able to generate lymphoid and myeloid progeny 
when treated with IL-7 or GM-CSF, correspondingly [Varnum-Finney et al., 2000; Stier et al., 
2002]. Stier et al., noted that transplantation of Notch1 transduced murine bone marrow 
Sca1+lin- cells into Rag-/- recipients shifted balance in donor-derived cells progeny towards 
more primitive phenotype. Yet, cell differentiation was not blocked and a leukemic population 
did not appear. The authors proposed that Notch1 triggers HSC differentiation towards 
lymphoid lineage in dispense of myeloid one (the default choice) [Stier et al., 2002]. Radtke et 
al., showed that transplantation of lethally irradiated wild type recipients with cells derived 
from Notch deficient animals reconstitute all hematopoietic lineages except T-cell one. [Radtke 
et al., 1999]. Therefore, in adults Notch specifically promotes T-cell differentiation and the 
absence of Notch signalling leads to early B-cell commitment [Radtke et al., 1999; Pui et al., 
1999]. 
Activation of the Notch pathway with a Delta-1 ligand by its overexpression in feeder 
layer or Delta-1 absorption on a plastic surface, induces dramatic expansion of Sca1+c-kit+lin- 




cells in culture revealed a multilineage engraftment, but loss of self-renewal potential, 
suggesting that in adults Notch is responsible for differentiation and expansion of HSC, but not 
for maintaining the stem cell phenotype [Varnum-Finney et al., 2000]. 
 
Notch signalling role in HSC specification 
Early wave of primitive haematopoiesis is independent on Notch signalling, as Notch 
deficient embryos maintain normal haematopoiesis in the yolk sac [Lawson et al., 2001; 
Robert-Moreno et al., 2008]. Further on, during the definitive wave of embryonic 
haematopoiesis, Notch1 signalling is indispensable for all processes related to HSC 
specification [Hadland et al., 2004].  Utilizing mouse embryo chimeras composed of wild type 
and Noth1-/- cells, Hadland et al., showed that Notch1-/- do not to contribute to adult 
hematopoietic lineage [Hadland et al., 2004]. 
Master regulator of HSC maturation, Runx1, is downstream under Notch1 signalling 
[Burns et al., 2005; Nakagawa et al., 2006; Richard et al., 2013]. At the time of HSC 
specification, disruption of Notch1 signalling abolishes Runx1 expression in para-aortic 
splanchnopleura (P-Sp). Runx1 enforced expression rescues Notch1 deficient cells isolated 
from E9 mouse embryo P-Sp. Rescued cells in the OP9 co-culture system are able to 
differentiate towards hematopoietic lineage (CD45+ cells) [Nakagawa et al., 2006]. There is 
an indication that Notch1 does not directly regulate Runx1 expression as Runx1 +23 enhancer 
region (which marks all definitive hematopoietic and clonogenic progenitors of the dorsal 
aorta, fetal liver, umbilical artery and IAC) does not have sequences binding Notch1.  Activity 
of Runx1 +23 enhancer depends on intact Gata2, Ets and SCL binding sequences. Hence, these 
transcription factors are upstream of the signalling cascade that induce HSC maturation 




Notch2 does not exhibit obvious hematopoietic defects while Notch3 is required for 
sclerotome development and acts on HSC specification indirectly [Kumano et al., 2003; Kim 
et al., 2014]. Notch4 is dispensable for embryonic haematopoiesis but has overlaps with Notch1 
roles [Krebs et al., 2000]. For instance, Notch4 is responsible for initiation of Gata2 expression 
while Notch1 is required for Gata2 expression maintenance [Leung et al., 2013].  
Similar to the adult bone marrow, E12-E17 mouse fetal liver cells express Notch 
receptors and ligands Jagged1 and Delta1 [Walker et al., 2001]. While the role of Notch 
signalling is clear for HSC specification, at the time when pre-HSC I and II appear in the dorsal 
aorta, dependence on Notch signalling decreases [Tang et al., 2013; Lizama et al., 2015; 
Souilhol et al., 2016]. Today it is not clear whether Notch signalling regulates maintenance and 
expansion of HSC in the fetal liver and later in embryonic bone marrow [Souilhol et al., 2016(a) 
and 2016(b)]. 
Regulation of HSC specification by the Notch pathway is proved to be complex, and 
the entire mechanism is yet to be elucidated [Gering M, Patient, 2010; Hori et al., 2013]. Notch 
signalling can take place on multiple levels: it can be triggered by Sonic Hedgehog (Shh), Etv6 
or Wnt16 and be mediated via diffusible VEGF, FGF or directly by cell to cell contacts, by 
Notch ligands or other factors [Lawson et al., 2002; Ohishi et al., 2003; Kobayashi et al., 2004; 
Kopan and Ilagan, 2009]. Initially, it was difficult to unlink the Notch signalling role in 
angioblasts migration, arterialization and HSC emergence [Robert-Moreno et al., 2008]. For 
instance, Notch ligand Jagged1 deficiency results in vascular defects, but still allows arterial 
markers (EphrinB2, CD44 and SMA) to be expressed. In E10.5-11 mouse Jagged1 KO, number 
of Gata2+Runx1+ cells are decreased and hemogenic endothelium fails to produce HSC 
[Robert-Moreno et al; 2008]. Delta4 deficiency leads to arterial defects and early lethality 
[Duarte et al., 2004; Krebs et.al., 2004]. Therefore, Notch signalling is required for both arterial 




Several mechanisms of HSC specification by Notch signalling regulation have been 
described.  
In zebrafish embryos, Sonic Hedgehog (Shh), which is expressed in floor plate of neural 
tube and notochord, induces production of vascular endothelial growth factor (VEGF) in 
somitic tissues [Lawson et al., 2002; Ciau-Uitz et al., 2010]. VEGF acts on its receptor 
VEGFR2 (also known as Flk1 or Kdr – kinase insert domain receptor, a type III receptor 
tyrosine kinase), expressed on migrating towards embryonic midline angioblasts and later on 
the dorsal aorta endothelium cells [Cleaver and Krieg, 1998; Hogan and Bautch, 2004].  Notch 
signalling activated by VEGFR2 regulates cell migration and their arterial identity. With 
Notch1 signalling activation in the DA endothelium, arterial markers EphrinB2 and/or 
hematopoietic transcription factors Gata2 and Runx1 start to be expressed [Lengerke et al., 
2008, Lawson et al., 2002].  
In Xenopus leavis, somitic expression of VEGFA is regulated by transcription factor 
Etv6 (also known as TEL1 or ETS Variant 6) [Ciau-Uitz et al., 2010]. In frogs (before DA 
assembly) vascular endothelium growth factor A (VEGFA) directs migration of Flk1+ DA 
precursors towards embryonic midline [Cleaver and Kreig, 1998]. If Flk1 or Notch1 are 
mutated, HSC fail to specify the DA endothelium. Injection of VEFGA morpholino that blocks 
all VEGFA isoforms led to abrogation of the DA precursors migration and absence of DA. 
Reduction of morpholino concentration allows the DA to assemble, but did not allow the 
hemogenic endothelium to form (detected as absence of Runx1, Gata2 and Notch1 expression). 
Expression of arterial markers (Dll4, Cx37) was present, but weak in comparison to WT [Ciau-
Uitz et al., 2010; Leung et al., 2013]. 
VEGFA is expressed in somites and notochord and its effect is dosage dependent: 




1996]. Three different VEGFA isoforms are expressed: short diffusible, medium and long 
membrane-bound forms. The diffusible short isoform is the most abundant in Xenopus somitic 
tissues. Cleaver and Krieg (1998) proposed that short diffusible isoform of VEGFA expressed 
in notochord regulates migration and assembly of the DA [Cleaver and Kreig, 1998].  Leung 
at al., (2013) has suggested that the short VEGFA isoform also controls lumenization and 
arterialization of DA cord [Leung et al., 2013]. Low concentration of VEGFA long and medium 
isoforms disrupt arterial specification, but not endothelial. Chen et al., (2010) proposed that 
soluble and membrane bound VEGFA isoforms activate different signalling cascades with 
different outcomes: vascularization, arterialization and HSC specification [Chen et al., 2010]. 
VEGFA long and medium isoforms specific KO phenocopies Eto2 knockout. Eto2 
(also known as CBFA2/RUNX1 Translocation Partner 3) is a transcriptional co-repressor 
participating in regulation of hematopoietic gene expression such as GATA-1, SCL/TAL1 and 
LMO2 [Fujiwara et al., 2013]. In Xenopus, Eto2 morphants have normal primitive erythroid 
lineage development. In Eto2 morphants, the aorta is formed and luminized; arterial markers 
(EphrinB2, Delta like 4, Notch4, Cx37) and vascular markers (VE-Cad, CD31, Tie2, Fli1) 
expression is normal. Yet, Runx1, SpiB (Pu.1 homolog), Gli1, Scl and Notch1 expression is 
absent in endothelial lining of the DA, indicating failure of hemogenic endothelium maturation. 
Interestingly, that expression of the Fli1 marker is downregulated by Notch1 by stage 39 
(frogs), yet in ETO2 morphants Fli1 expression persists [Leung et al., 2013]. In Eto2 
morphants, level of long and medium VEGFA isoforms were decreased in comparison to 
untreated embryos. In contrast, short VEFGA isoform concentration was largely not affected. 
Restoration of levels of long isoform could rescue hematopoietic marker expression (Runx1 
and Gfi1). Therefore, this Notch signalling pathway responsible for HSC specification can be 
described as: ETO2->VEGFRA->Notch1. This pathway is Hedgehog (HH) independent as 




(specific HH inhibitor) treatment also does not affect Eto2 expression (but affect Ptch1) 
indicating that this HSC specification pathway is not Hh dependent. 
Leung et al., (2013) proposed that expressed in somites, medium and/or long VEGFA 
isoforms induce Notch1 expression in the DA. In contrast, high levels of short VEGFA isoform 
in somites and dorsal lateral plate trigger arterial specification and Notch4 activation. Notch4 
upregulates Gata2 expression in the DA, while Notch1 is required for Gata2 maintenance 
[Leung et al., 2013].  
Another Notch activating mechanism was described by Kobayashi at al., (2014). 
Ventral sides of somites transmit signal to lateral plate mesoderm (LPM) cells that migrate to 
form the dorsa aorta endothelium. Ventral sides of somites express junctional adhesion 
molecules Jam2a and Jam1a - on LPM cells. Disruption of any of the Jam-s leads to failure to 
specify HSC while arterial specification still takes place. Enforced Notch ligands expression 
rescue the generation of hemogenic endothelium, but with different efficiency while abrogation 
of Jam1a expression abolishes expression of Notch1 in the dorsal aorta endothelium 
[Kobayashi at al., 2014].  
Ectopic activation of Notch1 in veins induces expression of Runx1 and c-myb and 
causes ectopic haematopoiesis [Burns et al., 2005]. This does not transform veins in arteries 
and it is not known whether the ectopic haematopoiesis produces HSC. Hence, it is not possible 
to conclude that HSC specification takes place only in arteries.  
Fibroblast growth factor (FGF) was found to be another molecule able to activate Notch 
signalling during HSC specification.  Somitic tissues, but not LPM cells express FGF receptors 
(FGFR1 and FGFR4). FGF acts in concert with Wnt and Notch signalling. Wnt16 (non-
canonical Wnt signalling) was shown to regulate expression of Notch ligands (DeltaC and 




Wnt16 acts via FGFR4 to regulate levels of Notch ligand DeltaC, but not DeltaD within somites 
[Lee at al., 2014]. 
Lee at al., (2014) used transgenic zebrafish embryos in which FGF signalling can be 
blocked by keeping the embryo at an elevated temperature. The authors utilized time-specific 
FGF pathway inhibition to target HSC specification only (14-17 hours post fertilization, hpf).  
When the FGF pathway was knocked out during early stages of development, this reduced 
some of the Notch pathway ligands expression: DeltaC, but not DeltaD and blocked HSC 
specification. In this model, ectopic activation of Notch signalling leads to rescue of HSC 
specification. Overexpression of DeltaC also rescued HSC specification. In this FGF KO, the 
hemogenic endothelium was not affected. At later stages of development, FGF inhibits HSC 
emergence, for instance by contracting BMP signals [Pouget et al., 2015]. Analysis showed 
that this FGF signalling does not interact with signalling pathways described above (Hh 
independent Eto2 or Etv6 -> VEGFA -> Notch1 and Shh -> VEFG -> VEGFR2 -> Notch), 
which are required for DA assembly, arterialization and HSC specification [Lee at al., 2014]. 
FGFR4 KO also leads to loss of HSC and does not affect vascular or arterial gene expression. 
Instead, FGFR4 KO leads to loss of sclerotome tissue [Lee at al., 2014]. Hence, Notch 
signalling within somites indirectly regulates HSC specification and does not affect 
vasculogenesis or arterialization. 
Sclerotome cells might contact migrating LPM cells before they contribute to the 
primordial dorsal aorta cord. Alternatively, smooth vascular muscle cells, precursors of which 
reside in somites, might migrate to envelop the DA and possibly induce final steps of HSC 
specification [Pouget et al., 2008; Kobayashi et al., 2014]. Nguyen et al., (2014) demonstrated 
the contribution of endotome cells (another somitic part) to endothelium of the DA. In chicken 
embryos, Pouget et al. (2006) showed that after intra-aortic hematopoietic clusters disappear 




[Wasteson et al., 2008; Pouget et al., 2006; Nguyen et al., 2014]. Hence, somites directly or 
indirectly regulate hematogenic endothelium maturation and HSC specification: by secreting 
factors regulating Notch signalling within lateral plate mesoderm or via direct contact with 
somatic cells or their derivatives.  Different branches of the Notch pathways network are 
dynamically involved in HSC specification, possibly enabling different steps of HSC 
specification maturation. Yet, the complete mechanism of HSC regulation by Notch signalling 
remains to be clarified. 
 
1.5. Maturation and expansion of HSC and their precursors ex vivo 
Today there is a shortage of HSC available for transplantations in clinics [Sauvageau et 
al., 2004, 2010; Batta et al., 2016]. One of the solutions for this problem is to expand the pool 
of HSC in donated chord blood or to derive functional HSC from human embryonic or 
pluripotent stem cells or somatic cells [Wang et al., 2005; Bhatia, 2007; Oubari et al., 2015]. 
Both methods include a HSC culture step. Culture conditions attempt to recapitulate the 
microenvironment in which HSC reside in vivo [Zhang and Lodish, 2008]. The aim of HSC 
culture is to direct HSC to divide with preservation of their self-renewal potential; mature into 
functional HSC from an HSC precursor or to differentiate. To date, the recreation of HSC 
microenvironment is carried out with utilization of feeder layers (mesenchymal stem cells); co-
culture with stroma cell lines; culture of HSC in various 3D scaffolds and by addition of 
cytokine cocktails to the culture medium [Oubari et al., 2015; Celebi et al., 2011; Heike and 
Nakahata, 2002]. In the HSC niche (AGM, fetal liver, adult bone marrow) cytokines are 
secreted by stromal cells, modulating HSC maintenance in this way [Nishikawa et al., 2001]. 
Cytokines were shown to induce upregulation of critical for HSC self-renewal and maturation 
genes: Gata2, Runx1, Tal-1, Gata1, Pu.1, Bmi-1, Lmo2 [ Noda et al., 2008; Stanley, 2009 Zhu 




An additional approach often utilized to generate hematopoietic cells is human 
embryonic stem cells (hESC) differentiation or somatic cells reprogramming into HSC by 
recreation of HSC niche microenvironment and enforced overexpression of transcription 
factors like Runx1, Gata2, Scl, Hoxb4, Pu.1 [Bhatia, 2007; Wang et al., 2005; Batta et al., 
2016]. This approach shows promising results. Some works reported short term cell 
engraftment and generation of cells of several hematopoietic lineages [Pick et al., 2007; Suzuki 
et al., 2013; Vereide et al., 2014]. In particular, Doulatov et al. demonstrated that enforced 
expression of Hoxa9, Erg, Rora, Sox4, and Myb in differentiated hESC generated short term 
engrafting lymphoid progenitors [Doulatov et al., 2013]. Overexpressing of Runx1a isoform in 
hESC allowed to derive short term engrafting multilineage potential HSC cells. [Ran et al., 
2013]. Gori et al., reconstructed the endothelial niche of maturing dHSC by culturing 
differentiating hESC in presence of endothelial cells expressing Notch ligands Jagged-1 and 
Delta-like ligand-4. This allowed the generation of HSC with high levels of long term 
engraftment [Gori et al., 2015]. Yet, methods using forced gene expression require further 
development to attenuate potential teratogenic outcome. Detailed discussion of the methods of 
HSC derivation from embryonic stem cells or induced pluripotent cells is reviewed in Batta et 
al., 2016. Below we will discuss the method of HSC expansion that recreates the HSC 
microenvironment with addition of exogenous cytokines and/or in the presence of cells that 
secrete these cytokines. 
 
The method of HSC (or their precursors) culture in presence of cocktails of growth 
factors is widely used in experimental procedures that are aimed to recapitulate mechanisms of 
HSC development [Heike and Nakahata, 2002]. Phenotypical HSC (in humans - CD34+ cells) 
or their precursors (in mice - VE-Cad+CD41+/lowc-kit+CD34-/+ cells) might be cultured on air-




cell or in presence of stromal cell lines (for example with OP9) [Celebi et al., 2011; Oubari et 
al., 2015] One of these methods, co-aggregation of pro-HSC cells with OP9 stromal cell line 
in presence of selected cytokines was utilized in this work (technical details are described in 
Materials and Methods). For instance, Rybtsov et al. showed that cells derived from caudal 
parts of E9 mouse embryos contain the very early CD34- HSC precursors (pro-HSC) that are 
able to mature into functional dHSC in the presence of SCF and OP9 stromal cell lines when 
cultured at air-liquid interface for prolonged period of time [Rybtsov et a., 2014]. For clinical 
applications, serum-free culture media has to be used. Serum is a known source of undefined 
growth factors, and the utilization of a serum-free medium might lead to reduction of HSC 
expansion method success [Solar et al., 1998; Alexander et al., 1996; Sauvageau et al., 2004]. 
There is no ideal cytokine formulation developed yet, but some working components have been 
identified. The most frequently used set of cytokines for HSC expansion or maturation is: SCF, 
Il3, Flt3-ligand, IL-6; IL-11, TPO and VEGF. More rarely used components are: Insulin-like 
growth factor 2 (IGF-2), fibroblast-growth factor 1 (FGF-1) and angiopoietin like 2 and 3 
[Heike and Nakahata, 2002; Zhang and Lodish, 2008; Batta et al., 2016]. 
Examples of combination of growth factors allowing significant expansion of HSC pool 
of cells are: SCF/TPO/Flt3-L and SCF/TPO/Flt3-L/IL-formulations. At these conditions the 
fraction of human CD34+ cells increased up to 1200-fold [Arrighi et al., 1999]. SCF/TPO/Flt3-
L/IL-3 and SCF/Flt3-L/IL-11 increased CD34+ fraction of cells in 6300-fold [Bryder and 
Jacobsen, 2000]. Culture with addition of SCF/TPO/Flt3-L and SCF/TPO/Flt3-L/IL-3 or 
SCF/Flt3-L/IL-11 allowed the preservation of long-term engraftment ability [Ramsfjell et al., 
1999]. In contrast, addition of SCF/TPO/Flt3-L/VEGF and SCF/Flt3-L/IL-3/IL-6 induces HSC 
differentiation into committed progenitors, but not HSC [Fu et al., 2005; McKinney-Freeman 
et al., 2008]. Regrettably, ex vivo methods of HSC expansion lead to decrease in self-renewal 




application of ex vivo CD34+ cells expansion currently might not be economically reasonable 
[Müller et al., 2016; Sauvageau and Humphries, 2010] 
Below we will discuss in detail role of three cytokines used in this work and the ones 




1.5.1. Role of stem cell Factor in ex vivo HSC expansion 
Stem cell factor (or c-kit ligand) is a ligand for the receptor-type protein-tyrosine kinase 
KIT (c-kit) [Anderson et al., 1990; Matsui et al., 1990; Broudy, 1997]. SCF is a pleiotropic 
factor found to be important for neural and hematopoietic cell development, hematopoietic cell 
survival, proliferation and migration [Keshet et al., 1991; Lev et al., 1994; Matsui et al., 1990]. 
SCF exists in 2 splice forms, one of which is secreted protein and another one is a membrane-
bound one [Anderson et al., 1990]. Both forms are identical in sequence except for a short (20 
AA) site for metalloproteinase cleavage on soluble form of SCF [Anderson et al., 1991]. Both 
splice forms of SCF are initially generated as membrane-bound proteins, the soluble form gets 
cleaved and acts as a long-range signalling molecule. Recently, it was reported that “soluble” 
SCF can be also generated by premature splicing termination [Saravanaperumal et al., 2012]. 
One of the roles of SCF is to guide HCS migration towards their niche. Hematopoietic 
cells migrate towards a higher concentration gradient of SCF emanating from the niche (fetal 
liver, spleen, bone marrow) [Meininger et al., 1992; Blume-Jensen et al., 1993]. Seeding of 
embryonic hematopoietic organs takes place over the days. During this time, dHSC circulate 
at low quantities in the embryo blood and gradually seed hematopoietic organs in response to 
SCF signalling [Driessen et al., 1993; Hoffman et al., 1993; Wang et al., 2016]. Therefore, SCF 




SCF binding to c-kit leads to c-kit autophosphorylation and activation of signal 
transduction regulating genes implied in haematopoiesis [Rönnstrand, 2004; choice 
[Nishikawa et al., 2001; Zhang and Lodish, 2008]. c-kit is expressed on all hematopoietic stem 
cells progenitors and HSC. After differentiation, c-kit expression is lost in all but dendritic and 
mast hematopoietic cells [Broudy, 1997; Okada et al., 1991]. During embryonic development, 
SCF/c-kit acts synergistically with other cytokines, promote HSC maintenance in the absence 
of cell division [Keller et al., 1995; Hoffman et al., 1993]. SCF/c-kit promotes activation of 
AKT1, RAS, RAF1 and the MAP kinases; promote activation of signal transducer and activator 
of transcription (STAT) protein family [Yu et al., 2009; Lennartsson et al., 1999; Rönnstrand, 
2004]. 
 
1.5.2. Role of interleukin 3 in ex vivo HSC expansion 
Interleukin-3 (IL-3), previously known as “haemopoietin growth factor” [Whetton et 
al., 1985] or “multi-colony stimulating factor (multi-CSF)” [Evans et al., 1999] belongs to the 
same family of cytokines as granulocyte-macrophage colony-stimulating factor (GM-CSF) and 
IL-5. These cytokines are involved in immune response and induce leukopoiesis. Il-3 is 
secreted by T cells, macrophages and stoma cell in bone marrow [Mangi and Newland, 1999; 
Kim et al., 2010] 
Signalling cascade activated by IL-3 is triggered via a heterodimeric receptor assembly. 
One of the receptor subunits is major signalling subunit (beta common, βc). βc subunit is not 
specific and binds any of the IL-3 cytokines family. The second receptor - major binding 
subunit (alpha, α) is specific for IL-3, GM-CSF or IL-5 [Broughton et al., 2012; 2015]. GM–
CSF/IL-3/IL-5 receptors are expressed at relatively low level on committed hematopoietic cells 
while specific IL-3Rα (interleukin -  3 receptor subunit alpha, CD123) is highly expressed on 




endothelial cells. IL-3 stimulation of endothelial cells increases these cell motility and 
vasculogenesis. [Dentelli et al., 1999]. Activation of GM–CSF/IL-3/IL-5 receptor initiates 
signalling cascade leading to activation of STAT (signal transducer and activator of 
transcription), MAPK (Ras-mitogen-associated protein kinase) or PI3K (phosphoinositol 3-
kinase). 
IL-3 activates a wide range of bone marrow cells (mast cells, basophils, neutrophils, 
eosinophils, macrophages, erythrocytes, megakaryocytes) and recruits basophils and mast cells 
to the lymph nodes [Mangi and Newland, 1999; Kim et al., 2010]. IL 3 is responsible for multi-
lineage hematopoietic progenitors and committed myeloid, erythroid and megakaryocytic 
lineages survival, maintenance or proliferation and/or differentiation [Guthridge et al., 1998]. 
Mice deficient for IL-3 have no apparent defect in haematopoiesis but show defect in immune 
response to parasites due to impaired recruitment of effector hematopoietic cells [Lantz et al., 
1998]. 
IL3 applicability for ex vivo HSC expansion is a controversial issue. [Bryder and 
Jacobsen, 2000; Yonemura et al.,1996]. According to published reports, IL3 can not only 
promote self-renewal of cultured HSC, but also can trigger their differentiation with decrease 
in long-engrafting property [Itoh et al., 1992; Yanai et al., 1995; Peters et al., 1996; Yonemura 
et al., 1996]. Effect of IL-3 on cells self-renewal or differentiation in vitro is concentration 
dependent and is synergistic with other cytokines. Presence of fetal calf serum in HSC culture 
strongly affects IL-3 action on cultured cells. Serum is well known undefined component of 
culture media that contains various growth factors and hormones. Hypoxic conditions can also 
alter extent of IL-3 action on cell culture [Bryder and Jacobsen, 2000]. 
Culture of human bone marrow HSC derived from IL-3 receptor mutants (α and βc 
receptors) and wild type HSC with addition of IL-3 abrogated B-lymphoid potential and 




1997]. Yonemura showed that culture of adult mouse bone marrow c-kit+ cells reduces 
numbers of repopulating cells. Donor cells contribution to hematopoietic system was ~70% 
when freshly isolated c-kit+ cells were injected in lethally irradiated recipients. On the contrary, 
donor contribution dropped to ~60% when c-kit+ cells were cultured with exogeneous SCF, 
IL-6, IL-11 for 7 days and to ~2% when culture was extended to 14 days. When IL-3 was added 
the culture, after 7 days culture, donor contribution was just 20% and after 14 days - ~1%. 
Decrease in number of injected cells also reduced donor contribution to recipients’ 
hematopoietic system [Yonemura et al.,1996]. Rybtsov et al. (2014) showed that IL-3 does not 
negatively influence maturation of very early dHSC precursors in mice, but can be omitted in 
cytokine cocktails for pro-HSC expansion [Rybtsov et al., 2014]. 
On the contrary [Bryder et al., 2000] found that addition of IL-3 to HSC cultures 
supports HSC self-renewal; increased the cycling of LSK HSC and it did not affect myeloid or 
lymphoid reconstitution. Possible explanation for this discrepancy is presence of FCS in 
cultures. FCS contains various undefined factors and as IL-3 acts synergistically, presence of 
FCS unpredictably affects HSC development. In serum free cultures, IL-3 was found to 
accelerate expansion of primitive and mature hematopoietic cells and heterogenic population 
of HSC. 
For today IL3 is widely utilized component of many cytokine cocktails for HSC ex-
vivo expansion. Due to heterogeneity of HSC, usability of IL-3 has to be tested separately for 
each set of target cells, with clearly defined concentration of other cytokines and utilization of 
calf serum of defined origin and concentration [Qui et al., 1999; Querol et al., 1998; Capmany 







1.5.3. Role of Fms related tyrosine kinase 3 ligand in ex vivo HSC expansion 
Flt3-ligand (FLTL) is the ligand for Fms-like tyrosine kinase 3 type receptor (FLT3 or 
CD135) [Gilliland and Griffin, 2002]. FLT3 in mice is known as fetal-liver kinase-2 (FLK-2) 
or in humans - stem cell kinase-1 (STK-1) [Matthews et al., 1991(a), 1991(b); Rosnet et al., 
1991; Jaye et al., 1992]. FLT3 shares structural homology with other tyrosine kinase type 
cytokine receptors, for example, stem cell factor receptor (c-kit) or platelet-derived growth 
factor receptor (PDGFR). FLT3 has extracellular (immuno-globulin like domains) and 
intracellular tyrosine kinase domain.  Similar to SCF, FLT3L exists is soluble and membrane-
bound forms and is secreted by bone marrow cells [Lyman et al.,1993; Lyman et al.,1994]. 
Soluble form of FLT3L is produced by alternative splicing by premature termination condone 
[Lyman et al., 1995; Saravanaperumal et al., 2012]. To activate signalling through FLT3, 
receptor subunits dimerization is required. FLT3 activation leads to induction of signalling 
cascades via STAT, ERK and PI3K. 
FLT3 signalling regulates differentiation, proliferation and survival of hematopoietic 
progenitor cells. FLT3 is expressed on myeloid and lymphoid progenitors. Injection of FLTL 
induces HSC migration of HSC into peripheral blood and trigger maturation of multipotent 
progenitors into myeloid and lymphoid lineages in dispense of megakaryocyte-erythroid 
lineages. Transgenic mice overexpressing FLT3L develop splenomegaly, blood leucocytosis 
and anaemia resulted from reduction of erythroid progenitors [Tsapoggas et al., 2014]. Mice 
deficient for FLT3 or FLT3L have impaired myelo- and lymphopoiesis and have deficit in B 
cells, natural killer cells and dendritic cells. Yet, neither Flt3-/- nor Flt3l-/- mice’ hematopoietic 
system development is not affected [McKenna et al., 2000; Sitnicka et al., 2002]. 
Previously it was supposed that FLT3 induces exclusively committed hematopoietic 
progenitors to differentiation and that treatment of HSC with FLT3 expands their pool, but with 




heterogeneous and contains HSC with various propensity to contribute to myeloid or lymphoid 
lineage (or both) and with long or short repopulation abilities. In humans Kikushige and others 
reported that human bone marrow and cord blood contain FLT3+CD34+ fraction of cells that 
support lifelong multilineage recipient reconstitution. Therefore, role of FLT3L stimulation 
might have several functionalities: HSC pool expansion and differentiation [Gabbianelli et al., 
1995; Shah et al., 1996; Kikushige et al., 2008]. This scenario is even more feasible having in 
mind that FlT3L acts synergistically with other haematopoietic growth factors and interleukins 
[Buza-Vidas et al., 2009; Diehl et al., 2007; Gilliland and Griffin, 2002]. In ex vivo HSC 
expansion protocols FLT3 ligand is often used in combination with SCF and IL3 or IL6 though 




McCulloch and Till introduced the term hematopoietic stem cell (HSC) to define the 
cell that is able to provide lifelong and complete hematopoietic system reconstitution of a 
lethally irradiated recipient [Becker et al., 1963, 2014; Wolf and Trentin, 1968]. E.g. HSC will 
provide precursors of all hematopoietic lineage (myeloid, lymphoid and erythroid) and is able 
to self-renew. To date it is hypothesised that some blood malignancies can result from 
uncontrolled proliferation of a hematopoietic stem cell that acquired a genetic lesion affecting 
it’s control of self-renewal [Carlesso and Cardoso, 2010; Babovic and Eaves, 2014]. Therefore, 
HSC studies are important for fundamental and for translational sciences. 
In adults, HSC are rare cells found in bone marrow, they slowly cycle and mainly 
remain in G0 phase [Copley et al., 2012; Muller-Sieburg et al., 2012; Crisan and Dzierzak, 
2016]. This slowly cycling of HSC preserves them for the host lifetime. HSC is positioned at 




2010]. HSC gives rise to multi-potent hematopoietic progenitors (MPP), which are different 
from HSC in that that they lost their self-renewal property [Babovic and Eaves, 2014; Seita 
and Weissman, 2010]. Recently it was discovered that HSC pool is heterogenic. There are 4 
types of HSC: α, β, γ and δ cells [Weissman, 2015; Bush et al., 2015]. α-HSC mainly produce 
myeloid lineage progenitors, while β-HSC produce both myeloid and lymphoid progenitors; γ 
and δ cells support multilineage life-long engraftment, but are not able to repopulate secondary 
recipients [Seita and Weissman, 2010; Dykstra et al., 2007]. 
HSC transplantation is the method of choice in blood malignancies treatment and some 
immunodeficiencies [Sauvageau et al., 2004, 2010; Batta et al., 2016]. For clinical applications, 
HSC are isolated from bone marrow, new-borns umbilical cord blood or adults peripheral blood 
[Hopman and DiPersio, 2014]. Due to the need to match blood allotypes of the donor and the 
recipient, there are still shortages in bone marrow donors [Hardy and Ikpeazu, 1989; Hopman 
and DiPersio, 2014; Schwaber et al., 2016]. Hence, development of in vitro methods of HSC 
expansion and derivation are of the great interest for regenerative medicine. 
In vitro culture conditions attempt to recapitulate the microenvironment in which HSC 
reside in vivo [Zhang and Lodish, 2008]. The culture systems utilize cocktails of cytokines to 
stimulate HSC maturation and proliferation. There is yet no ideal cytokine formulation 
developed, but some working components have been identified. The most frequently used set 
of cytokines for HSC expansion or maturation is: SCF, Il3, Flt3-ligand, IL-6; IL-11, TPO and 
VEGF. More rarely used components are: Insulin-like growth factor 2 (IGF-2), fibroblast-
growth factor 1 (FGF-1) and angiopoietin like 2 and 3 [Heike and Nakahata, 2002; Zhang and 
Lodish, 2008; Batta et al., 2016]. Yet, to date attempts to expand the pool of donor HSC were 
mainly fruitless as HSC culture leads to HSC differentiation and loss of the cells self-renewal 




vitro methods of HSC maturation was more successful for embryonic HSC [Rybtsov et al., 
2011; 2014]. 
Additional approach that can be utilized in future to generate hematopoietic cells is 
human embryonic stem cells (hESC) differentiation or somatic cells reprogramming into HSC. 
This is achieved by recreation of HSC niche microenvironment and enforced overexpression 
of transcription factors like Runx1, Gata2, Scl, Hoxb4, Pu.1 [Bhatia, 2007; Wang et al., 2005; 
Batta et al., 2016; Pick et al., 2007; Suzuki et al., 2013; Vereide et al., 2014; Doulatov et al., 
2013; Ran et al., 2013; Gori et al., 2015]. Yet, methods using forced genes expression require 
further development to attenuate potential teratogenic outcome. 
Delineation of the ontogeny and the process of hematopoietic stem cells maturation in 
vivo is of a great interest in the field of regenerative medicine and would allow to recreate HSC 
maturation in vitro [Rowe et al., 2016]. 
In early mouse embryo (embryonic day 7-9), cells with hematopoietic potential reside 
in various locations (yolk sac, allantois, placenta, dorsal aorta, fetal liver) [Melchers, 1979; 
Godin et al., 1995; Yoder et al., 1997; Palis et al., 1999; Kumaravelu et al., 2003; Alvarez-
Silva et al., 2003; Gekas et al., 2005; Ottersbach and Dzierzak, 2005; McGrath and Palis, 2005; 
Zeigler et al., 2006; Corbel et al., 2007; Rhodes et al., 2008; Lux et al., 2008;  Dieterlen-Lièvre 
et al., 2010; Yoshimoto et al., 2012; Arora and Papaioannou, 2012]. However, first 
transplantable HSC (or definitive HSC, dHSC) are identified in midgestation embryo, in the 
aorta-gonad mesonephros region (AGM) [Medvinsky et al. 1993; Muller et al., 1994; 
Medvinsky and Dzierzak, 1996; de Bruijn et al., 2000; Taoudi and Medvinsky, 2007].  In 
particular, in ventral aspect of dorsal aorta (DA) in E10-E11 mouse embryos [de Bruijn et al., 
2002; Taudi and Medvinsky, 2007; Rybtsov et al., 2011] and in human [Péault et al., 2002; 




endothelium that gives rise to Runx1+ intra-aortic clusters (IAC) [Jaffredo et al., 1998, 2005; 
Zovein et al., 2008; Boisset et al., 2010; Bertrand et al., 2010; Kissa and Herbomel, 2010; 
Swiers et al., 2010]. Embryonic Runx1 knock-out is lethal [Okuda et al., 1996; Wang et al., 
1996]. Mouse embryos die prematurely around embryonic day (E) E11-E12 due to anaemia 
and widespread haemorrhaging. Runx1-/- embryos have normal primitive haematopoiesis, but 
do not develop any dHSC precursors and present signs of anaemic fetal liver [Samokhvalov et 
al., 2006; 2014; Tanaka et al., 2012; Liakhovitskaia et al., 2014]. Runx1 null embryos lack cells 
populations identified to give engraftment in myeloablated recipients (CD41+Vec+CD45+) 
and pre-HSC precursors (CD41+/lowVec+CD45-) [Okuda et al., 1996; Liakhovitskaia et al., 
2014]. Runx1 KO embryos also lack specific intra-aortic clusters (IAC) that are believed to 
contain developing dHSC [Samokhvalov et al., 2006; 2014]. Therefore, Runx1 is the critical 
mediator of HSC maturation and can be used as a marker of maturing HSC in early mouse 
embryos. 
Immuno-fluorescent and histochemical studies of early mouse embryo tissues revealed 
multiple sites of vascularised tissues containing clusters of Runx1+ cells, resembling cell 
clusters found in dorsal aorta [Yokomizo and Dzierzak, 2010; Yokomizo et al., 2011]. During 
embryogenesis, Runx1 is widely expressed in all sites of haematopoiesis (yolk sac, placenta, 
allantois, dorsal aorta), in hematopoietic cells, and in particular in hemogenic endothelium of 
dorsal aorta floor and intra-aortic clusters [Lam et al., 2010; Swiers et al., 2010; Chen et al., 
2011; Samokhvalov et al., 2014]. Runx1+ clusters of cells were detected in extraembryonic 
arteries, allantois, placenta and head – all sites of definitive haematopoiesis identified in E11 
embryos [Palis et al., 1999; Sugiyama et al., 2007; Yoshimoto et al., 2012; Zovein et al., 2010; 
Mizuochi et al., 2012; Vodyanik et al., 2005; de Bruijn et al., 2000; Gordon-Keylock et 
al.,2012; Zovein et al., 2010; Gekas et al., 2005; Inman et al., 2007; Zeigler et al., 2006]. 




only in caudal part of future AGM [Zovein et al., 2006; Rybtsov et al., 2014]. Thus, while 
looking for a niche where dHSC specification takes place, special attention has to be paid to 
mouse embryo caudal part. In younger mouse embryos (E8) dHSC precursors are most 
probably localized to splanchnopleuric mesoderm – situated in the caudal portion of the 
embryo. The golden standard to prove dHSC potential of the cells is to try them in a 
transplantation assay. However, cells derived from early mouse embryos are immature, for 
example do not express MHC1 and therefore eliminated by NK cells in recipients. To overcome 
this difficulty early mouse embryo tissues/cells have to be cultured in a potent HCS maturation 
system cell tracing experiments have to be tried out. 
 All early dHSC precursors express endothelial markers: vascular endothelial markers: 
vascular cadherin (CD144), endothelial marker CD31, VEGFR2 [Garcia-Porrero et al., 1998; 
Fraser et al., 2002; Rybtsov et al., 2011; 2016]. Early dHSC precursors express low levels of 
CD41 and are negative CD45, CD43 [Ferkowicz et al., 2003].  In general, molecular phenotype 
of dHSC precursors found in E9.5 (pro-HSC) mouse embryos can be described as: VE-Cad+ 
CD41low/+CD45−CD43− [Rybtsov et al., 2011; 2014; 2016]. dHSC gradually upregulate 
expression of CD41 and CD43 markers becoming pre-HSC type I with molecular phenotype 
of VE-Cad+ CD41+ CD45−CD43+ at E10.5 [Rybtsov et al., 2014; 2016; Mikkola et al., 2003; 
Hashimoto et al., 2007;]. Finally, CD45 marker starts to be expressed at E11.5 and dHSC transit 
to pro-HSC type 2 cells with phenotype VE-Cad+ CD41+ CD45+CD43+. After culture step 
with OP9 stromal cell line, pre-HSC type II become transplantable into adult irradiated 
recipients [Rybtsov et al., 2011; 2014; 2016]. Utilization of these markers allows to evaluate 
process of maturation of dHSC in the culture system. 
Regulation of HSC specification is orchestrated by molecular ques that are either 
secreted from surrounding dorsal aorta tissues (somites, notochord, neural tube floor plate, or 




side of somites or dorsal aorta endothelium cells) [Lawson et al., 2002; Lee at al., 2014; 
Clements and Traver, 2013]. Some of these markers are Bone Morphogenic Protein (BMP, 
expressed in ventral embryonic part) and Wnt (Wingless-related integration site or WNT 
protein, expressed in dorsal part) [Gilbert, 2003; Hohan, 1996]. Hh (hedgehog) is expressed in 
neural floor plate and notochord and specifies dorsal cell fates [Wilkinson et al., 2009]. BMP 
signalling antagonists Chordin and Noggin prevent premature dorsal aortae fusion [Resse et 
al., 2004; Garriock et al., 2010]. Garriock et al., (2010) showed that Chordin downregulation 
and presence of Vascular endothelial growth factor (VEGF) and Sonic hedgehog (Shh) are 
necessary for DA fusion [Garriock et al., 2010; Nagase et al., 2006]. Comparing patterns and 
timeline of morphogens and growth factors expression and appearance of dHSC potential in 
early mouse embryo allows to propose that dHSC appear after DA fusion events takes place. 
Therefore, those two events could be linked and application of BMP or Shh in in vitro cultures 





1.7. Early stages of avian embryo development  
After fertilization, chick embryo zygote appears as a disc (termed blastodisc) that floats 
on the top of yolk (Figure 4., A). Series of cleavages take place in the blastodisc gradually 
transforming it into a 5-6 cells thick layer of cells (Figure 4 C, i). Cells situated at the central 
lower part of blatodisc shed and die out leaving a monolayer of cells called epiblast. Epiblast 
cells absorb overlaying them albumin (egg white) and secrete it on the opposite side creating 
in this way a cavity between the yolk and epiblast (subgerminal space), (Figure 4, C,ii).  At this 
stage, epiblast looks like a transparent discoidal formation surrounded by opaque ring of tissue 
(Figure 4., B) [Eyal-Giladi and Kochav, 1976]. The transparent epiblast area is termed area 
pellucida and opaque zone – area opaca. There are multiple layers of cells underneath area 
opaca, also called marginal zone. Then, some epiblast cells delaminate and migrate into 
subgerminal space forming primary hypoblast.  Other cells, also contribute to hypoblast. For 
example, deep layer of cells from marginal zone of prospective posterior end of the embryo 
migrate towards primary hypoblast. Delaminated epiblast cells and deep layer cells from 
marginal zone together from secondary hypoblast. Epiblast, blastocoel and hypoblast all 







































Figure 4. Pre-gastrulation chick embryo development. Chick embryo zygote 
appearance (before egg is laid) (A). Red line shows cross-section through the embryo and 
yolk. Schematic representation of this section Is given in (C,i). Appearance of chick 
embryo shortly before gastrulation (B). Red line represents crossection schematically 
represented in (C, iv). Delamination of epiblast cells and formation of subgerminal cavity 
(C,ii). Migration of deep layer of cells from prospective posterior part of marginal zone 
(C, iii). Formation of secondary hypoblast and blastoderm (C, iv). Not to scale.  A –







1.7.2. Chicken embryo gastrulation 
Gastrulation is the process of tissues specification. In chicken embryo, gastrulation 
starts around 6 h of egg incubation (by Hamburger and Hamilton classification, HH, stage 2) 
[Hamburger and Hamilton, 1951]. First, a special structure, primitive streak, starts to form at 
the prospective posterior part of the embryo (Figure 5.). PS is formed by epiblast cells 
migrating towards the prospective embryo midline. Starting from 12h of egg incubation 
(HH3) cells in PS undergo epithelial- mesenchymal transition and migrate (ingress) into 
blatocoel. Cells ingressing through PS form a depression (primitive groove) along primitive 
streak. In about 18 h of egg incubation (HH4), at the anterior end of the primitive streak a 
thickening is formed - the Hensen’s node. There is a funnel-shaped deepening inside HN, 
which is another entry site for epiblast cells into blastocoel [Bellairs and Osmond, 2005; 
Gilbert, 2003]. 
As cells migrate thought primitive streak, it continues to extend. When primitive 
streak reaches approximately 75% of the area pellucida length, avian embryo is considered to 
be at the stage of full primitive streak extension (or at HH stage 4). From this moment, 
primitive streak starts to regress (shortens). Epiblast cells continue their ingression through 
PS till the very end of gastrulation. Cells ingressing gradually slows down starting from 2.5 
days of egg incubation (HH 16) and completely ceases at HH24 (4 days of incubation) 










Figure 5. Initial stages of gastrulation. Primitive streak appearance at HH3. Black 
arrows show epiblast cells migration towards forming primitive streak (A). Primitive 
streak at full length. Black arrows show epiblast cells migration towards primitive streak. 
Dotted line shows approximate border prospective mesoderm/ectoderm. Red line shows 
position of cross-section shown in C (B). Cross-section through middle primitive streak 
at stage HH4. Black arrows show migration of ingressed epiblast cells (C). Trajectories 
of prospective mesoderm cells migration (D). Lower layer of blastoderm showing 
hypoblast cells, future yolk sac endoderm (blue) with and already ingressed prospective 







1.7.3. Primitive streak and epiblast fate maps 
umber of works were devoted to the primitive streak and epiblast fate mapping. 
According to published fate maps, the first cells which migrate (ingress) into blastocoel will 
form definitive endodermal tissue (gut) [Psychoyos and Stern, 1996; Sweetman et al., 2008]. 
These cells migrate anteriorly and deep – they insert themselves in-between of hypoblast cells, 
pushing the latter anteriorly. Cardiac progenitors ingress after endoderm progenitors (HH3-4) 
[Selleck and Stern, 1991; Sawada and Aoyama, 1999]. Mid-primitive streak gives rise to 
paraxial, intermediate and lateral plate mesoderm. Caudal primitive streak also contributes to 
the lateral plate mesoderm, but for extra-embryonic tissues (yolk sac) [Ooi et al., 1986; Lopez-
Sanchez, et al., 2001; Withington et al., 2001]. The regions of PS and epiblast giving rise to 
different progenitors partially overlap, so there are no exact borders between PS regions giving 
rise to one or another particular tissue, nor exact borders dividing primitive mesoderm into 
embryonic- or extra-embryonic mesoderm [Schoenwolf et al., 1992; Hatada and Stern, 1994]. 
The part of the lateral plate mesoderm that overlies the endoderm will form the 
splanchnic mesoderm, which gives rise to mesentery, endothelium, vessels and hematopoietic 
cells [Downs et al., 2004, 2009]. Lateral plate mesoderm that lies underneath ectoderm will 
form somatic mesoderm that gives rise to vessels and connective tissues of body wall and 
limbs. Neural and surface ectoderm will be formed by epiblast cells that do not ingress through 
the primitive streak during gastrulation. Hypoblast cells do not contribute to the embryo proper 
tissues [Psychoyos and Stern, 1996; Sweetman et al., 2008]. Hypoblast contribute to extra-
embryonic membranes, e.g. to the yolk sac endoderm (Figure 4.). 
The fate of ingressed epiblast cells depends on their position in PS indirectly. E.g. the 




will be determined by the microenvironment cues [Bellairs and Osmond, 2005; Gilbert, 2003; 
Lopez-Sanchez, et al., 2001]. As the migratory routes of epiblast cells depend on their position 
in PS, cells position in PS determines destination of the epiblast cells in the embryo. Therefore, 











1.8. Ontogeny of hematopoietic stem cells in chicken embryo 
 
1.8.1. Haematopoietic stem cells and their precursors originate in embryo proper 
One of the key questions in the field of haematopoiesis, the origin of the hematopoietic 
stem cells, was first answered with help of a chicken embryo. Observing chick embryo 
development, it was noticed that the newly forming erythroblasts and endothelial cells appeared 
in the yolk sac in close proximity inside the so-called blood islands. Based on this observation, 
Sabin proposed that there is a common progenitor that gives rise to endothelial and 
hematopoietic cells [Sabin, 1917]. In 1932 to describe this common progenitor, Murray coined 
the term “hemangioblast” [Murray, 1932].  However, at that time not all hematopoietic cells 
were considered to originate from the common mesodermal progenitor. For instance, the 
lymphocytes were suggested to appear from an endodermal-epithelial precursor [Le Douarin 
and Dieterlen-Lièvre., 2013]. Moore and Owen were the first to question this hypothesis about 
a common mesodermal progenitor [Moore and Owen., 1965]. The authors carried out vascular 
anastomosis (operation to connect two vessels carrying blood) between two early chick 
embryos. They have demonstrated that if such anastomosis took place before embryonic day 7 
(E7), the thymus of each of the embryos would be populated by the T cells specific for both 
embryos. Hence, they proposed that thymus is colonized by the lymphocyte progenitors 
derived from the blood flow before E7. To verify their findings, Moor and Owen used yolk sac 
suspension of E7 chick embryos to restore the hematopoietic system of the irradiated E14 chick 
embryo. As the engraftment of the yolk sac cells was successful, Moore and Owen extended 
their conclusions proposing that the common precursor of HSC resides in the YS. Yet, Owen 
and Moore did not consider that the blood circulation was already established and so, the cells 
they collected from the yolk sac tissues could come from the embryo proper. In addition, 




As we discuss in the next chapter, later on Dieterlen-Lièvre overturned Moor’s and Owen’s 
hypothesis and demonstrated that definitive hematopoietic stem cells arise in the embryo 
proper [Dieterlen-Lièvre., 1975; Lassila et al., 1979; 1982]. 
In 1969, Dourain and colleagues developed the new advanced microsurgery method 
that allowed to graft quail embryos onto the yolk sac of the chick embryo [Le Douarin, 1969; 
Le Douarin and Dieterlen-Lièvre., 2013]. In 1975, Dieterlen-Lièvre and his colleagues used 
this technique in lymphopoiesis studies [Dieterlen-Lièvre, 1975]. Surprisingly for the authors, 
they discovered that the major hematopoietic organs (thymus, and spleen) in quail-chick 
chimeras were populated by the quail (donor) hematopoietic cells. This contradicted Owen’ 
and Moore’s hypothesis about the yolk sac as the place of origin of hematopoietic stem cells 
[Dieterlen-Lievre F., 1975]. 
 As chick and quail phases of embryonic development might be different, cell-cell 
interactions could have been affected in Dieterlen-Lièvre experiments. To solve this issue, 
Lassila et al., in 1978 created chick-chick chimeras in which host and graft tissues differed 
from one another by sex [Lassila et al., 1978]. To exclude the possibility that cells from embryo 
proper enter yolk sac, Lassila and colleagues used pre-circulation chick embryos in this 
experiment. According to the design of the experiment, when embryos were grafted randomly, 
there would be 50% of grafts whose sex is different from the host tissues. In a report by Lassila 
and colleagues’ results, authors did not discover embryo sex hematopoietic cells in the spleen, 
thymus or bursa opposite to the host. However, the rare cells of opposite to the host sex were 
detected in the bone marrow – the final niche of hematopoietic stem cell. This meant that all 
hematopoietic cells were derived from the host embryo proper, but rare primitive erythrocytes 





1.8.2. Hematopoietic stem cells and their precursors migrate into yolk sac from 
embryo proper  
To establish the possibility of intraembryonic HSC migration into YS tissues, Lassila 
and colleagues designed the following experiment. The authors used allogeneic chick-chick 
chimeras (derived from genetically different zygotes). For this, they grafted the whole central 
area of blastoderm of the chick line B2B2 (donor) on the area opaca of chick line B15B15 
(host). Therefore, graft and host derived cells were of different chicken allotypes which allowed 
easy identification of the cells origin by the cells surface antigens expression. Five days after 
grafting, yolk sacs were removed, and the cell suspension was prepared. This cell suspension 
was transplanted into irradiated E14 recipient chick embryos. After recipient embryos hatched, 
engraftment of yolk sac cells and input of cells derived from embryo proper were evaluated. 
According to the authors, the majority of blood cells were derived from the embryo proper 
[Toivanen et al., 1982; Lassila et al., 1982]. Only low numbers of recipient’s peripheral blood 
erythrocytes came from donor’s yolk sac. Hence, the authors proposed that the YS provides 
significant numbers of primitive erythrocytes progenitors during embryogenesis. Yet the 
number of YS derived erythrocytes turned out to be below the limit of detection after embryo 
hatching. Simultaneously, erythrocyte progenitors coming from embryo proper produce 
definitive erythrocytes in increased numbers during embryonic life and apparently are the only 
source of erythropoiesis after embryo hatching [Lassila et al., 1982].  
 
To demonstrate that the detected intraembryonic HSC precursors give rise to the 
functional HSC, Martin et al., created chick-chick embryo-yolk sac chimeras before the onset 
of circulation [Martin et al., 1979]. Eighteen chimeras survived after transplantation, hatched 
and were analysed at age of 5-20 weeks. Analysis of chimeras revealed that their embryo proper 




normal levels of IgM and IgG upon stimulation. From this, Martin and colleagues verified that 
adult-type HSC originate from the embryo proper, but not from the YS. 
Therefore, the hematopoietic stem cells and their precursors do not originate in the yolk 
sac but migrate there from the embryo proper with blood circulation. Yolk sac produces 
primitive erythroblasts, which in limited quantities persist till embryo hatching and disappear 
shortly after that. In addition, colonization of hematopoietic organs was not demonstrated for 
the YS derived cells.  Soon after establishment of the blood circulation, the second definitive 
hematopoietic wave takes place in the embryo proper. During this time, hematopoietic 
precursors [and/or HSC] colonize the hematopoietic organs (bursa, thymus, bone marrow, 
spleen). Intra-embryonic HSC precursors mature during the second wave of definitive 
haematopoiesis and give rise to the stem cells that maintain adult haematopoiesis [Toivanen et 
al., 1982; Lassila et al., 1982].  
 
1.8.3. Location of hematopoietic stem cells and their precursors in the embryo 
proper 
 In 1996 Medvinsky et al reported that in the mouse embryo, definitive hematopoietic 
stem cells reside in the so-called aorta-gonad-mesonephros region (AGM) [Medvinsky and 
Dizerzak, 1996].  Later it was also revealed that the hematopoietic activity in mouse AGM is 
localized to the ventral part of the main AGM vessel, the dorsal aorta. [Taoudi S, Medvinsky 
A., 2007]. In the DA, in contrary to the YS hematopoiesis, endothelium appears first before the 
generation of the hematopoietic cells (while in yolk sac they appear simultaneously). Perhaps 
because of this, the paradigm of ontogeny of hematopoietic stem cells has shifted from the 
“hemangioblast” to the “hemogenic endothelium”. Currently, hemogenic endothelium is 
recognized to be the tissue that gives rise to HSC and/or their precursors. According to fate 




particular, the spnanchnopleura derivative: splanchnic mesoderm overlaying endoderm 
[Cumanp et al., 2001]. In search of definitive hematopoietic cell precursors, Pouget and 
colleagues performed grafting of the quail somatopleural derivative in place of the last two 
formed somites in the chicken embryo. The authors observed formation of vascular networks 
formed from quail angioblasts (reviled with quail specific QH1 antibody that specifically 
recognizes quail endothelium) [Pouget et al., 2006]. The descendants of the quail somatopleural 
mesoderm were detected in all somatopleural derivatives (e.g. kidney, limbs, body wall). Quail 
angioblasts were also found to be integrated into the roof and sides of the dorsal aorta. In 
contrast, quail angioblasts were never found in the floor of the dorsal aorta or any other visceral 
organs. From this, Pouget and colleagues concluded that somatopleura serve as the source of 
angioblasts for vasculatization of the dorsal aspect of the embryo, including the roof and sides 
of the dorsal aorta and thus excluding hemogenic endothelium [Pardanaudt et al., 1996; 1999; 
Pouget et al., 2006]. 
 Grafting of quail spnanchnopleura into the place of last 1-2 somites in chicken 
embryos provided the opposite results. Here, quail angioblasts emigrated into the visceral part 
of the embryo, formed the floor of the dorsal aorta, and gave rise to hematopoietic cells. From 
here it was concluded that the dorsal aorta is the chimerical vessel, which is formed by two 
distinct endothelial lineages, derivatives of somatopleura and spnanchnopleura, respectively. 
Only one of their derivatives, namely spnanchnopleura, is endowed with hematopoietic 
potential [Pardanaudt et al., 1996; 1999; Pouget et al., 2006].  
It is still unclear how endothelial to hematopoietic transition occurs. Recently, some 
insights were obtained with experiments of Pardanaud and Dieterlen-Lièvre where the 
mesoderm was pre-treated under various conditions before its grafting. The mesoderm was 
conditioned in presence of germ layers that normally surround it in the embryo (endoderm or 




the conditioning with endoderm as well as conditioning with endoderm derived growth factors 
(VEGF, bGFG and TGFbeta1) gives rise to progenitors with endothelial and hematopoietic 
potential, while conditioning with ectoderm and ectoderm derived growth factors (EGF/TGF) 
completely abolishes hematopoietic potential of spnanchnopleura [Pardanaud L, Dieterlen-
Lièvre F., 1999].  
Another critical mediator involved in endothelium to hematopoietic transition is 
transcription factor Runx1. Jaffredo and colleagues studied Runx1 expression in avian embryos 
by means of in situ hybridization. They have discovered that Runx1 starts to be expressed in 
dorsal aorta 1 day before the intraembryonic hematopoiesis takes place. The pattern of 
expression is different from that observed in the mouse. In chick embryos, Runx1 is expressed 
in paired dorsal aortae bi-laterally. It is only after DA fusion, Runx1 expression was observed 
in the ventral aspect of the dorsal aorta. During intra-embryonic hematopoiesis, Runx1 is 
expressed in the whole dorsal aorta floor and in intra-aortic clusters (IAC). In contrast, in mouse 
embryos, sub-aortic cells express Runx1 at a high level (in chick, the adjacent sub-aortic 
mesenchyme remains Runx1 negative). Therefore, Jaffredo and colleagues proposed that the 
sub-aortic mesenchyme is not the source of HSC precursors in chick embryos but serves as an 
inductive tissue to promote endothelial to hematopoietic transition [Jaffredo et al., 2000; 
Dieterlen-Lièvre and Jaffredo, 2009]. 
To conclude, to initiate hematopoietic stem cell maturation from mesoderm precursors, 
the lateral plate mesoderm needs to be in contact with the endoderm. Lateral plate mesoderm 
that is in contact with the endoderm is called spnanchnopleura and experimentally it was 
demonstrated that this tissue forms the dorsal aorta floor. The initiation of HSC maturation in 
the mesoderm is mediated by endoderm secreted growth factors (VEGF, bGFG and TGFbeta1). 
Successful initiation of HSC maturation will be highlighted by upregulation of Runx1 








 1.8.4. Lateral plate mesoderm is the reservoir of cells forming intra-aortic 
clusters in the chick embryo 
 To determine the origin of intra-aortic clusters, Jaffredo and colleagues performed an 
elegant experiment where they mechanically separated lateral plate mesoderm from the newly 
formed dorsal aorta. Runx1 expression and hematopoietic clusters formation was absent on the 
operated sides of the embryo while IAC appeared at normal frequency and size in non-operated 
sites [Jaffredo et al., 1998; 2005; Bollerot 2005]. This might mean that LPM induces Runx1 
expression and IAC appearance. On the other hand, it could be a consequence of disruption of 
cell migration from the mesoderm to the DA. To exclude the second possibility, in a separate 
experiment, Jaffredo et al. labelled the lateral plate mesoderm with permanent lipophilic dye 
and observed LPM cells migration into the DA. On examination, labelled cells were absent in 
the endothelial lining of the dorsal aorta or in IAC. From this, Jaffredo and colleagues 
concluded that the sub-aortic mesenchyme is not the source of HSC precursors. Yet, it induces 
Runx1 expression and in the DA endothelium and so triggers HSC maturation. These 
conclusions however shall be clarified: at the stage when the DA is already formed, LPM might 
induce HSC maturation in endothelial and do not contribute new cells to the DA, yet LPM shall 
give rise to the DA at the earlier stages [Richand C. et al., 2013]. 
 
1.8.5. Tracing fate of intra-aortic clusters  
To delineate the fate of IAC, IAC were labelled with a retroviral vector engineered to 




the labelling of the hemogenic endothelium took place. At E3 IAC were labelled. By tracing 
progeny of labelled cells in the DA, Jaffredo et al. were able to distinguish 2 groups of cells. 
The first was shed into the bloodstream and the second migrated into the dorsal mesentery and 
formed their so-called para-aortic foci [Jaffredo et al., 2000]. 
Para-aortic foci appear around E6-7 after intra-aortic hematopoietic events, but before 
the colonization of main hematopoietic organs. By the series of works, Dieterlen-Lièvre proved 
that hematopoietic cells which were derived from foci colonize hematopoietic organs 
[Dieterlen-Lièvre F, Martin C., 1981]. Lassila and colleagues also showed that hematopoietic 
foci contain definitive hematopoietic cells. For this, they performed transplantation of the E14 
irradiated chick embryos with cell suspensions derived from dorsal mesentery [Lassila et al., 
1979]. Dorsal mesentery provided hematopoietic reconstitution in parallel to functional 
restoration of the lymphoid cell compartment [Lassila et al., 1979; Dieterlen-Lièvre F, Martin 
C., 1981]. These findings show that mesenchymal para-aortic foci could be a transitory niche 
for maturing hematopoietic stem cells on their way to main hematopoietic organs: thymus, 
spleen, bursa and bone marrow. 
To conclude, the hematogenic endothelium seems to be the origin for HSC and para-
aortic foci to be a temporary niche for maturing HSC. Intra-aortic clusters migrate in the area 
where para-aortic foci are formed and hence IAC might contain precursors of HSC. Yet, there 
are no reports showing a direct link between hemogenic endothelium-IAC-para-aortic foci-
HSC. For example, experiments described above could not reject the possibility that HSC 
appear in the para-aortic foci from another source, e.g. from the blood flow. To clarify this 
question, the DA endothelium would need to be permanently labelled and its derivatives traced 
in adult chicks. There are technical challenges to do this. For example, there are no known 




experiment labelling lateral plate mesoderm that contributes to dorsal aorta endothelium, first 
fate mapping of dorsal aorta shall be completed. 
  Even though we know that vasculature and the DA in particular is the mesoderm 
derivative, we do not know the exact region of the LPM will contributes to IAC. For example, 
the heart is formed by LPM regions closely adjacent to each other. Munstenberg et al., show 
that two closely adjacent regions of HH3-3+ anterior primitive streak give rise to two separate 
regions of the heart. Namely, to a) anterior heart field and b) combined primary, secondary and 
anterior heart fields [Yue et al., 2008; Münsterberg and Yue, 2008; Sweetman et al., 2008; 
Camp and Munsterberg, 2011]. The primary heart field forms the heart tube, while anterior 
heart field forms the outflow myocardium. Hence, cells from anterior heart field reside in 
splanchnic mesoderm awaiting the signal to contribute the outflow of myocardium. Therefore, 
it could be that a similar scenario is applied to dorsal aorta formation. For example, different 
regions of PS might contribute to the dorsal aorta floor or intra-aortic clusters. Mapping of the 
DA will allow the eludication of this question. 
1.8.6. Dorsal aorta formation 
Regardless of the fact that a number of works were devoted to fate map the primitive 
streak, no works were done to construct a fate map of the dorsal aorta. We generally know that 
LPM will contribute to the dorsal aorta and that splanchnopleura grafts will contribute to the 
hemogenic endothelium [to Jaffredo et al., 2000]. Psychoyos and Stern and others developed 
detailed fate maps of the primitive streak [Psychoyos and Stern, 1996; Downs, 2003; Sato, 
2013]. According to these maps, intra-embryonic LPM is generated by the middle portion of 
the PS. 
Other works which were devoted to dynamics of the DA assembly show that the 
assembly of the DA follows these steps. First, primitive mesoderm cells randomly transform 




Hiruma 1981, 1983, 1995; LaRue et al., 2003]. Starting at HH9 (6 sp), angioblasts migrate and 
align bi-laterally at some distance from the embryonic midline. These angioblasts coalesce 
forming short, tubular vascular plexi. According to recent studies, these primary vascular plexi 
have a dynamic nature [Sato et al., 2010]. E.g. cells of these plexi still possess motility and the 
direction of these cells movement is not necessarily coordinated. With time, these initial 
vascular plexi move towards each other and merge forming one single aorta. With the use of 
two photon-laser scanning microscopy and a tie1-eYFP transgenic quail embryo, Sato et. al 
observed DA formation and concluded that the dorsal aorta walls get contribution from mainly 
intra-embryonic endothelial cells. In contrast, caudal regions of the DA are built from extra-
embryonically derived endothelial cells (Sato et al., 2010). This result requires further 
clarification as it will be critical to label the intra-aortic part of the DA exclusively. 
An additional insight in DA formation from the earliest stages of embryo development 
could be done with in situ hybridization screens done for angioblast or cells expressing 
endothelial markers. For example, endoglin is a good marker for endothelial cell identification. 
The Geisha project provides a detailed endoglin expression screen (GEISHA Id ENG.UApcr) 
for chick embryos at stages HH 4-25 [Bell et al., 2004; Darnell et al., 2007]. From the in-situ 
endoglin screen, it follows that the first angioblasts are scattered in extraembryonic spaces. At 
HH9, angioblasts already assemble into primordial DA simultaneously with formation of the 
area pellucida vasculature. At HH10 the anterior part of DA (paired) is already formed, together 
with the heart tube. The area pellucida vasculature is almost assembled. By HH12, which is 
when blood circulation starts, the anterior DA is completed and joined to the area pellucida and 
the yolk sac vasculature. Area pellucida is densely vascularized starting from HH10. Therefore, 
lateral plate mesoderm grafting shall not be done later than the beginning of stage HH9, e.g. 
when the DA lumen is formed. Operation of luminised DA will destroy the fragile DA lumen 




Clusters bearing endothelium is a long stretch of mesoderm which at HH9 extends from heart 
loop to the Hensen’s node. It will be difficult to label this long stretch of mesoderm surgically. 
A much easier alternative would be to label a lateral plate mesoderm that contributes to 
intraembryonic part of the DA. Though, as was mentioned above, to fulfil this goal one would 
need to fate map the DA first. 
 
1.8.7. Conclusions 
In her pioneering works with quail-chick chimeras, Dieterlen-Lievre (1975) established 
that major hematopoietic organs in chicken (thymus, and spleen) were populated by the quail 
(donor of intraembryonic tissues) derived hematopoietic cells. This meant that, similar to 
mammals, all hematopoietic cells are derived from the host embryo proper in chickens. Later, 
Lassila showed that only rare primitive erythrocytes temporarily home to the bone marrow 
[Toivanen et al., 1982; Lassila et al., 1982; Martin et al., 1979]. This might be compared to 
Cumano et al (2011) reports where some yolk sac derivatives home to the mouse fetal liver 
where they might contribute to some obscure pool of HSC. 
Similar to mice, in chicken embryos after establishment of the blood circulation that 
carry primitive YS derived erythrocytes, the second definitive hematopoietic wave takes place 
in the embryo proper. During this time, hematopoietic precursors [and/or HSC] colonize the 
hematopoietic organs (bursa, thymus, bone marrow, spleen – in contrast to mouse where pro-
HSC and HSC colonise the fetal liver).  
Currently, the hemogenic endothelium is recognized to be the tissue that gives rise to HSC 
and/or their precursors. According to fate mapping studies, the aortic endothelium is a 




the dorsal aorta is the chimerical vessel, which is formed by two distinct endothelial lineages, 
derivatives of somatopleura and splanchnopleura. Somatopleura serves as the source of 
angioblasts for vascularisation of the dorsal aspect of the embryo, including roof and sides of 
the dorsal. Only spnanchnopleura derivatives contribute to the DA floor and are endowed with 
hematopoietic potential [Pardanaudt et al., 1996; 1999; Pouget et al., 2006]. Chick mesoderms 
show some plasticity in cells fates: mesoderm conditioning with endoderm as well as 
conditioning with endoderm derived growth factors (VEGF, bGFG and TGFbeta1) gives rise 
to progenitors with endothelial and hematopoietic potential. Mesoderm conditioning with 
ectoderm and ectoderm derived growth factors (EGF/TGF) completely abolishes 
hematopoietic potential of spnanchnopleura [Pardanaud L, Dieterlen-Lièvre F., 1999; Jaffredo 
et al., 1998; 2005; Bollerot 2005]. Therefore, in chicken embryo development of hematopoietic 
cells (and HSC in particular) it is position dependent. 
In chicken embryos, during intra-embryonic phase of haematopoiesis Runx1 is 
expressed in the whole dorsal aorta floor and in intra-aortic clusters (IAC).  In contrast, in 
mouse embryos, Runx1 is also expressed in subluminal tissues. Jaffredo and colleagues 
proposed that the sub-aortic mesenchyme in chicken embryos is not the source of HSC 
precursors, but serves as an inductive tissue to promote endothelial to hematopoietic transition 
[Jaffredo, 2000; Dieterlen-Lièvre F, Jaffredo, 2009] 
By tracing progeny labelled in DA cells, Jaffredo et al. were able to distinguish 2 groups 
of cells. The first was shed into the blood stream and the second migrated into the dorsal 
mesentery and formed their so-called para-aortic foci [Jaffredo et al., 2000]. Dorsal mesentery 
provided hematopoietic reconstitution in parallel to functional restoration of the lymphoid cell 
compartment [Lassila et al., 1979; Dieterlen-Lièvre F, Martin C., 1981]. Hence, mesenchymal 
para-aortic foci could be a transitory niche for maturing hematopoietic stem cells on their way 




reports showing a direct link between hemogenic endothelium-IAC-para-aortic foci-HSC. It 
could be also possible, that HSC appear in para-aortic foci from another source, e.g. with the 
blood flow. To clarify this question, cell tracing experiments of the DA endothelium would 
need to be done. 
No DA mapping experiments were conducted to date. For instance, it is not known 
what region of the LPM will contribute to IAC bearing portion of the DA. For example, the 
heart is formed by LPM regions closely adjacent to each other [Yue et al., 2008; Münsterberg 
and Yue, 2008; Sweetman et al., 2008; Camp and Munsterberg, 2011]. Therefore, it could be 
that adjacent LPM regions contribute to hemogenic and not hemogenic portions of the DA. 




1.9. Project aims 
Tp define the area containing prospective early HSC precursors in mouse and in chicken 
embryo. For this: 
I. By means of immunofluorescence: 
-  map Runx1+ cells in wild type E7-8 mouse embryo; 
- describe dynamics of Runx1+ cells appearance in early mouse embryo (E7-8). 
II. Isolate tissues containing prospective pro-HSC (Runx1+CD31+CD41+ cells) from 
precirculation mouse embryos (E7-E8) and determine these tissues definitive hematopoietic 
potential in transplantation assays; 
- cells isolated from early mouse embryos are not directly transplantable. Therefore, 
implement a culture step to mature prospective pro-HSC: 
  - with utilization of the protocol of 3D co-aggregation with stromal cells; 
  - whole tissues explants. 
III. Map the dorsal aorta from the primitive streak (PS) stages of chick embryo development. 
For this: 
- establish chick embryo culture and the method of PS labelling that allows easy visual 
recording; 
- determine the area of the primitive streak that contributes exclusively to intra-aortic 
clusters bearing portion of the dorsal aorta; 


























Mouse cell and tissue culture medium. IMDM (Sigma-Aldrich, I3390), 
HyClone™ Fetal Bovine Serum (GE healthcare Life Sciences, SH30071.03) – 20%; 
Penicillin/streptomycin solution (Sigma-Aldrich, P4333)  1:100; L-glutamine solution (Sigma-
Aldrich, 59202C) – 1:50; Sodium pyruvate solution (Sigma-Aldrich, S8636) -  1:100. For co-
aggregation and embryo explant cultures, this media was supplemented with IL-3 (100ng/ml); 
SCF (100ng/ml) and Flt3 (100ng/ml). 
 
Nitrocellulose filter membranes (0.65 μm) for air-liquid interface co-aggregate cultures 
were purchased from Sigma-Aldrich (N9022). Membranes were washed in autoclaved milliQ 
water 3 times for 15 minutes each time. Then, membranes were dyed in a laminar hood. Before 
loading cell co-aggregates, membranes were carefully deposited on the surface of culture media 
(2 mL) in 6-well plates (Nunc, ThermoFisher Scientific, 140675). All procedures were carried 
out in aseptic conditions. 
 
Beta-galactosidase staining buffers – recipes are given in Appendix A9. 
 
DiI and DiO stains.  DiI and DiO were purchased from Thermo Fisher Scientific (1,1'-
Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine Perchlorate, D282; 3,3'-
Dioctadecyloxacarbocyanine Perchlorate, correspondingly, D275). 
Dye stock preparation: Dye in the tube was dissolved in 10 uL of 100% ethanol. DiI 




Working solution preparation. On the day of injection, 10 uL of dye stock was dissolved 
1:10 with preheated to 40-45 oC 0.3M sucrose. 
 
 
Collagenase/dispase (Roche, 11097113001), 1 mg/mL on PBS (Ca++/Mg++). 
 
Pannett and Compton saline for early chick culture was prepared according to [Pannett 
and Compton, 1924; New, 1966; Stern, 1993]. Recipes are given in Appendix A10.  
 
Plates preparion for early chick culture. Plates were prepared minimum 2 hours in 
advance before the experiment. Egg albumine was collected from 6 fresh eggs. 50 mL of 
warmed up to 49 oC albumin was mixed with 50 mL of 0.6% of agarose (Difco Agar, 
RF214530) dissolved on Pannett-Compton saline.  Immediately, liquid agarose/albumin mix 
was dispensed in plates (~ 5mL/plate) and left to set at room temperature. 
 
Paper rings (frames) for chick embryo culture were cut from Whatman 
Chromatography Paper (3mm Chr, Cat. # 3030 017, GE Healthcare UK Limited). The opening 
in a paper ring was not of cloverleaf shape, but of an oval. Paper rings size: outer diameter – 
24 mm; internal ellipse diameters: 13mm and 11 mm. 
 
2.2. Animal husbandry 
Bl6 and AML1LacZ/+ animals were housed within the University of Edinburgh 
according to Animals Scientific Procedures Act, UK, 1986. All procedures were carried out 




light/10 hours dark cycle in a pathogen free environment. Mice were provided a sufficient 
supply of food and water. 
 
Fresh (laid on the day of the experiment) fertile chicken’ eggs were sourced by a 
Transgenic Chicken Facility from Roslin Institute (Edinburgh, Scotland). Embryos from the 
brown leghorn line were used as wild type embryos. Fertile eggs containing transgenic embryos 
ubiquitously expressing membrane bound form of GFP were also sourced by the Transgenic 
Chicken Facility with the permission of Helen Sang who derived this transgenic chick line 
(Roslin Institute) [McGrew at al., 2004].  
 
2.3. Mouse embryos collection and dissection 
For embryonic tissue collection, timed matings were set overnight. In morning, upon 
discovery of a vaginal plug in female mice, embryonic day was assumed to be E0.5. 
Mouse tissues were dissected in 7-10% FCS/PBS (Ca++/Mg++) solution. Embryo 
stage, number of somites were recorded and embryos were pooled according to their stage: 0-
5sp; 6-15 sp. 
For the transplantation experiments, Bl6 recipients were irradiated with full body doze 
of ionizing radiation (3.5 Gy at 0.75 Gy/min). After irradiation, animals were kept on 10% 
Baytril solution (Bayer) for 4 weeks. Blood chimerism was assessed starting from the 6th week 
after transplantation by tail vein veno-puncture. 
 
2.4. Mouse tissues preparation for hematopoietic potential assessment 
Cell suspension preparation. To prepare cell suspension from fresh embryonic tissues, 
cultured explants or co-aggregates, tissues/membranes with cells were carefully transferred 




topped up with 1 mg/mL collagenase/dispase solution (Roche) in 7% FCS-PBS (+/+). Prepared 
tubes were incubated in set to 37 oC shaking water bath for 35 min. After incubation, the tube 
was topped up with one mL of 7% FCS-PBS(Ca-/Mg-), penicillin/streptomycin solution 
(1:100).  Tubes were centrifuged for 5 min (400G, Beckman Coulter Allegra X-15R Centrifuge 
with SX4750A Rotor). 1 mL of the solution was discarded while the rest of the solution was 
used to disaggregate tissues by pipetting up and down. Used nitrocellulose membranes were 
discarded and tubes were spinned down again for 5 min (1500 rpm). 
Co-aggregate cultures. To prepare co-aggregates, 20 uL of cells suspension (for 
example, mixture of cells isolated from E8 embryo and 100 000 stroma cells) were loaded in 
sealed 20-200 uL pipette tips. The tips were spun down at 400G for 12 min in Beckman Coulter 
Allegra X-15R Centrifuge with SX4750A Rotor.  Obtained cell pellets are denoted in this work 
as co-aggregates.  The seals on pipette tips were opened and the co-aggregates were deposited, 
floating on the medium membranes. 3-5 co-aggregates were cultured on one membrane. 
Explant cultures. Dissected embryonic tissues were placed on: (a) floating on complete 
medium nitrocellulose membranes or (b) on the bottom of 6 wells plate and spinned down at 
400G for 5 minuts in Beckman Coulter Allegra X-15R.  
Plates with explants or co-aggregate cultures were incubated in humidified conditions 
at 37 oC, 5% CO2 for 3-7 days. In 24h after culture initition, the medium was exchanged for a 
fresh one. 
Stroma cells preparation. AGM cell suspensions in 7% FCS/PBS (no Ca/Mg ions) were 
stained with 1:200 anti-CD16/32 (clone 93, Abcam); 1:100 anti-CD45-biotin (clone 30-F11, 
BD Pharmingen), 1:100  anti-CD43-biotin (clone eBioR2/60, eBioscience), 1:100 anti-CD41-
biotin (clone MWReg30, BD eBioscience); 1:100 anti-Ter119-biotin, (clone TER-119, BD 
Pharmingen) for 30 minutes on ice. After staining, cells were washed with 7% FCS/PBS (no 




BSA/PBS (no Ca, Mg ions) Streptavidin Particles Plus-DM (BD Biosciences). Cells were 
incubated with the beads for 20 min. Bead separation from CD41-CD43-CD45-Ter119- cell 
suspension was carried out with the BD IMagnet™. Separation was carried out twice. 
 
2.5. Blood chimerism assessment 
Blood samples (about 50 uL) were collected into a plate (round bottom wells) prefilled 
with 200 uL of 5 mM EDTA in 2% FCS – PBS(Ca-/Mg-). Samples were mixed, and the plate 
was centrifuged at 13000 rpm (250-400G) rpm for 5 min at 4 oC. Plasma was removed, and 
200 uL of lysis buffer was added (BD Pharm Lyse buffer diluted with water 1:10). Red blood 
cells lysis continued up to 15 min.  
Cells were stained in 30-50 uL/well in diluted up to 1:200 Fc block and antibodies set 
A or set B (Appendix A26).  Antibodies were diluted in 2% FCS-PBS for 30 min at 4 oC. Cells 
were spun down and then stained with vital dye 7AAD (BD, 1:30)  in 20 uL of 2% FCS-PBS. 
In this buffer, cells were transferred into FACS tubes and analysed on BD FACS Calibur for 
antibodies set A and FACS Fortessa for antibodies set B (Appendix A26). 
Since early pre-HCS (E9 pre-HSC) showed only low levels of blood chimerism 
(Appendix A11), E8 pro-HSC would produce either similar or even lower levels of blood 
cihemrism. Therefore, a cut-off level of donor cells contribution below in which a recipient is 
considered to be not repopulated had to be established. This level was chosen on the basis of 
flow cytometric analysis of blood samples drawn from mice injected with either carrier cells 
alone (105 Ly5.1 cells) or a mix of OP9 cell suspension and carrier cells. We injected 300 000 
OP9 cells per a recipient (an equivalent of three OP9 co-aggregates). In total there were five 
mice injected with control cell suspensions at different time points. For determining percentage 
of blood chimerism, we utilized two different sets of antibodies. Background level of false 




antibodies, level of false positive staining was in the range of 0.027 – 0.1%. 0.1% of 
background staining level is the highest observed here and therefiore, 0.1% cut-out level shall 
be suitable to discriminate genuine hematopoietic system repopulation from antibodies 
unspecific binding. Hence, we have set the cut-out level to be 0.1% of blood chimerism. 
Table 3.2.2. Background anibody staining assessment 
Donor Recipient 
Mice injected with 105 
Ly5.1 carrier cells only 
Mice injected with 105 
Ly5.1 carrier cells and 







































































































Ly5.1/2het 1 0.004(A) 0.018(B) 0 N/A N/A 
Ly5.1/2 
het 










Background staining for Ly5.1/2+ cells in 
blood drown from Ly5.1 recipients with antibodies 
set #1, mean±SD 
0.04±0.03 
A – antibodies set A; B - antibodies set B (Appendix A26) 
 
2.6. Beta-galactosidase staining on mouse embryos 
Embryos were dissected from the uterus (leaving aside yolk sac) in Buffer A. Then we 
fixed embryos in Buffer B. Embryos E6.5 and E7.5E were fixed for 10 minutes (on ice); 
embryos E8.5 were fixed for 15 minutes (on ice). 
After fixation, embryos were washed in Buffer C using the following procedure. First, 
embryos were briefly rinsed. Then, they were washed three times for 15 minutes each in a cold 




at 37oC. For this, embryos were incubated in a thermostat without a CO2 supply. Afterwards, 
we fixed embryos in 4% PBA-PBS for 1h or overnight. 
 
2.7. Early chick embryo culture 
Chick embryo extraction. Embryo extraction was carried aseptically in a hood. All 
equipment for this procedure (forceps, paper rings, wipes) was sterilized. The following 
procedure was employed. An egg was first opened into a 15 cm plastic dish. The thick albumen 
above the embryo was removed with sterile tissues. A sterile paper ring was placed around the 
embryo. The vitelline membrane was partially cut around the embryo at "9-3 hours". The 
released edge of the paper ring (from the site of cut vitelline membrane) was picked up using 
forceps. Then, two simultaneous movements followed: 1) the rest of vitelline membrane was 
cut; 2) the paper ring was tangentially removed from the yolk (direction – towards the first cut 
of vitelline membrane). 
Embryos collected on the paper rings were carefully cleaned from the yolk with the 
help of the forceps and were washed with Pannet-Compton saline. Cleaned embryos were 
placed ventral side up on the surface of agar plate taking care so that no air bubbles were 
trapped between the embryo and the agar surface. The lid was placed on the 30mm agar plate 
and the plate was transferred into a140 mm plate containing wet tissues and a 30mm plate with 
water. Six embryos were cultured in one 190 mm plate. Until six embryos had been collected, 
extracted embryos were kept in a closed 190mm plate in the hood. After six embryos had been 
collected, they were taken into a dissection room where they were either injected with a 
lipophilic dye or grafted with tissues from GFP+ embryos. 
Extracted embryos were incubated in humidified plates in Brinsea incubator set to 37.8 





2.8. Chick embryo grafting 
Grafting was carried out with conventional methods under Nikon AZ100 
stereomicroscope. In short, sections of primitive groove were excised from GFP+ donor and 
transplanted (complete tissue substitution) into stage-matched wild-type chick embryo donors 
in iso- or heterotopic position within the recipient primitive groove. Graft position and embryo 
development were recorded with the Nikon stereomicroscope using NIS Elements software. 
Images were processed with open source software ImageJ. Where labels were required, they 
were overlaid in with Photoshop software.  
 
2.9. DiI DiO chick embryo labelling 
Chick embryos were injected under PBS solutions with a mouth pipette with a pulled 
glass capillary loaded with working solutions of DiI or DiO. After injection, embryos were 
washed twice, checking under epifluorescent microscope for dye residues. 
 
2.10. Gelatin cryostat sections 
Tissues (mouse and chick embryos) were collected in PBS, washed and then transferred 
into 4% PFA for 2h. Tissues were then transferred into 15% sucrose/PBS(Ca-/Mg-) buffer and 
left for 2h at 4 oC to equilibrate. After the tissues sank to the bottom of the tube, they were 
further transferred into 15% sucrose/7% gelatine in PBS(Ca-/Mg-) buffer. Tissues in 15% 
sucrose/7% gelatine PBS (Ca-/Mg-) were incubated at 37 oC for 2h or till they sank to the 
bottom of the tube. 
Prepared for freezing tissues, were transferred into moulds with help of glass wide 
mouth pipette and set into 37oC incubator for equilibration. In 30 minutes, moulds were frozen 




Before cryoectioning, tissues were equilibrated at -28 oC in cryostat and cut for 7um 
thick sections. 
 
2.11. Immunohistochemistry with alkaline phosphotase on sections 
Gelatine from sections was removed by submerged slides in PBS slides and treatment 
in microwave owen (10-20 s). Sections were twice washed with fresh PBS and dried at room 
temperature for 10 minutes in the dark. Tissue sections were encircled with “Liquid blocker” 
PAP pen (Sigma-Aldrich, Z672548) and left to dry for another 5 minutes. Tissue sections were 
blocked for unspecific protein binding in the block solution (0.1% Tween 20, 10% FCS, 10% 
normal goat serum) for 30 min at 21 oC. Incubation with primary antibodies was carried out 
either for 18h at 4 oC or for 2 h at 21oC.  Sections were incubated in block solution with 1:1000 
diluted a-GFP rabbit serum (Invitrogen) for 1 h at 21oC or for overnight at 4oC. After 
incubation, sections were washed with PBS 3 times for 5 min. Sections were incubated in 
secondary antibody (1:1000 goat-anti-AP, Vector) for 1h at 21 oC.  
For alkaline phosphotase (AP) detection, vector Blue kit was used according to the 
manufacturer instructions (Vector, SK-5300). Sections were counterstained with nuclear fast 
red dye (Vector, H-3403) for 1 minute and washed for 10 minutes under running water. Then 
the slides were dehydrated in ethanol (2 minutes 90% ethanol/H2O; 2 minutes 100% ethanol) 
and cleared in Histo-clear (Agar) for 5 minutes twice. Tissue sections were mounted in 









2.12. Immunofluorescence on cryostat sections 
Initially slides were prepared the same at in section 2.11.  
After blocking, sections were incubated with primary antibodies (1:250 anti-CD45, Ab 
Serotech) or 1:100 anti-Runx1 (Abcam) in 0.1% Tween-20, 5% FCS/PBS for 18h at 4 oC. On 
the next day, sections were washed for 2 h at 4 oC first in fresh PBS and then in 0.1% Tween 
20, 10% FCS, 10% normal goat serum in PBS. 
Secondary antibodies (anti-rabbit-A647, Invitrogen; anti-mouse-A546, Invitrogen) 
were added and diluted to 1:250 in 0.1% Tween-20, 5% FCS, PBS. Incubation with secondary 
antibodies was carried out for 18h at 4 oC. 
Anti-GFP antibody was applied on the 3d day, after wash and 2h sections block in 10% 
FCS, 0.1% Tween-20, PBS. Rabit-anti-GFP antibody was from Invitrogen, applied diluted to 
1:250 in block solution for 2h at 21 oC. 
After immunostaining, sections were thoroughly washed with PBS (2h at 21oC) and 
conterstained with 1:500 DAPI in PBS. Rinsed in PBS sections were mounted in Vectashield 
Antifade Mounting Medium (Vector, H-1000) according to manufacturer instructions. Sections 
were analysed under a confocal microscope Leica SP8. 








3.1. Mapping early hematopoietic precursors based on Runx1 expression 
 
3.1.1. Introduction 
To date the mechanism of HSC development is not clear. To elucidate this mechanism 
of HSCs maturation, it is necessary to study HSC development from the very first steps of HSC 
specification.  Previously published works cite multiple sites of early HSCs appearance: dorsal 
aorta; yolk sac, placenta, head, heart. Today, there is still a disagreement as for the origin of 
pro-HSC [Medvinsky et al., 2011; Cumano et al., 2001; Rybtsov et al., 2014; Dzierzak and 
Speck, 2008; Gordon-Keylock et al., 2013; Samokhvalov et al., 2013; Gekas et al., 2010; Li et 
al., 2012; Nakano et al., 2013]. 
Runt related transcription factor 1 (Runx1, also known as Acute Myeloid Leukaemia 
protein 1, AML1) was identified to be the critical mediator of HSCs maturation [Okuda et al., 
1996; Tanaka et al., 2012]. Generally,  mouse   embryos   lacking   functional   Runx1   gene 
(AML1-/-)_appear to be normal till embryonic day 11 (E11). Around E11.5, AML1 knockouts 
(KOs) exhibit pale livers and at E12 AML1-/-_mutants develop haemorrhages in the central 
nervous system (CNS) and die. Microscopic examinations of fetal livers, yolk sac sections and 
blood samples derived from AML1 KOs revealed that these mutants completely lack definitive 
haematopoiesis in both the yolk sac and the fetal liver. Only primitive nucleated erythrocytes 
generated in the yolk sac were detected in AML1-/- embryos. All other blood elements 
(erythroid, myeloid, megakaryocytes or platelets) were absent [Okuda et al., 1996]. Most 




repopulating HSC [Mikkola et al., 2003; Liakhovitskaia et al., 2009 and 2014]. None of the 
other animal knock out models that affect haematopoiesis (tal/SCL, PU.1, GATA1, GATA2, 
GATA3, c-myb null mutations) has this widespread abrogation of all hematopoietic lineages 
development [Shivdasani et l., 1995; Polli et al., 2005; Gao et al., 2013; Fujiwara et al., 1996; 
Pandolfi at al., 1995; Hahl et al., 2009].   
Rescue of definitive haematopoiesis was demonstrated to be possible in the 
conditional Runx1 (AML1+/SACRE) model [Samokhvalov et al., 2013; Liakhovitskaia et al., 
2009 and 2014]. In AML1+/SACRE mouse model, upon tamoxifen injection, one copy of the 
Runx1 gene is reactivated, leading to normal haematopoiesis and embryo survival. On the basis 
of the results obtained in timed rescue experiments, Samokhvalov et al. (2013) suggested that 
dHSC specification takes place early during embryo development - around E7.5±1 day. 
To summarise, Runx 1 is the earliest regulator involved in hematopoietic stem cell 
maturation and/or a factor that controls development of HSC niche. In either way, expression 
of Runx1 shall mark a niche where pro-HSCs reside in early mouse embryos. According to 
several previous reports, Runx1 haploinsufficiency might lead into spatio-temporal alteration 
of Runx1 expression pattern [Cai et al., 2000]. Therefore, while useful insights have been 
obtained with utilization of Runx1+/LacZ transgenics [Daane and Downs, 2011], here we 
concentrated on Runx1+ cell mapping in wild type mouse embryos by means of 
immunofluorescence. This approach also allowed obtainmentm of better 3D representation of 




3.1.2. Experimental approach 
To detect prospective pro-HSCs in early mouse embryos (from neural plate to early 
somites stages of development, embryonic day 7-8), we mapped cells expressing Runx1 
transcription factor by means of immunofluorescence. Specificity of the Runx1 antibody was 
tested on AML1 LacZ/LacZ KO embryos (Appendix A1). To verify our findings for early somitic 
mouse embryos we also carried out beta-galactosidase staining on AML1+/LacZ heterozygotes. 
No differences in Runx1 expression in haploinsufficient AML1 and wild type early mouse 
embryos were found (Appendix A2 and A3). To get an insight into the phenotype of Runx1+ 
cells, some embryos were co-stained with endothelial (CD31 or VE-Cad), hematopoietic 
(CD41), or stem cell (c-kit) markers. Embryo staining was performed according to the 







3.1.3. Mapping Runx1+ cells in early mouse embryo 
3.1.3.1. Runx1+ cells location in the neural plate stage mouse embryo 
In the neural plate stage, gastrulation is not completed yet and the primitive streak 
(PS) cells continue to contribute to the embryonic and extraembryonic tissues. One of the latest 
extraembryonic tissues posterior PS contributes to is the allantois [Stern, 2004; Psychoyos and 
Stern, 1996; Sweetman et al., 2008]. Allantois is responsible for establishing a fetal-maternal 
interface by fusion with chorionic plate and later on transforming into an umbilical artery. 
Currently two alternative hypotheses exist for the allantois formation. According to the 
“classical” hypothesis, allantois is generated by the mesoderm displaced from the embryonic 
area [Tam and Beddignton, 1987; Parameswaran and Tam, 1995]. An alternative hypothesis 
developed by Downs states that allantois is generated by the posterior primitive streak only 
[Downs et al., 2004, 2009]. In the latter case, the posterior PS physically spans the embryonic-
extraembryonic boundary and remains there to give rise to allantois and to coordinate 
alignment of the umbilical artery and the dorsal aorta. Extraembryonic part of the posterior PS 
forms so called “allantoic core domain” (ACD)– reservoir of cells responsible for allantois 
elongation. ACD was also implicated in maintenance of Primordial Germ Cells during 
gastrulation. Recently, several reports have been published claiming allantois, umbilical cord 
and placenta are a niche for dHSC [Zeigler et al., 2006; Dieterlen-Lievre et al., 2010]. 
Therefore, in our mapping we have paid special attention to Runx1+ cells observed in the base 
of allantois or in its body. 
According to our results, in neural plate stage (no bud, early bud or late bud stages) 
there is no Runx1+cells present in embryo proper (Table 3, Figure 7.). In small number of cases 




and in the middle of the allantois (Table 3, and Figure 7.). In relation to the ACD, Runx1+ cells 
were found at the edge of the ACD, in the ACD or in more distal position from the ACD. Our 
results mainly agree with Runx1 expression reported by Downs et al. (2011) for 
haploinsufficient Runx1 mutants. One exception is we did not identify Runx1 staining in the 
distal allantois and the endoderm of the visceral yolk sac. When we carried out beta-
galactosidase staining on haploinsufficent AML1+/LacZ, we also did not find these cells. We 
could explain this by the LacZ staining modification (enhancement) performed by the authors. 
However, our main conclusions about the presence of Runx1+ cells in the ACD and later on in 
umbilical artery (UA) and omphalomesenteric artery (OMA), agree. 
Single Runx1+ cells were also found at the edge of the ACD, adjacent to the 
extraembryonic visceral endoderm, Figure 7., E. We would speculate that these cells were 
marking prospective vessel of confluence (VOC). VOC is poorly defined in the literature vessel 
that connects embryonic (dorsal aorta) and extra-embryonic (omphalomesenteric and umbilical 
arteries) vasculature [Inman and Downs, 2006; Daane and Downs, 2011]. When we examined 
older embryos, we found clusters of Runx1+ cells in the same position in forming VOC (Figure 
8, B and F). 
In all examined neural plate embryos, the yolk sac contained bright Runx1+ in large 
quantities. In three out of 19 embryos, Runx1+ cells were also found in chorionic plate lining 
(Figure 7, C, D). In four out of 19 cases, Runx1+ cells were found in clumps of cells protruding 
from the chorionic plate (Figure 7, D). We also found these cell clusters in the chorionic plates 
of older embryos. Strikingly, similar clusters of Runx1+ cells were previously reported for 
placenta lining in E10-11 mouse embryos and were found to be associated with definitive 




No staining except in the yolk sac was found for hematopoietic CD41 (four samples) 
and endothelial CD31 (three samples) markers in neural plate mouse embryos. We could not 
identify c-kit+ cells in any of the examined neural plate (NP) embryos (three samples, 
Appendix A4). Similar observations with immunofluorescent CD31 and CD41 antigens 
detection were reported by other authors, indicating weak, if any expression of these genes in 
other parts of the NP mouse embryo [Rhee and Iannaccone, 2012]. 
Table 3. Runx1+ cells location in early mouse embryo 
Location* 
Embryo development stage 
NP HF 1-13 sp 
Embryos # with given localization/ 
Total embryos # examined, (%) 




























































* - in all examined embryos yolk sac contained Runx1+ cells. Neural plate stage 
comprises: NB – no bud, EB – early bud and LB – late bud stages. Headfold stage comprises: 
EHF – early head fold and  HF – headfold stage; sp – number of somite pairs. Embryos 






Figure 7. Runx1+ cells location in the neural plate mouse embryos. Scheme of 
mouse embryo in neural plate stage of development. The image of DAPI stained mouse 
embryo in late bud stage is shown (A). Runx1 is expressed in all NP embryos in the yolk sac 
(B-F). In some embryos Runx1+ cells were also found in allantoic bud (B-D); in ACD (D), 
in chorionic plate (E,F) and in cells clusters in ChP (F). Scale bar is 500 µm. Allantoic bud 
(Al), allantoic core domain (ACD), amniotic cavity (AC), amniotic membrane (Am), 
Chorionic plate (ChP), ectoplacental cavity (EPC), exocoelomic cavity (EC), 





 3.1.3.2. Runx1+ cells in headfold stage mouse embryo 
With progression of mouse embryo development from neural plate (NP) to late head 
fold (HF) stage, number of embryos in which Runx1+ cells were found in allantoic core domain 
(ACD) or in the middle of the allantois increased (from 5 to 30% and from 11 to 50% of 
embryos, correspondingly), Table 3. During HF stage, the yolk sac vasculature expands, 
allantois and vessel of confluence (VOC) vasculogenesis begins. In contrast to the neural fold 
stage, at HF stage, endothelial cells (CD31+) were found not only in the blood belt, but also at 
the border of the embryo proper (Figure 8., C). On 3D reconstruction of the embryo surface, it 
is visible that endothelial cells are not dispersed homogeneously on the surface of the yolk sac 
but are aligned along the prospective vessels. Between these CD31+ cells (reaching almost to 
the embryo proper) rare cells express Runx1 transcription factor (Figure 8., C). Simultaneously, 
rare endothelial cells start to appear in the embryo proper - presumably along the future dorsal 
aorta (DA), (Figure 8., D). Initiation of the DA at HF stage was previously documented with 
staining for CD34, Flk1, CD31 and other endothelial markers [Wood et al., 1997; Strilic et al., 
2009; Drake and Flemming 2000].  
Vascularisation of the allantois takes place at a more rapid pace than that for the 
embryo proper. At the end of the HF stage, main allantoic vessel is already formed and it is 
marked by CD31+ and CD41+ cells, Figure 8., D-F. Rare separate Runx1+ cells were detected 
in the middle of the allantois, Figure 8., D. At the base of allantois, Runx1+ cells were found 
in the nascent vessel of confluence, VOC (Figure 8, B, and Appendix A5). VOC is initiated at 
the edge of the allantois adjacent to the yolk sac as a one-cell size opening at the allantois 
border [Inman and Downs, 2006; Daane and Downs, 2011]. This opening gradually increases 
in size, and VOC spouts towards the DA, the allantoic vessel and yolk sac vasculature. In 
observed embryos, this one-cell size opening was surrounded by CD31+Runx1+ cells (Figure 




CD41+Runx1+ cells in examined embryos (three samples), see Appendix A5. c-kit+ cells were 
dispersed in allantoic core domain (ACD) but did not particularly localize to VOC (Appendix 
A5). It is worth noting that primordial germ cells (PGC) migrate through the ACD at E8 are c-
kit positive. Hence, relating c-kit+ cells to pro-HSC at E8 could be misleading [Manova and 
Bachvarova, 1991]. 
To summarize, similarly to the NP stage, the majority of Runx1+ cells in the HF stage 
are localized to the blood islands belt. Rare Runx1+ cells appear in forming yolk sac 
vasculature, VOC and allantoic vessel. We did not observe Runx1+ cells in embryo proper in 





Figure 8. Rare Runx1+ cells localize to non yolk sac extraembryonic space in HF mouse embryo. Morphological features of headfold stage mouse embryo. 3D reconstruction. Anterior view showing 
the headfold (i); lateral view (ii); Posterior view showing posterior primitive streak and allantois (iii); Optical cross-section of headfold embryo (iv) (A); Runx1 expression in the point of initiation of the vessel of 
confluence (B); Spreading of CD31+ yolk sac vasculature and Runx1+ cells identified at the border of the embryo proper (C); Initiation of allantoic vessel formation: at early HF stage, CD31+ cells dispersed in 
allantois body; at late HF stage, they assemble into a branched. Rare Runx1+ cells localize to the body of the allantois (D); CD31_ allantoic vessel with no visible Runx1 cells inside it (E); Similar to F, CD41+ 
allantoic vessel (F). Af – amniotic fold; EPC – ectoplacental cone; ng – neural groove; nd – node; Hf – head fold; Al – allantois; PS – primitive streak; AC – amniotic space; EX – exocoelomic cavity; ChP – 






3.1.3.3.  Runx1+ cells in the early somites mouse embryo 
One of the signifying features of the early somites mouse embryos is the rampant 
development of intra-embryonic vasculature [Wood et al., 1997; Strilic et al., 2009; Drake 
and Flemming 2000]. Blood circulation starts gradually at 5 sp, but it is already 
completely established in the eight somite pairs mouse embryo [Jones, 2011; McGrath et 
al., 2003]. 
At the beginning of early somatic stage, Runx1+ cells were appearing in yolk 
sac vasculature bordering the vessel of confluence (VOC). Simultaneously Runx1+ cells 
were bordering VOC from the side of allantois (Fig 3.1.3.., D-F). Inside the allantois, 
Runx1+ were expressed along the nascent allantoic vessel so that its backbone now could 
be distinguished not only by CD31 or CD41 staining, but also by Runx1 staining (Figure 
9., G). 
Extra-embryonic and intra-embryonic vasculature could now be completely 
visualized by endothelial cell markers (CD31, VE-Cad) staining (Figure 10., E). We 
found that at the beginning of the somitic stage, nascent vessels were formed by the cords 
of endothelial cells consisting not only of spindle-like cells (representing endothelial 
cells), but also by round cells which are usually characteristic of migrating cells (Figure 
11., A, E). These cords were formed almost entirely from Runx1 negative cells. In the 
cords that would become a straight portion of the vessel, only spindle-like cells express 
Runx1 transcription factor (Figure 11., E). However, we found clusters of round 
Runx1+CD31+ cells at the junction between allantois and VOC (Figure 8., C). At the 




formations, strikingly resembling blood islands usually found in the yolk sac blood belt 
(Figure 10., D, F). These Runx+ cell clusters were expressing CD41 and CD31 markers. 
Clusters of Runx1+ cells were also found in the chorionic plate and inside the allantois 
(Figure 10. B). 
When we examined processed beta-galactosidase staining sections of 
haploinsuficient (AML1 +/LacZ) early somitic mouse embryos, we found Runx1+ cells in 
clusters in the VOC, allantois and chorionic plate. Therefore, at least at the early stages 
of mouse embryo development, the spatio-temporal pattern of Runx1 expression is not 
affected in AML1 haploinsufficient embryos [Cai et al., 2000]. 
Earlier, it was reported that in E9-E10 mouse embryos, clusters endowed with 
hematopoietic potential were found in the placenta, omphalomesenteric and umbilical 
arteries [Wood et al., 1997; Zeigler et al., 2006; Rybtsov et al., 2014].  We envision that 
these reported clusters are the descendants of the Runx1+ cell clusters we identified here 
in VOC, allantoic mesoderm and chorionic plate. 
At around the 13 sp embryo, when embryo turning has been initiated, we found 
polarized Runx1 expression in the lining of the dorsal aorta (Figure 15, F). Interestingly, 
this Runx1 expression was oriented towards the omphalomesenteric artery (or according 
to Downs, VOC that becomes a part of OMA). In contrast, the forming of an umbilical 
artery (allantoic vessel, future umbilical artery, UA) was not represented by one vessel at 
this time point, but by a branching tree of vessels and cords. Some cells in nascent UA, 




Figure 9. In early somitic mouse embryo, Runx1+ localize to nascent extraembryonic vasculature of allantois and VOC. Scheme of early somitic embryo (A); Vascular structure of pre-circulation 
embryos (B); Vascular structure of embryo with formed DA and initiated blood flow. Note elongated VOC (C); Spread of extraembryonic vascular network on the surface of the yolk sac in early somitic embryo. 
Arrows point to Runx1+ cells localized to endothelial cells aligned along nascent YS vessels. Some of the Runx1+ cells reached YS-embryo proper border. Black outline – caudal part, connected to allantois (D); 
Runx1+ cells form a branch of VOC (E); Runx1+ cells symmetrically outline VOC – YS vasculature junction (F); Runx1 is expressed in backbone of CD31+ allantoic vessel (G). Al- allantois; YS – yolk sac; hg – 






Figure 10. Runx1+ cells clusters in early somitic embryos localize to VOC, allantois and chorionic plate. Runx1+ clusters in the middle and the base of CD31+ allantoic vessel (A); 3D 
reconstruction of early somitic embryo. Pair of Runx1+ cell clusters in the base of allantois (i); Runx1+ cells cluster in chorionic plate (ii) (B); CD31+Runx1+ cluster of cells at the junction allantois – VOC 
(C); Optical cross-section of 5 sp embryo showing CD31+ extraembryonic vasculature with Runx1+CD31+ cluster in VOC (D); Optical cross-section of mouse embryo with established blood circulation 
showing CD41+ extra- and intraembryonic vasculature connected by VOC. CD41+Runx1+ cells cluster in at the base of VOC (F); 3D reconstruction of the stack of optical sections showing extra- and 
intra-embryonic vasculature (red) connected by VOC (white) (E). Al- allantois; CP – caudal part; YS – yolk sac; hg – hindgut; sp – somites; Ht – heart; Hd – head; Am – amnion; DA – dorsal aorta, VOC 





Figure 11. Forming in early somites vasculature gradually acquire spatially-defined Runx1 expression. Five sp mouse embryo DA optical cross-section showing Runx1+ primitive erythroblasts in DA 
lumen and large CD31+ cells with philopodia. DA lining is Runx1 negative (A); General view of mouse embryo with established blood circulation (B); Inset from B. Optical section showing caudal part 
focusing on OMA lumen. OMA lining expresses Runx1(C). Inset from C. CD31+ Runx1+ cells clusters symmetrically surround base of OMA (D); DA in pre-circulation embryo is formed from endothelial 
cell cords. Some cells exhibit round morphology characteristic for migrating cells. Only rare spindle-like cells express Runx1 (E). Inset from B. Optical section showing caudal part focusing on DA lumen. DA 
lining exhibits polarized Runx1 expression (F); Allantois from embryo show on B. Early stage of UA formation. Highly branched structure of CD31+ endothelial cords is visible with some CD31+ cells 
expressing Runx1 (G); Inset from G. A subset of CD31+ endothelial cells nascent UA show Runx1 expression (H). Al- allantois; CP – caudal part; YS – yolk sac; OMA – omphalomesenteric artery; Ht – heart; 







In agreement with prior reports, our mapping of Runx1+ cells show that in pre-somitic 
mouse embryos the majority of Runx1+ cells are localized to the yolk sac blood islands and 
the chorionic plate [Lacaud et al., 2004; Samokhvalov et al., 2006; 2009; 2014; Challen and 
Goodell, 2010; Yokomizo and Dzierzak, 2010; Yokomizo et al., 2011]. Rare single Runx1+ 
cells were found in the allantois. Runx1+ cells were identified in the base of the allantois, where 
they  were marking the site of initiation of the vessel of confluence (VOC). These observations 
are in agreement with those obtained with haploinsufficient AML+/LacZ embryo mutants  
[Zeigler et al., 2006; Downs et al., 2009; Daane et al., 2011].  With embryo development 
beyond the headfold stage, Runx1+ cells were also found in clusters situated in the VOC. We 
envision that found Runx1+ cell clusters are the predecessors of hematopoietic clusters found 
in later stages of embryo development in the placenta and the umbilical artery [Zovein et al., 
2010; Wood et al., 1997; Zeigler et al., 2006].  To elucidate whether these Runx1+ cell clusters 
have HSC potential, one would need to mature and expand these cells in in vitro culture 
[Cumano et al., 1996; 2001]. In this work we attempted E8 pro-HSC maturation in co-aggregate 
and explant culture. These results are described in the next chapter. 
According to our observations, initially intro-embryonic and intro-alantoic 
vasculature is built from cords of endothelial cells. These cords are built from two types of 
cells: CD31+ flat, elongated (spindle-shaped) cells and round CD31+ cells. Runx1 expression 
is rare in these cords and if present, restricted to spindle-like endothelial cells. Spindle-like 
cells have the same morphology as the endothelium lining cells found in the dorsal aorta. 




example, formation of the dorsal aorta in an embryo might be followed in vitro by means of 
light sheet fluorescence microscopy. 
 In embryos with established blood circulation (e.g., starting from 5-8 somite pairs, 
sp) Runx1+ cells are found in caudal parts in the lining of the dorsal aorta (DA). Runx1 in the 
DA is expressed in a polarized fashion. Specifically, according to our data, in E8-E9 mouse 
embryos are the only cells of the dorsal aorta wall that are the closest to the omphalomesenteric 
artery (OMA) expresses Runx1+. To note, in older mouse embryos, Runx1 is expressed in 
endothelia cells of the ventral and dorsal aorta walls and in sub-aortic spaces as well [Boisset 
et al., 2010; Yokomizo and Dzierzak, 2010; Yokomizo et al., 2011]. 
Our results show that in the E8 mouse embryo, the vessel of confluence (VOC) is 
marked with intensive Runx1 staining. This pattern of Runx1 expression is preserved till E9, 
when the DA fusion takes place. Site where the first DA fusion events take place co-insides 
with the site where Runx1 expression is upregulated in the early E9 mouse embryo. According 
to Rybstov et al. (2014) fist transplantable HSC in the E9 mouse embryo also originate from 
that portion of the DA. Therefore, the DA fusion might be a signal necessary to initiate 
maturation of Runx1+ HSC precursors. The DA fusion depends on bone morphogenic protein 
(BMP),  vascular endothelial growth factor (VEGF) and Sonic hedgehog (Shh) signalling 
[Garriock et al., 2010; Nagase et al., 2006]. Therefore, OP9 stromal cells transduced to express 






3.2. Early hematopoietic precursors engraftment potential 
 
3.2.1. Experimental approach 
According to the preceding reports, cells isolated from early mouse embryos 
(embryonic day 7-8, E7-E8) do not reconstitute the hematopoietic system of irradiated 
recipients directly [Medvinsky and Dzierzak, 1996; Cumano et al., 2001; Godin et al., 1993; 
Fraser et al., 2002]. In this work, hematopoietic stem cell precursors contained in the E7-8 
mouse embryo are denoted as pro-HSC and HSC precursors contained in the E9-E10 mouse 
embryo – as pre-HSC. To reveal pro-HSC hematopoietic potential, early embryo tissues must 
be cultured in vitro: as explants or co-cultured with stromal cell lines [Cumano et al., 2001; 
Fraser et al., 2002]. Successful engraftment with pre-cultured pro-HSC was demonstrated in 
transplantations into severe combined immunodeficient (SCID) or in natural killer-deficient 
Rag2γc-/- mice [Godin et al., 1993; Cumano et al., 2001]. Pro-HSC are unable to engraft 
immunocompetent recipients due to the lack of sufficient expression of major 
histocompatibility complex (MHC) class I molecules [Cumano et al., 2001; Kieusseian et al., 
2012]. Cells missing MHC-I molecules become targets of recipients’ natural killer cells 
[Cumano et al., 2001; Kieusseian et al., 2012]. Mature dHSC in contrast to pro-HSC express 
sufficient levels of MHC-I. It was demonstrated that during in vitro maturation, HSC precursors 
upregulate MHC-I expression and become transplantable [Kieusseian et al., 2012]. 
In our group, an efficient method of early (E9 derived) pre-HSC maturation and 




approach consists of pre-HSC co-aggregation with the OP9 stromal cell line [Sheridan et al., 
2009; Gordon-Keylock et al., 2013; Rybtsov et al., 2014; Rybtsov et al., 2016]. The OP9 
stromal cell line has been shown to stimulate maturation and expansion of hematopoietic 
progenitors and embryonic stem cells [Vodyanik et al., 2005; Ji et al., 2008; Rybtsov et al., 
2014; Gordon-Keylock et al., 2013; Souilhol et al., 2016). HSC precursors and stroma cells are 
mixed together and brought together by centrifugation. Formed co-aggregates are cultured on 
the top of floating nitrocellulose membranes for 4-7 days. An air-liquid interface culture 
method increases gas exchange within a co-aggregate, which might facilitate HSC maturation. 
Although the process of pre-HSC maturation in co-aggregate in not entirely understood, we 
hypothesize that this method will allow us to reconstruct a HSC niche microenvironment by 
promoting cell-to-cell contacts between pre-HSC and stroma cells. Therefore, in this work we 
utilized the co-aggregation technique to induce maturation of the E8 mouse pro-HSC.  
Prior data suggests that stromal cell lines derived from the AGM possess capacity to 
induce HSC maturation [Weisel et al., 2006; Oostendorp et al., 2002; Krassowska et al., 2006]. 
Assuming that the AGM stoma cells have similar properties to fresh AGM stroma, we tested 
co-aggregation of freshly isolated stroma cells with E8 tissues. For stroma cells, we used E9 or 
E10 CD45, CD41, CD43, Ter119 negative cells isolated from the mouse embryos AGM region. 
E8 cells were co-cultured with AGM stroma in two steps. First, E8 cells were co-cultured with 
E9 AGM stroma cells. Then, co-aggregates were dissociated and obtained cells were co-
aggregated with E10 AGM stoma cells. In this way, E8 cells are gradually positioned in the 
environment in which HSC mature. We were particularly interested to see if cells from the base 
of allantois (to which Runx1+CD31+CD41+ cell clusters were mapped) would repopulate the 




To compare efficiency of HSC maturation induced by fresh stoma to that induced by 
OP9 cells, in a separate experiment we substituted co-aggregation with fresh stroma by co-
aggregation with OP9 cells. 
As an alternative method of pro-HSC maturation, we carried out a previously 
described explants culture method (at air-liquid interface or as a submerged culture) [Cumano 
et al., 2001; Kieusseian et al., 2012]. In a separate experiment, cells isolated from explants were 
further co-aggregated with OP9 cells. The summary of culture methods used for E8 pro-HSC 






Table 4. Pro-HSC maturation culture methods used for E8 tissues 
Culture Step 1 Culture Step 2 
Culture at air-
liquid interface 
E8 cells co-aggregated with 
fresh E9 stroma 
Cells from Step 1 co-aggregated 
with fresh E10 stroma 
Cells from Step 1 co-aggregated 
with OP9 cells 
E8 explants culture 
Cells from Step 1 co-aggregated 
with OP9 cells 
N/A 


































































3.2.2. Pro-HSC maturation at air-liquid interface by co-culture with stromal cells 
Stromal cell lines and fresh stoma cells derived from the AGM possess a capacity to 
induce HSC maturation and expansion [Weisel et al., 2006; Oostendorp et al., 2002; 
Krassowska et al., 2006; Nishikawa et al., 2001; Souilhol et al., 2013A and 2016B].  Therefore, 
a co-culture of E8 mouse embryo derived cells with E9 stoma cells might also induce pro-HSC 
maturation. In our experiments, E8/E9_stroma co-aggregates were cultured for two days at air-
liquid interface. Then, these co-aggregates were dissociated and re-aggregated with E10 stoma 
cells (producing E8/E9_stroma/E10_stroma co-aggregates) Figure 12. In this way, E8 pro-HSC 
would be subsequently placed in microenvironments in which E9 and then E10 pre-HSC reside. 
Appearance of GFP+VE-Cad+CD45+ cells in co-aggregates would indicate E8 pro-
HSC maturation into transplantable pre-HSC [Rybtsov et al., 2011 and 2014]. When 
E8/E9/E10 co-aggregates were analysed by flow cytometry, we found that the GFP+ fraction 
of cells essentially disappeared from co-aggregates (Appendix A7 and A8). No GFP+ cells 
with a transplantable pre-HSC phenotype (VE-Cad+CD45+) were detected. Remarkably, in all 
cultures, GFP negative (GFP-) VE-Cad+CD45+cells appeared, indicating that some HSC 
precursors are negative for CD41, CD45 and CD43 markers were contained in E9 and E10 
AGM fraction of stroma cells. There could be several explanations for this: (1) non-complete 
stroma cells depletion from CD41low pre-HSC, or (2) maturation of negative for hematopoietic 
markers, but positive for endothelial marker VE-Cad+ cells into pre-HSC. If CD41low cells 
were retained in the stroma cells population, they could mature into CD45+VE-Cad+ pre-HSC. 
For instance, in a separate set of experiments we showed that E9.5 pre-HSC are VE-
Cad+CD45-CD41lowCD43- cells dispersed between stroma cells underlying the dorsal aorta. 
In addition, E9 pro-HSC maturation depends on the presence of stem cell factor (SCF) – one 




As no GFP+ cells with a pre-HSC phenotype were found after the co-aggregate 
culture, we substituted the co-culture step with E10 AGM stroma by a co-culture step with OP9 
stroma cells. When the content of these co-aggregates was analysed, we only observed the 
increase in GFP+ cells number in yolk sac cultures (Figure 13. and Appendix A7 and Appendix 
A8). Similar to E8 tissues co-aggregated with E9/E10 stroma, no GFP+ cells having a 
transplantable pre-HSC phenotype (CD45+VE-Cad+) were found in E8/E9_stroma/OP9 co-
aggregates. The same as in the previous experiment, a small number of CD45+VE-Cad+ cells 
were detected in the GFP negative fraction. We propose that the GFP-CD45+VE-Cad+ cells 
were derived from the E9 VE-Cad+CD41low cells. Therefore, the E9 mouse embryo aorta and 
subaortic space already contain hematopoietic stem cell precursors, which express endothelial 
marker VE-Cad, but do not express sufficient levels of hematopoietic markers (CD45, CD41, 
Ter119 or CD43). These cells can be matured into HSC in a prolonged co-aggregate culture (7 
days). Yet, E8 pro-HSC do not mature or expand in such a co-aggregate culture. 
To test whether the rare GFP+ cells after co-aggregate culture can proliferate in 
favourable conditions (for example, in a semi-solid medium supplemented with growth factors) 
we seeded cell suspensions obtained from dissociated co-aggregates in a MethoCult 
methylcellulose medium. GFP+ cells formed colonies in none of the cultures seeded with E8 
embryo proper tissues. It is only in YS co-cultures that multiple GFP+ cells were identified. 
These GFP+ cells did not proliferate more than forming clumps of 3-6 GFP+ cells and did not 
form any hematopoietic colonies. To note, cells derived from E9 stoma cells formed multiple 
hematopoietic colonies (Appendix A10). Therefore, pro-HSC contained in the E8 mouse 






Figure 13. Cellular composition of co-aggregates after culture.  Co-
aggregates were prepared with cells isolated from E8 or E9 mouse GFP+ embryos and 
with E10 or OP9 (GFP-) cells.  Caudal part (CP), allantois (AL), the region of the vessel 
of confluence (CPAL), yolk sac (YS). GFP+ cells – are E8 or E9 CP derived cells. 
GFP- cells – are  CD41-CD45-CD43-Ter119- cells (stroma) isolated from AGMs of 





 One small scale transplantation experiment was carried out with cell suspensions 
derived from cultured co-aggregates. All the recipient mice were injected with 2.5 embryo 
equivalents (ee) of an initial E8 isolated cell suspension. Recipients blood chimerism analysis 
showed that no E8 embryos derived GFP+ cells that were able to engraft the recipients, Figure 
14. and Appendix A11. Yet, the recipients’ haematopoietic system was repopulated with GFP- 
cells (up to 30% of blood chiemrsims) derived from the AGM region of E9 or E10 mouse 
embryos. These GFP- HSC shall be derived from the AGM cells population - e.g. from CD41-
CD43-CD45-Ter119- population assumed to be stroma cells. Notably, in accordance to prior 
reports, only E9 and E10 cells derived from caudal parts, but none from the yolk sac were able 
to engraft the recipients [Müller and Medvinsky et al., 1994; Godin et al., 1995; Medvinsky 
and Dzierzak, 1996; Cumano et al., 1996 and 2001]. Therefore, the utilized HSC maturation 
co-aggregate culture method is a powerful one and allows the revelance of hematopoietic 






Figure 14. Engraftment of E8 and E9 embryo derived cells. Blood 
chimerism 6 weeks after transplantation with cells obtained from dissociated co-
aggregates. Co-aggregates were prepares from cells isolated from E8 mouse embryo 
caudal parts and CD41-CD45-CD43-Ter119- cells (stroma) isolated from AGMs of E9 
or E10 mouse embryos or OP9 cell line. Caudal part (CP), allantois (AL), the region of 







3.2.3. Dorsal aortae fusion in E9 mouse embryos and its potential role in 
pro-HSC maturation 
According to our data, cells isolated from the E9 mouse embryo caudal parts 
proliferate and survive better in culture than those from the E8 embryo (Figures 13). Cells 
derived from 22-26 somite pairs (sp) of the E9 mouse embryo possess low definitive 
hematopoietic potential, which is comparable to that of the younger E8 embryo (Appendix 
A11). In contrast, cells derived from mouse embryos having more than 26 sp are able to mature 
into potent highly engrafting dHSC.  Number of transplantable pre-HSC rise sharply after 
embryo develops beyond 26 sp [Rybtsov et al., 2014].   
We investigated what changes take place in the mouse embryo AGM when the embryo 
acquires 26 somites pairs.  For this, we extended our Runx1 mapping to E9 mouse embryos. 
We specifically were looking at the 6-23sp area which was reported to possess the highest 
definitive hematopoietic potential. Three E9 mouse embryos were examined by 
immunofluorescence for a Runx1 expression pattern. 
According to our observations, the pattern of Runx1 expression in the caudal portion 
of the E9 mouse embryo remained the same as in early somitic E8 embryos: intensive staining 
in the omphalomesenteric artery (OMA) and polarised Runx1 expression in the dorsal aorta 
(Appendix A13). Clusters of Runx1+ cells are still observable in the OMA, Figure 15. 
According to prior data, the OMA carries multiple clusters of cells [Wood et al., 1997; Zovein 
et al., 2010]. Yet, as it was shown in Rybtsov et al., (2013) the area containing these clusters 
does not possess definitive hematopoietic potential. 
Polarisation of Runx1 expression in the dorsal aorta (DA) was different only in  how 




cells were localized to the medium DA wall, while in E9 mouse embryo Runx1+ cells were 
situated in the floor of the DA. 
3D reconstruction of the stack of optical sections done for three E9 caudal parts 
revealed that Runx1 expression is the strongest and specific to the ventral aspect of the DA 
around the level of the hind limb buds (Figure 15 and Appendix 6). At the same position we 
detected initiation of DA fusion, Figure 16. Similar to Udan et al. (2014) results, we found that 
DA fusion is initiated at several sites simultaneously. Remarkably at the same portion of the 
DA, the dHSC providing the highest level of engraftment was identified. Therefore, we can 
propose that maturation of pro-HSCs is initiated by events associated with DA fusion. Whether 
pro-HSCs maturation spreads to other parts of the DA, following aortae fusion is the question 
that shall be answered in the consequent experiments. 
If DA fusion is the necessary step that precludes pro-HSC maturation, what would be 
the trigger that causes this maturation? Runx1 is already expressed in this portion of the DA 
and therefore, Runx1 by itself should not serve as this trigger. Runx1 then shall be a permissive 
factor allowing initiation of pro-HSC maturation. Could it be that factors that stimulate dorsal 
aorta fusion also trigger pro-HSCs maturation? 
Garriock et al., (2010) in studies on chicken dorsal aorta fusion showed that Chordin 
(Chrd, a BMP antagonist) downregulation is necessary to allow DA fusion to occur. Authors 
demonstrated that Chrd expression is spatially and timely downregulated over the regions of 
the DA before aortae fusion. It is unclear how Chrd is downregulated in the notochord. Having 
in mind widespread BMP expression in early embryos, authors proposed that BMP signalling 
only primes endothelial cells to receive further positive vasculogenesis signals: vascular 
endothelial growth factor (VEGF) and Sonic hedgehog (Shh). They found that VEGF and Shh 




2010]. Inhibition of Shh delays DA fusion in chicken and mouse [Garriock et al., 2010; Nagase 
et al., 2006]. 
According to prior works, factors listed above also play a role in HSC maturation. 
Pardanaud and Dieterlen-Lièvre (1999) have shown that VEGF, fibroblast growth factor 
(bFGF) and transforming growth factor b (TGF-beta1) were able to induce hemangiopoietic 
(endothelial and hematopoietic) potential in the mesoderm. Bmp4, another positive 
vasculogenesis factor, was identified to be expressed in the mesenchyme underlying the DA in 
E10.5-E11 mouse embryos – in the site where pro-HSCs were found to reside [Le Douarin and 
Dieterlen-Lièvre, 2013; Pimanda et al., 2007; Rybtsov et al., 2011]. Inhibition of Bmp4 in the 
AGM explants abolishes development of [Souilhol et al., 2016A and 2016B]. Strikingly, miss-
expression of Bmp4 in midline of DA pre-fusion chick embryos causes precocious aortae fusion 
[Garriock et al., 2010)]. 
To summarise, the site of appearance of first detectable pre-HSC in E9 DA coincides 
with the site where the DA fusion starts. BMP signalling was demonstrated to be implicated in 
both: DA fusion and in modulation of pre-HSCs maturation. Therefore, in future works on the 
development of the systems for early HSC maturation, it is necessary to explore effects of BMP 
signalling on E8 cells maturation. For example, by E8 cells co-culture with stoma lines 






Figure 15. Runx1 is expressed in polarized fashion in E9 caudal vascular network. General view of E9 embryo (A); Structure vascular connection between extra- (OMA, UA) and intro- (DA) 






Figure 16.  DA region carrying the highest number of pre-HSCs undergoes paired aortae fusion shortly before HSC potential is detected. Superposition of dorsal aortae and OMA in E9 mouse embryo 






3.2.4. Pro-HSC maturation in explants with subsequent co-aggregation with OP9 
cells  
According to our results, early mouse embryo pro-HSC do not survive in utilised co-
aggregate culture. There could be several explanations for that. For example, E8 tissues 
collagenisation might destroy the niche in which early pro-HSC reside [De La Garza et al., 
2016]. The niche disaggregation separates pro-HSC from their cellular environment leaving 
pro-HSC devoid of stimuli which are necessary for their survival and maturation. A good 
candidate to be the pro-HSC niche is in the vicinity of the vessel of confluence where we 
identified clusters of Runx1+ cells (VOC) [Zeigler et al., 2006; Daane et al., 2011]. Therefore, 
the next pro-HSC maturation method we applied was E8 mouse embryo tissues explant culture. 
In the explant culture, small sections of E8 the caudal part (CP) or allantois (AL), yolk 
sac (YS), head, heart and somites (Ht, Ht or HH and Som) or the region of the vessel of 
confluence (VOC or CPAL) were cultured as an intact section of tissue. Tissues were cultured 
as explants on the floating nitrocellulose membranes for five days. After the explants culture, 
tissues were dissociated and either co-aggregated with OP9 cells or directly injected into mice 
recipients (Appendix A4 and Appendix A7). To compensate for E8 cells loss, we increased the 
dose of injected E8 cells to 6-10 ee per recipient. 
Analysis of blood chimerism in mice injected with cells after explant culture showed 
that 6 out of 15 mice (40%) had donor derived cells 6 weeks after transplantation (short term 
repopulation , STR). 5 out of 15 mice (33%) had donor derived cells in blood flow 3.5 months 
after transplantation (long term repopulation, LTR). Levels of blood chimerism were low (up 
to 0.3% of donor derived cells for STR and up to 0.2% in LTR) but above the cut-off level 




recipient and carrier cell populations (Appendix A13). Therefore, explants culture is preferable 
for E8 pro-HSC preservation. Though, this explant culture does not allow to mature E8 pro-
HSC –to the state when they fully repopulate the recipient’s hematopoietic system. 
In 3.5 months after injection, 33% of mice still contained donor derived cells in their 
blood flow. Not all of these mice had a level of blood chimerism above 0.1% at six weeks after 
transplantation (STR). In some mice that had blood chimerism above 0.1% in STR, further on 
number of donor derived cells dropped below 0.1% (the background level). 
Recipients peripheral blood was analysed for multilineage cell engraftment (3 
recipients transplanted with cells derived from 3-8sp embryos and having blood chimerism 
above 0.1%). According to our results, the majority of donor derived cells were of T-lymphoid 
lineage (Appendix A13). In contrast to our observations, Nishikawa et al. (1998) showed that 
after co-culture with OP9 stromal, cells from E8.5 mouse embryos exhibited myeloid potential. 
Previously, Fraser et al. (2002) reported that the E8.5 mouse embryo caudal part or yolk sac 
does not contain myeloid or lymphoid progenitors. It is only E9 embryos or older which contain 
these progenitors. Prior reports lack consistency as for the E8 cells contribution, yet all reports 
agree that lymphoid contribution is only observed for intraembryonically (caudal part) derived 
cells. Since we were able to identify lymphoid progenitors in immunocompetent recipients one 
day earlier that it was reported before, our explants method (prolonged culture at air-liquid 
interface in presence of growth factors) is superior to that reported before [Fraser et al., 2002; 
Matsuoka et al., 2001; Cumano et al., 1996; Nishikawa et al., 1998]. 
Therefore, E8 pro-HSC for their survival and maintenance require a 
microenvironment in which they reside. However, this niche does not contain maturation 




by blood circulation, heartbeat or DA fusion. OP9 stromal cell line do not provide E8 pro-HSC 
maturation signals and hence co-aggregation with OP9 does not mature of E8 into pre-HSC. 
 
 
3.2.5. Pro-HSC maturation in explants at an air-liquid interface 
According to our conclusions in the previous part, co-aggregation with OP9 cells does 
not mature E8 pro-HSC. Instead, low levels of engraftment (0.1-0.3%) are observed in mice 
injected with cells derived from explant cultures of E8 mouse embryo tissues. Therefore, here 
in a small-scale experiment we tested whether co-aggregation with OP9 has any effect on donor 
cell engraftment. For this, we cultured a caudal part with allantois and yolk sac as explants for 
five days. Resulted explants were collagenized and injected into recipients directly after the 
culture. 
Our results show that co-aggregation with OP9 neither positively nor negatively 
affects pro-HSC fraction. Pro-HSC are still able to engraft recipients at the threshold level 
(above 0.1%). However, the donor population is reduced below the level of detection 3.5 
months after engraftment. Judging by our flow cytometric analysis of recipients ’peripheral 
blood, even though the donor cell fraction is very small, it is distinguishable from the recipient 
and carrier cells fraction, and the number of donor cells is larger than the number of false-
positively stained cells (Appendix A15). 
We analysed the multilineage composition of donor derived cell population and found 
out that the majority of donor cells are of T-lymphoid lineage, the same as in a previous E8 
culture experiment conducted with OP9 step co-culture. Low numbers of B-lymphoid cells and 





3.2.6. Pro-HSC maturation in submerged culture 
Since pre-cultured at an air-liquid interface, E8 mouse embryo cells did not seem to 
provide significant levels of recipient mice engraftment, next we used a culture method 
described in Cumano et al. (2001). In short, we cultured explants in submerged conditions for 
four days. Cumano et al. (2001) reported that the four days explant culture is the optimal period 
of time that allows us to maximize the yield of multipotent HSC. The difference between this 
method and methods of culture that we used before is that the cells inside submerged explants 
shall be under hypoxic conditions. For example, in prior publications it was shown that in 3D 
tissue cultures, the concentration of oxygenation is limited in tissue structures thicker than 100-
200 [Muschler et al., 2004; Malda et al., 2007; Volkmer et al., 2008]. Hence, all cells localized 
inside explants deeper than 200 µm will be under hypoxic conditions. We hypothesized that 
these hypoxic conditions could imitate the microenvironment in which pro-HSC exist before 
the onset of blood circulation. 
All E8 tissue explants (caudal part and allantois - CPAL, yolk sac - YS, Heart – Ht 
and head - Hd) showed efficient cell proliferation in culture. Extensive outgrowth (adherent 
cells) were observed around explants except for in the yolk sac (YS) cultures. 
Yolk sac explants description. In YS cultures, tissues were increasing in size, but they 
were rarely attached to the floor of the plate. Usually, tissues formed sphere-like structures, 
which floated at the top of the culture medium. Inside these structures, patches of red blood 
cells were appearing in the space of 2-4 days. According to our observations, the YS tissues 
floating was caused by YS tissues “healing” (re-connecting cut YS tissue) and forming sphere-
like structures resembling a YS of reduced size. According to our observations, YS tissues 




what makes YS cultures float on the top of culture medium. Therefore, Yolk sac explants were 
not at hypoxic conditions during culture. 
Description of explants of caudal part and allantois. Head and heart explants. In these 
explant cultures, extensive cells outgrowth was observed around the tissues laying on the 
bottom of the well. Acidification of the culture medium was also evident from the phenol red 
colour change. In the caudal part and allantois (CPAL) explants, allantois produced vessel-like 
structures around which round hematopoietic-like cells appeared in 2-4 days. Previously, 
similar observations were reported by Matsuoka et al. (2001). Heart explants in two days 
developed rhythmic contractions. 
In total we carried out three transplantation experiments with cells obtained from 
submerged explants. Mice were transplanted with an increased dose of cells, e.g. each mouse 
obtained an injection equivalent to ten E8.5 embryo equivalents, Appendix A22. Two later 
experiments (Appendix A16 and A17) were designed to distinguish maternal (Ly5.2 homo 
cells) contribution from that of donor embryonic cells (Ly5.1/2 het cells). No maternal 
contribution was found.  
7 out of 54 (13%) of recipients had donor cell contribution above the threshold level 
(0.1%) in a short term (6 weeks) donor cells engraftment assessment. Two recipients had the 
highest observed level of contributionin this study: 1.2 and 0.3% of donor cells. These two 
mice were transplanted with cells obtained from head and heart (HdHt) explants from 6-13sp 
(established blood circulation) mouse embryos. In 3.5 months after transplantation, the level 
of blood chimerism in these two mice dropped to 0.3% and 0.13%, correspondingly. When we 
looked at the components of the donor cell population in these recipients, we found that the 
mouse with the highest blood chimersim observed in this study (STR blood chimerism - 1.2%) 




derived cells were most probably myeloid and lymphoid progenitors, but not genuine HSC. On 
the other hand, the detailed development of HSC is still not elucidating. Thus, it is possible, 
that the earliest pro-HSC have restricted hematopoietic potentials and will generate multipotent 
HSC later in embryonic life. For example, mature HSC are not a uniform population of cells 
and have different myeloid and lymphoid potentials [Dykstra et al., 2007]. For today, it is 
unknown where and when this heterogeneity originates in the embryo. 
The other recipient (STR blood chimerism - 0.3%) similar to other recipients which 
showed donor cells blood chimerism 0.1-0.2% had mainly contribution to T cell lineage 
(88.5%). Therefore, we could propose that the early mouse embryo contains lymphoid 
progenitors or pro-HSC prone to generate lymphoid cells only. In this work we detected this 
lymphoid potential one day earlier than it was previously reported and in all studied 
compartments (yolk sac and embryo proper) [Fraser et al., 2002; Matsuoka et al., 2001; 
Cumano et al., 1996; Nishikawa et al., 1998]. In contrast to this, when myeloid donor derived 
cells were detected, the level of recipient engraftment was much higher than in other cases. 
Nishikawa et al., (1998) reported that contribution to myeloid lineage takes place earlier than 
to lymphoid lineage, yet detectable at E8.5 embryos. The levels of blood chimersim in 
peripheral blood using CD45.1 and CD45.2 markers are not reported in prior works [Fraser et 
al., 2002; Matsuoka et al., 2001; Cumano et al., 1996; Nishikawa et al., 1998]. Therefore, it 
might be that the recipients with the level of blood chimerism about 0.1% were not considered 
as having been repopulated and therefore were not studied in detail. If only recipients with 
higher levels of blood chimerism were studied, E8.5 mouse embryo tissues contribution to 







Figure 17. Recipients engraftment with cells derived from early mouse embryo tissues (embryonic day 8) after tissues culture 
as explants at air-liquid interface. Levels of donor cells blood chimerism (A); Multilineage engraftment (B). In circles – recipients whose 
blood was analysed for lymphoid and myeloid cells contribution. YS- yolk ac; CPAL – caudal part and allantois; HH – head and heart; sp – 









Figure 18. Recipients engraftement with cells derived from early mouse embryo tissues (embryonic day 8) after tissues culture 
as submerged explants. Levels of donor cells blood chimerism (A); Multilineage engraftment (B). In circles – recipients whose blood was 
analysed for lymphoid and myeloid cells contribution. YS- yolk ac; CPAL – caudal part and allantois; HH – head and heart; sp – somite pairs; 






Runx1 mapping described in Chapter 3.1. shows that early somitic embryos (E8) 
contain Runx1+ cell clusters in the nascent omphalomesenteric artery (OMA) and allantois. 
Similar clusters of cells were found in E9-E10 embryos and were proposed to possess 
hematopoietic potential [Wood et al., 1997; Zovein et al., 2010]. Around E8 upregulation of 
Runx1 expression takes place in the dorsal aorta (DA) endothelium, which indicates the 
beginning of pro-HSC maturation [Lam et al., 2010; Swiers et al., 2010; Chen et al., 2011; 
Samokhvalov et al., 2014]. Having in our hands the new powerful method of pre-HSC 
maturation in co-aggregates, we endeavoured to attempt to reveal the potential of early pro-
HSC contained in E8 mouse embryo tissues. 
In this chapter, we discussed results of transplantation experiments carried out with 
cells derived from early mouse embryo tissues (embryonic day 8-9, E8-9, 0-26 somite pairs). 
Mouse tissues were preconditioned in a set of culture systems ranging from co-aggregation 
with OP9 or E9-10 AGM stroma cells to tissue explants. 
The most efficient culture condition to detect hematopoietic potential of E8 embryo 
tissues was proved to be the explants submerged culture (Table 5). The percentage of donor 
derived cells in recipients’ blood flow was low (0.1%-1.2%), but donor derived cells formed a 
clearly distinguishable population on flow cytometry plots. Here using mice engrafted with 
carrier cells and/or stromal cells only we established the cut-out level of blood chimerism above 
which the recipient reconstitution can be considered to be the valid one. This allowed us to 




According to our data, after culture, cells derived from explants demonstrate limited 
lymphoid and myeloid potentials. In all but one reconstituted recipient, engrafted cells 
produced mainly T-cells and limited numbers of B- and myeloid cells. Interestingly, in the only 
case when donor cells produced substantial number of myeloid cells, the overall level of 
repopulation was an average tenfold higher than the observed level of blood chimerism (1.2% 
versus 0.1-0.3%). In this case, in contrast to all other reconstituted recipients, T-cells were 
absent in the recipient’s peripheral blood. Some previous works reported the appearance of 
myeloid cells prior to lymphoid ones. At E8.5 lymphoid potential was found to be restricted to 
the embryo proper tissues [Fraser et al., 2002; Matsuoka et al., 2001; Cumano et al., 1996; 
Nishikawa et al., 1998]. Yet, from the prior reports it is unclear what percentage of donor 
derived CD45+ leukocytes were the reconstitution threshold level. Therefore, it is possible that 
recipients showing low levels of reconstitution (around 0.1% of blood chimerism) were 
previously not studied in detail and therefore the hematopoietic potential of cells derived from 
early E8 mouse embryos was missed. Using our criteria of recipient reconstitution allowed us 
to detect engraftable hematopoietic cells one day earlier than it was demonstrated before. Yet, 
this hematopoietic potential was limited – low levels of donor derived cells contributing mainly 
to the T-lymphoid lineage. According to the hematopoietic stem cell definition – HSC is a cell 
able to fully reconstitute recipient’s hematopoietic system to the high level [Urso and Congdo, 
1957; Till and McCulloch, 1961; Becker et al., 1963; Seita and Weissman, 2010]. Our culture 
conditions failed to mature E8 pro-HSC into mature HSC. Whether this is because we detected 
early hematopoietic progenitors or HSC, requires further investigation. For example, to prove 
HSC nature of identified hematopoietic progenitors, it might be necessary to conduct secondary 
transplantation experiments (e.g., donor cells isolated from primary hosts re-transplanted into 






Table 5. Efficiency of pro-HSC maturation culture methods used for E8 tissues 








aggregated with E9 
stroma 
Cells from Step 1 
co-aggregated 
with E10 stroma 
0/3 N/A 
E8 cells co-
aggregated with E9 
stroma 
Cells from Step 1 
co-aggregated 
with OP9 cells 
0/3 N/A 
E8 explants culture 
Cells from Step 1 
co-aggregated 
with OP9 cells 
6/15 5/15 
E8 explants culture N/A 1/1 0/1 
Submerged 
culture E8 explants culture 
N/A 6*/34 6/34 
 
None of the applied methods were efficient enough to trigger complete E8 pro-HSC 
maturation. Cells, assumed to be AGM stoma cells (CD45-CD43-CD41-Ter119-), derived 
from caudal parts of E9 and E10 mouse embryos did not stimulate E8 pro-HSC maturation. 
Yet, these cells in co-culture with E10 stroma cells produced low level repopulating HSC and 




already contains almost mature pre-HSC; (2) E9 and E10 tissues do not contain factors that 
induce pro- and pre-HSC maturation; (3) OP9 stroma cell line induce HSC maturation and 
expansion of pre-HSC contained in E9 mouse embryos. 
Subaortic tissues of E9 and E10 mouse embryos contain pre-HSC precursors. For 
instance, cells isolated from the AGM region of E9 and E10 mouse embryos and depleted from 
CD41, CD45, CD43 and Ter119 positive cells after a culture step were able to engraft onto 
irradiate recipients. This could be explained by retaining in this cell suspension VE-Cad 
positive CD41low (endothelial) cells. Rybtsov et al. (2014) have demonstrated that pre-HSC are 
primed by low expression of CD41. In agreement with Rybtsov et al. (2014), pro-HSC in 22-
26 sp (E9) embryos have only low repopulating potential, which is comparable to E8 
repopulating potential.  It is still unclear why earlier E8 pro-HSC cannot be matured in culture 
systems. In our experiments, we show that a fraction of E8 cells when co-cultured with other 
cells rapidly disappear. In contrast, E9 cells have superior proliferation and survival potential 
to E8 cells. Therefore, one of the possibilities could be that the E8 cells have blocked 
proliferation and in culture are outcompeted by faster proliferating E9 cells. To elucidate what 
could be the trigger inducting E8 pro-HSC proliferation, we investigated the events that take 
place in AGM of 21-29 sp mouse embryos. 
In early E9 mouse embryos, intensive vessels remodelling in caudal parts takes place 
[Walls at al., 2008; Garcia-Porrero et al., 1998; Zovein et al., 2010]. For instance, the midline 
of the DA extends from mid-trunk caudally into the proximal part of the tail region. With the 
application of optical projection tomography, Walls et al. (2008) have demonstrated that by 26 
sp diameter of ompalomesenteric artery (also called vitelline artery, VA) becomes much 
smaller than that of the umbilical artery. The authors suggested the blood flow shifts towards 




At the beginning of E9, the vitelline artery is initially connected to the umbilical 
arteries. By 22 sp the vitelline artery (VA) establishes a new connection with the DA [Garcia-
Porrero et al., 1998]. Soon after the VA disconnects from the umbilical artery, large clusters of 
CD31+VE-Cad+ cells appear in the ompalomesenteric artery (OMA) [Zovein et al., 2010]. 
These events coincide with the appearance of dHSC precursors in the E9 embryo [Rybtsov et 
al., 2014]. We envision that the clusters we identified in early somitic embryos (E8) are the 
predecessors of those described by others in E9 and E10 embryos [Wood et al., 1997; Zovein 
et al., 2010].  
When we examined early E9 embryos, we found that the Runx1 expression pattern is 
not essentially changing when embryo develops from E8 to early E9 embryos. Intensive Runx1 
expression is observed around the vessel of confluence (VOC). VOC is the point of 
amalgamation of the omphalomesenteric artery (OMA), umbilical artery and dorsal aorta 
[Zeigler et al., 2006; Daane et al., 2011]. Runx1 expression in the dorsal aorta (DA) is 
polarized. Runx1 is specifically expressed in the section of DA adjacent to the VOC. We also 
found that the area reported by Rybtsov et al. (2014) to bear the pre-HSC in fact is the site 
where paired aortae first fuse. According to our data, the aortae fusion takes place immediately 
before transplantable HSC cells appear in the embryo.  
Garriock et al. (2010) reported that BMP antagonist (chordin) downregulation is 
required for DA fusion. Overexpression of Bmp4 triggers precocious DA fusion, while Shh 
and VEGF inhibition delays the fusion. Therefore, we envision an intimate connection between 
DA fusion events and induction of pro-HSC maturation. Hence, future studies in the direction 
of development of pro-HSC maturation systems shall also involve cultures treatment with BMP 
signalling mediators. For instance, Bmp4-expressing stromal cell lines could be utilized. Most 
probably, such pro-HSC maturation would require a fine tuning of multiple mediators, which 




3.3. Tracing DA progenitors in early chick embryo 
 
3.3.1. Experimental approach 
Since existing to date methods of pre-HSC maturation are not applicable to mature the 
earliest precursors of HSC (pro-HSC), another approach had to be developed to clarify the 
ontogeny of embryonic HSC. 
Today it is broadly accepted that first HSC arise in the aorta-gonad mesonephros 
region (AGM) [Medvinsky et al. 1993; Muller et al., 1994; Medvinsky and Dzierzak, 1996; de 
Bruijn et al., 2000]. Specifically, appearance of transplantable HSC coincides with the 
appearance of so-called inta-aortic clusters (IAC) [Babovic and Eaves, 2014; Bhatia 2007; 
Boisset et al., 2010, 2011; Bollerot et al., 2005; de Bruijin et al., 2002; Bertrand et al., 2010]. 
These clusters can be found in the floor of the mouse embryo’s dorsal aorta starting from 
embryonic day 10.5 (E10.5) [Taoudi and Medvinsky, 2007; Rybtsov et al., 2011]. Similarly, 
in chick embryos, clusters of Runx1+ cells appear in the dorsal aorta (DA) floor around 
embryonic day 3 (ED3) [Jaffredo et al., 1998, 2005; Zovein et al., 2008; Boisset et al., 2010; 
Bertrand et al., 2010; Kissa and Herbomel, 2010; Swiers et al., 2010]. Therefore, one of the 
methods to trace ontogeny of HSC would be to label the DA and IAC and to trace their progeny 
in adult animals. Since transgenic mouse models that allow exclusive DA labelling are not 
developed yet, a method of surgical labelling of the DA, for example by grafting, would suffice 
this aim. The chick embryo is a robust animal model allowing various surgical manipulations 
and capable of surviving into adulthood afterwards [Stern, 2004]. Therefore, we have selected 
chicken embryo as a model for labelling the DA. Our first task was to identify an area that 




Prior data suggest that the DA is formed by lateral plate mesoderm descendants. 
According to Stern, lateral plate mesoderm (LPM) arises from the middle-primitive streak 
(mid-PS) [Stern and Psychoyos, 1996]. Yet, as for today no studies were conducted to identify 
the exact primitive streak (PS) position and stage at which the LPM generates DA precursors. 
Therefore, our task here became to identify a PS area generating DA portion that bears IAC. 
To fulfil our goal, we labelled PS with lipophilic dyes and by grafting labelled PS regions 
(sections of GFP+ PS extracted from stage-matched GFP+ chick embryo donors). We also 
established a chick embryo culture facility at Scottish Centre for Regenerative Medicine 
(SCRM) and worked out conditions allowing us to culture generated chimeras in vitro for 3 
days. 
All chimeras and donors were photographed at several time points: at the time of 
grafting and at least once a day for the next 3 days. For the timed observations, chimeras were 
photographed every 3 hours. First, chimeras were scored for DA contribution under 
stereomicroscope in culture on day two (so-called “early chick embryo culture”, EC day 2). 
This method of scoring was verified with the whole mount anti-GFP stained chimera under 
confocal microscope. Chimeras were collected and preserved at EC day 2-3 (chimeras showing 
signs of deterioration were terminated at EC day 2). Some chimeras were examined as whole 
mounts under confocal microscope. Other chimeras were cryosectioned and processed to reveal 
GFP staining with anti-GFP alkaline phosphatase or combined immuno-fluorescent method to 
examine GFP, Runx1 and CD45 expression in chimera’s tissues. Generalized conclusions as 
for DA contribution presented below were drawn on pooled data for stereomicroscopic 
chimeras observation at EC day 2. Conclusions as for contribution to other tissues and 
contribution to DA lining and intra-aortic clusters (IAC) were made on the data obtained with 




3.3.2. Defining early aortae landmarks for scoring contribution to the dorsal 
aorta 
To enable scoring grafts contribution to the dorsal aorta (DA) we had to decide on a 
set of landmarks that would enable DA identification in transparent pre-circulation chick 
embryos. For this we initially looked at in ovo cultured chick embryos with initiated blood 
circulation (48-50h embryos). Embryos were extracted and prepared as they would be observed 
in early chick culture (EC), i.e. oriented ventral side up (Figure 19., A). In a 48h old chick 
embryo the dorsal aorta is situated directly above the somites. It is represented by two 
transparent aortae (Figure 19. B and C). When the DA is filled with blood cells, its 
identification does not present difficulties. However, when the DA is devoid of blood, it might 
be difficult to spot an aorta. In this case, we found it helpful to identify the DA wall that faces 
the embryo midline (Figure 20., C). This wall appears to be built from a single layer of spindle-
like angioblasts. Due to these cells’ elongated shape and refraction properties, they form a 
distinct feature that allows the DA identification from the very beginning of its formation 
(happens at Hamburger and Hamilton stage of chick embryo development 9, or HH9) 
[Hamburger and Hamilton, 1992]. 
To guide us on the margins of the DA, we injected a blue fluorescent dye (extracted 
from a common highlighter, according to Takase et al., 2013) into the vascular system of 50h 
old chick embryos. Embryo examination showed that caudally to the vitelline vessels (VV), 
the DA is not formed yet. It is represented by the interrupted line of spindle-like cells 
(angioblasts) rostrally to the VV. Laterally, the DA wall is not continuous. It is merged with 
area pellucida vessels in multiple sites. Similarly, in younger embryos, forming DA also can 
be identified by its facing embryo midline wall (lateral DA wall virtually does not exist). The 
DA is intimately merged with the area pellucida (AP) vasculature and so, to the yolk sac. As 




body folds becoming totally encircled by the embryo body around HH20 (72h). From this point 
it is impossible to tell the contribution to DA without sectioning off the embryo (Figure 21.). 
As our final goal is to culture chimers till hatching, non-invasive methods of validation 
contribution to DA are preferable. We have selected EC day 2 to be the time point when initial 
scoring of grafts contribution to DA is carried out. 
 
Figure 19. Distinguishing dorsal aorta in chick embryos and embryo 
development in culture. Chick embryo appearance in in ovo and in EC culture (A). 50h in ovo 
cultured chick embryo injected with a blue fluorescent dye (according to Takase et al., 2013). 
Dorsal aorta identification is possible when focusing on the cord of angioblasts next to the 





3.3.3. Embryo survival and development in early chick embryo culture 
EC chick embryo development is similar to that observed for in ovo cultured embryos 
(Table 6.). 
At EC day 1 the embryo reaches HH stage 10-11. The number of somites increases 
totalling on average 10 sp. At the end of EC day 2, heartbeat starts. Heartbeat initiation 
correlates with embryo survival in the culture at day 1 (93.8±13%), Table 6.  No lag in 
development of cultured embryos is apparent at EC day 1. 
At EC day 2, the number of somites continue to increase reaching at the end of EC 
day two twenty-five somites on average. In the in ovo cultured embryos, the number of somites 
would reach 30; therefore, at EC day 2 embryos start to show signs of lagging development. 
Visually EC cultured embryos are smaller, but otherwise they are comparable to those cultured 
in ovo (Figure 19., A). At EC day 2, area pellucida vasculature expands and connects intra- and 
extra-embryonic circulation loops; the DA matures, and blood circulation is initiated.  Visually, 
blood circulation rate is slower in EC embryos; however, it is hard to address this question as 
upon examination of EC embryos, they are exposed to a lowered temperature (which drops 
from 38 to 22 oC during embryo examination). Temperature drop slows down blood circulation. 
Blood circulation is re-established when the embryo is returned to the incubator. EC embryos 
look paler than in ovo cultured ones; yet, blood cells are present in their circulation. Visually 
the amount of blood cells in EC cultured embryos is lower than that in in ovo cultured ones. 
We have established that the absence of blood circulation is a sure sign of embryo 
deterioration at day 3. Embryo decomposition happens on a rapid scale in EC culture, leading 




exhibiting poor development at EC day 2 were terminated and preserved for further 
examination. 
Contribution to the DA becomes evident at EC day 2. Further on, the DA is encircled 
by the embryo body, and non-invasive examination of the DA becomes impossible. Therefore, 
initial scoring of the contribution to DA was done at EC day 2. Further below we show that 
this scoring corresponds well to GFP+ cells contribution to the DA, which was revealed on 
sections or with whole mount confocal microscopy (Figure 25.).  The only discrepancy between 
scoring at EC day 2 and at EC day 3 on sections was observed for grafts that contributed to the 
caudal portion of the DA. In these embryos, contribution to the DA is not yet evident. 
Contribution to the caudal DA takes place at the end of EC day 3. Here, we need to notice that 
the contribution to caudal DA is not of main interest in this work, as caudal DA does not bear 
IAC. 
EC day 3 was the last day of an embryo in EC culture. Less than 10% of embryos 
survived into day 4 in in vitro conditions. For our purposes, embryo culture beyond day 3 was 
not required. First, we were looking at the contribution to DA anterior to omphalomesenteric 
artery (OMA). This kind of contribution is evident at EC day 2. Second, we were looking for 
IAC production by cultured embryos. In ovo, IAC are formed starting from HH19 and peak at 
HH21 (84h). At EC day 3, the total embryo age in hours is 84, which corresponds to the age 
when the maximum number of IAC could be observed. Therefore, at the end of EC day 3 
embryos were collected and preserved for further examination. 
Lagging of embryo development in EC culture becomes evident at EC day 3. The 
embryo head is underdeveloped, the heart is extended, blood circulation is slowed or 
interrupted, and the embryos are pale. Yet, the number of somites increases, reaching 35-40, 




19.). We have identified that the critical factor in embryo survival in EC culture is the freshness 
of the used eggs. E.g., eggs used for EC culture started at HH3-4 shall be laid at the day of the 
experiment. Otherwise, the embryos deterioration becomes evident starting from EC day 2 and 
embryos survival till day 3 becomes impossible. 
Table 6. Grafted chick embryo survival and development in early chick 
embryo culture (EC) versus in ovo intact embryo culture 
 
EC day 




Embryo stage at grafting 
HH4 HH5 HH6 
Observed in EC (expected in ovo) 
stage of embryo development, HH 
























3.3.4. Labelling by injection with lipophilic dyes is not efficient method to trace 
mesodermal progenitors of dorsal aorta 
Initially, we attempted to trace mesodermal progenitors of the dorsal aorta (DA) with 
primitive streak (PS) labelling done with lipophilic dyes (DiI and DiO) by injection. This 
method was widely utilized before for mapping the chick embryo primitive streak [Psychoyos 
and Stern, 1996; Sweetman et al., 2008; Limura et al. 2007; Sawada and Aoyama et al., 1999].  
For this, HH4-10 embryos were injected with dyes in the groove of PS, trying to label only a 
limited number of cells. 
With lipophilic dyes injections, we found that it was hard to achieve visual DA 
labelling. For example, from 27 labelled embryos, only 3 exhibited limited labelling of the DA 
wall: one, labelled at HH5 at 62% of PS length, and two embryos labelled at HH6 in PS 
positions 57 and 61% (Figure 20.). In these embryos, contribution to the DA was presented 
only by a short stretch of cells in the DA wall. Even though we were able to see extensive dyes 
contribution to lateral plate mesoderm, contribution to the DA was not evident. This finding 
contradicted our expectations built on previously published results for PS mapping [Psychoyos 
and Stern, 1996]. For instance, the lateral plate mesoderm that gives rise to the DA is derived 
from the middle region of HH3-6 PS, and therefore DA labelling shall be evident with HH3-6 
PS labelling at positions from 40% to 60%. On the other hand, to date there are no works 
published showing dyes contribution to DA. For us that indicated inherent unsuitability of dyes 
labelling method to trace cells contribution to such structures as the DA. In addition, due to the 
need to wash out dyes residues after injection, embryo survival dropped, so that the embryos 
rarely developed beyond EC day 2, making assessment of dye contribution to intra-aortic 




After we performed PS labelling by grafting, it has become clear why DA labelling 
with dyes was problematic. As we observed (Figure 20.), cells forming the DA migrate from 
the bulk of lateral plate mesoderm cells. At every stage of gastrulation, the PS produces the 
bulk of the lateral plate mesoderm (LPM) cells that migrate laterally and anteriorly, and then 
limited numbers of LPM cells migrate medially to contribute to the DA. The rest of LPM cells 
stay at lateral positions and later on contribute to the area pellucida vasculature or lateral body 
wall. Therefore, limiting the number of labelled PS cells in turn limits the number of labelled 
DA. It would require further investigation whether LPM cells that contribute to DA are random 
LPM cells, or these cells are pre-fated to become DA cells. Answering this question would help 
to label the DA more precisely, avoiding co-labelling of LPM. To sum up, cells that contribute 
to the DA are intermixed with the rest of LPM cells, and exclusive DA labelling is not possible 
by labelling the pull of LPM cells. In other words, at present DA labelling is not possible 
without co-labelling of LPM. For DA sufficient DA labelling, numbers of labelled in PS cells 







Figure 20. Labelling by lipophilic dyes injection is not efficient method to trace 
mesodermal progenitors of DA. EC day 2 chick embryo overlaid with the scheme of tissues 
to which dyes contribution was scored (A); EC day 2 chick embryo overlaid with scheme 
showing localization of extra-embryonic vasculature (ExV) and dorsal aorta (DA). DA is 
split in caudal and rostral parts (B); Example of an embryo showing contribution to DA. 
HH5 chick embryo was injected with DiI at approximately 62% of PS length. In 30h in EC 
culture, contribution to DA became evident. DiI+ cells formed midline facing DA wall 
(white arrows). Cells labelled with DiO at approximately 68% of PS length contributed 
mainly to pre-somitic mesoderm and somites (white arrowheads) (C); Summary of 




3.3.5. Tracing dorsal aorta progenitors with primitive streak grafting 
3.3.5.1. Primitive streak grafting is an efficient method of dorsal aorta labelling 
 When the chicken embryo primitive streak (PS) was isotopically grafted with 
tissues derived from PS of a GFP+ stage matched embryo, clear DA labelling was achieved 
(Figure 21.). As it was shown with dyes labelling, first GFP+ graft cells migrated to form the 
lateral plate mesoderm, and then to contribute to the DA or area pellucida vessels. In contrast 
to dyes labelling, enough cells were labelled with grafting procedure that allowed illuminating 
the entire dorsal aorta wall. 
At “early chick embryo culture” (EC) day one grafted cells migrate anteriorly and 
laterally contributing to LPM. At EC day 2 GFP+ lateral plate mesoderm (LPM) cells start to 
migrate towards the chimera’s midline to contribute to the DA or laterally – to contribute to 
area pellucida vessels (Figure 21., A). Though, the majority of cells stay in LPM. Together 
with enhancement of DA visualization, we increased visualization of the area pellucida 
vasculature, which is also derived from the same portion of the LPM that contributes to the 
DA. At EC day 3 the embryo grows and elongates. Because of this, visually the GFP+ region 
of the DA moves to the anterior. Yet, in fact GFP+ DA position stays unaffected. This can be 
verified, if DA contribution is reported in relevance to the level of somites, next to which DA 
contribution is recorded. 
Reconstruction of confocal optical sections recorded with EC day 3 whole mount 
chimeras showed contribution to the DA, which agrees with scoring results obtained under 
stereomicroscope for these chimeras at EC day 2. Confocal microscopy and cryosections 
analysis revealed that GFP+ cells also contributed to: dorsal mesentery, peri-neural vascular 
plexus, somatic and splanchnic lateral plate mesoderm, and vessels of area pellucida (Figure 





Figure. 21. Primitive streak labelling with GFP+ grafts allows to visualize dorsal aorta. HH4 chick embryo isotopically grafted 
into approximately 55% of PS length. During EC day1, GFP+ grafts cells migrate laterally and to the anterior, contributing to LPM. At EC 
day 2, LPM cells contribute to DA and area pellucida vasculature (A); Close up of DA in EC day 2 chick embryo. Contribution to DA wall 
cells is shown with white arrowheads. At EC day 3, grafts become surrounded by lateral body wall, and scoring contribution to DA becomes 
impossible. Optical sections reconstruction of the chimera are shown in (A-B). Dorsal aorta is labelled with red star. GFP+ cells are shown 






Full 3D visualization of scanned chimeras does not give clear representation due to 
wide-spread LPM labelling, which obscures the DA. The best visualization results were 
achieved by optical two plane reconstruction (e.g. XY or YZ or XZ planes). Therefore, for 
future, we utilized cryosectioning as a way to explore the labelled DA area. 
 
3.3.5.2. In early chick embryo 30-70% region of primitive streak contributes to 
dorsal aorta 
HH3-HH7 chicken embryos were grafted at various positions in the primitive streak 
(PS) (from 10 to 90% of its length), Appendix A7. As described above, contribution to the DA 
was scored at EC day 2. From 111 analysed embryos, 35 were excluded due to stage or position 
mismatch. The rest (76) were analysed for contribution to the following tissues: DA, lateral 
plate or intermediate plate mesoderm; area pellucida and area opaca vasculature; somites and 
pre-somitic mesoderm; head and heart region (Figure 22.). 
In HH3-4, grafts also intensively labelled extra-embryonic vasculature (area pellucida 
and yolk sac vasculature). PS region that did not contribute to the yolk sac (60-70%) still 
contributed to AP vessels (Figure 22.). the Area pellucida gives rise to both extra- and intra-
emryembryonic vasculature. In addition, as we will show later, the area pellucida might be 
implicated in blood cell generation that would complicate interpretation of grafts contribution 
to haematopoiesis. For our purposes, we had to identify the PS region that does not contribute 
to pre-aortic haematopoiesis (extra-embryonic haematopoiesis). For instance, 50-60% of HH5 
PS region do not contribute significantly to area pellucida vasculature. The only detail to verify 




According to our observations, long stretch of PS (30-70% of its length) contributes 
to the DA: at HH3-5 – from 30 to 70% of PS length, and at HH 6-8 – from 30 to 60 % of PS 
length (Figure 22. and Appendix A7). Obtained results are in accordance with previously 
reported maps of PS contribution to LPM. [Psychoyos and Stern, 1996; Sweetman et al., 2008; 
Limura et al. 2007; Sawada and Aoyama et al., 1999]. Not reported before, contribution to the 
mesoderm that gives rise to DA cells continued over the several stages of embryo development, 
apparently producing the same stretch of DA (Figure 25.). Therefore, we have decided to 
investigate contribution to rostral and caudal parts of the DA in more detail, and to try to 








Figure 22. Grafts contribution to DA and adjacent tissues. Mid-primitive streak 
(30-60% of PS length) contributes to DA over several stages of chick embryo development 
(A); HH3 and HH4 mid-primitive streak contributes to embryonic and extra-embryonic tissues. 
Contribution to YS tissues is ceased in HH5 mid-PS, though PS still contributes to area 





3.3.5.3. At different gastrulation stages, mid-primitive streak contributes to 
overlapping portions of the dorsal aorta  
What we found surprising in our results is that the same region of the primitive streak 
(30-60% of its length) in HH3-6 chick embryo contributes to overlapping portions of the dorsal 
aorta (DA). Within the same embryonic stage, different regions of primitive streak (PS) also 
contribute to overlapping portions of the DA; however, anterior mid-streak contributes to 
rostral DA, and caudal mid-PS – to caudal DA. Additionally, the length and exact position of 
labelled DA portion varied from chimera to chimera. Therefore, to pool observations and be 
able to compare chimeras, we had to introduce an additional parameter. As such, we introduced 
an index of embryo length, which shows where GFP+ cells contribution took place by embryo 
length. We assigned value “1” to the first somite in the embryo and value “0” to the 20th somite. 
According to our observations, in 50-60h chick embryos, the omphalomesenteric artery (OMA) 
connects to the DA approximately at the position of 20th somite, and conveniently indicates the 
middle of the embryo (Figure 25.). Below OMA-DA junction somites are not formed yet and 
so, expressing DA contribution in somites number becomes impossible. To approximate length 
of GFP+ DA caudally to OMA, the caudalmost point of the embryo was assigned value “-1”. 
In this way any point along embryo axis could be expressed in numbers, from -1 to 1 with “0” 
indicating the OMA-DA junction. 
Thirty-four chimeras, in which somites could be clearly counted, were used in analysis 
of contribution to the DA by embryo length. When grafts were pooled for their corresponding 
grafting position (20-30; 30-40; 40-50; 50-60; 60-70%) and plotted for their position relative 
to the embryo length, it has become evident that older grafts contribute to overlap, but shifted 
caudally portions of the DA (Figure 23.). Within the same embryonic stage, 30-70% PS 
position contributes to be overlapping, but slightly shifted portions of the DA: more anterior 




Visualized in this indirect way, contribution to DA revealed dense cross-overlapping 
of LPM contribution to DA – within the same stage and between different embryonic stages of 
development.  
 
Figure 23. Mid-streak grafts contribution to DA by embryo length. Primitive 
streak (PS) grafts contribute to overlapping portions of DA. White arrow indicates 1st somite; 
red arrow indicates 20th somite – position around which OMA connects to DA. Black arrow 
shows 15th somite – position where first IAC are observed (A); Mid-primitive streak in older 
embryos contributes to more caudal DA portions. Within the same embryonic stage, more 
anterior mid-streak contributes to more anterior DA portion. Neighbouring regions in mid-




3.3.5.4. Cells from adjacent regions of PS migrate by different trajectories, but 
contribute to overlapping portions of DA 
To directly verify that the same portion of the dorsal aorta (DA) is built from 
descendants derived from different regions of the mid-primitive streak, we carried out 
additional series of multiple grafting experiments. In these experiments chick embryo hosts 
were isotopically grafted with two or more differentially coloured grafts. In this way, migration 
of the cells derived from two (or more) primitive streak (PS) regions could be distinguished 
and traced simultaneously. 
Our prior experience with multiple grafts of mid-streak showed that grafts spaced as 
far away as 10% would contribute to overlapping areas (not shown). Therefore, we had to 
invent a way to label grafts with different markers. As described above, dye injection does not 
allow labelling a sufficient number of cells in the PS to be able to label entire portion of the 
DA. However, cells staining with lipophilic dyes by itself is quite stable (lasts 2-3 days) and 
allows to mark within the area to which contribution takes place. Therefore, we hypothesized 
that if we stain grafts externally in DiI, the grafts (a) would provide a sufficient number of cells 
to trace their contribution to the DA and (b) graft position could be distinguished by DiI 
presence in the area. Therefore, here we combined PS grafting with GFP+ tissues and GFP+ 
tissues externally stained with DiI (e.g. by immersion in DiI solution). 
Figure 24. shows tripe graft (35-45-55% of PS length) done on HH4 recipient. As it 
is shown on the figure, migrating cells form a fan-like shape, illuminating migratory routs of 
PS cells. Yet, already at 13h after grafting, labelled areas are tightly adjacent to each other. 
Anterior-most PS region (labelled with GFP only) contributes to the upper limit of the lateral 
plate mesoderm (LPM) and to the corresponding DA portion. Contribution to the DA becomes 




grafts and contributes to the lower portion of the DA at 31 - 42 h of culture. The most caudal 
GFP+ graft contribute to the area pellucida and yolk sac vasculature from 42 to 70h of culture. 
Therefore, contribution to lower portions of the DA takes place later than that for more anterior 
portions of the DA. 
Similar results were obtained with HH5 embryo multiple grafting (25-40-50-60% of 
PS length), see (Figure 25.). Initially well-spaced grafts show typical fan-like migratory routes, 
but labelled LPM becomes compacted by 16h of embryo culture. By 42h, all labelled areas 
fuse into one stretch of LPM that does not have any unlabelled gaps within it. This indicates 
intermixing of mesoderm cells – descendants of adjacent PS regions. Moreover, according to 
our observations, cells gradually exit the graft position. (Figure 25., 3h – 13h). In this way, 
labelling the PS at an earlier stage is simultaneously PS labelling at all later stages of the 
embryo development. We did not investigate whether that would be the same position in 
shortened PS. This might be an interesting topic for further investigation. 
To directly visualize and register LPM cells position before they migrate to contribute 
to DA and/or extra-embryonic tissues, we carried out timed observations of isotopically grafted 
(20-70%) HH4 and HH5 chick embryos (Figure 26.-31.). According to our observations, 
except 20-30% HH4 PS grafts (Figure 26.-9), all 30-70% HH4 PS grafts contributed to the DA. 
In accordance with our prior observations, HH4 30-50% grafts also contributed to the area 
pellucida and/or to the yolk sac vasculature. The main difference in migratory routes of LPM 
cells was their lateral-medial position before these cells initiated secondary lateral or medial 
migration, leading to their final positions in the DA or yolk sac. It is worth noting here that the 
bulk of LPM cells stayed in the lateral body wall. As it can be seen from time lapse images, 
within the same developmental stage anterior-caudal position of labelled LPM cells depends 




Since we have discovered that adjacent PS regions contribute to overlapping portions 
of the DA, we looked again at the fraction of embryos excluded from analysis (35 chimeras). 
We selected embryos grafted within 30-70% with positional mismatch. Maximum mismatch 
was 15% and the minimum one – 10% of PS length. All these chimeras with a positional graft 
mismatch contributed to the DA, in agreement with PS grafted position. Therefore, final 
position of migrating mesodermal cells does not depend on their origin in PS, but on the 
position where they started their migration from PS to LPM.  
To verify this hypothesis, we carried out an additional small scale heterotopic grafting 
experiment. Since it has become clear that adjacent regions of the PS would produce 
overlapping portions of DA, we had to distinctly label grafts. For this, we used GFP+ grafts 
and “wild type” PS grafts stained with DiI. To increase dye penetration into tissues, we reduced 
size of DiI grafts, and this in turn affected our results. E.g., cells in smaller grafts had to migrate 
to the border of PS grove, while cells in wider grafts have already covered some distance in the 
LPM. As a result, (a) small grafts located anteriorly to the wide grafts ended up at the same 
position as cells from wide grafts; (b) small grafts located caudally to wide grafts ended up 
directly behind cells from wide grafts in LPM. Therefore, we can conclude that the width of 
the graft affects contribution to LPM and cells caudal-lateral position in the DA. the Size of 
the graft also affects the length of the labelled DA section. Yet, this did not affect globally 
grafts contribution to the DA and /or extraembryonic vasculature. 
For instance, on Figure 32. we show results of heterotopic grafting with 35% DiI graft 
transplanted into 55% PS, and GFP graft from 60% of PS grafted at 45% (Table 7., graft 3). 
The same as it was described above, the graft was located caudally in the mid-streak (GFP+ 
graft on Figure 32.) contributed to LPM portion at more lateral position than DiI+ mid-streak 
graft. Most importantly, grafts derived from 35% of PS (DiI+ graft) did not contribute to 




graft contributed to the DA located above OMA, as was predicted by grafting position at 55% 
of PS length. GFP+ graft which was originally positioned at 60% of PS contributed to the area 
pellucida vessels, in accordance to its grafted position at 45% of recipient’s PS (Figure 32.). 
Therefore, we can conclude that the whole mid-streak contributes to the dorsal aorta 
(DA). Exact cell position in DA is determined by this cells migration route in lateral plate 
mesoderm (LPM). Not all LPM cells will contribute to the DA. The anterior region of mid-
streak contributes cells to anterior part of the DA, and caudal region of mid-streak – to caudal 
DA. As the embryo develops, the mid-streak contributes to more caudal portions of the DA; 
yet, those still overlap with DA sections built with prior PS descendants. The caudal mid-streak 






Figure 24. HH4 chick embryo triple graft (35-45-55% of PS length) shows contribution to different portions of DA that substantially overlap.  Grafted cells migrate along fan-like trajectories 
(3-20h). Cells ingressing at more caudal position migrate more laterally than cells ingressing at anterior PS. Labelled LPM areas become closely adjacent (20h). Contribution to rostral DA is evident at 31h 
of culture (white arrows), while contribution to caudal DA is noticeable at 42 h. Labelled cells (GFP+, DIi+ cells) form one uninterrupted area indicating substantial overlap between descendants of adjacent 






Figure 25. HH5 chick embryo multiple graft (25-40-50-60% of PS length) show contribution to overlapping DA parts. Initially ingressing through mid-streak cells migrate along well separated 
trajectories (0-13h). By 16h LPM cells align forming one uninterrupted stretch of cells. This stretch of LPM is formed by compacted and so intermixed descendants of neighbouring regions of mid-streak (16h). 






Figure 26. Contribution to extra-embryonic vasculature and DA in chimeras grafted at HH4 20-45% of PS length. Graft position in host embryos (A); PS overlaid with 0-100% scale to show exact 
graft location (B); GFP+ grafts contribution to extra-and embryonic vasculature, EC day 2. Only in chimera grafted at 20-30% of PS graft did not contribute to DA. In other chimeras, grafted from 25 to 45% of PS 





          Figure 27. Migration of grafted GFP cells (HH4, positions: 20-45%) to the dorsal aorta.  In all but 20-30% grafted chimeras, GFP+ cells first migrate to form LPM (0-18h); The more laterally cells 






Figure 28. Contribution to DA in HH4 embryos grafted at 45-70% of PS length. Grafts position in the embryo (A); PS overlaid with scale to show exact graft location (B); Insets for Figure 29. 








Figure 29. Migration of grafted GFP cells (HH4, positions: 45-70%) to the dorsal aorta.  At 0-20h in EC culture grafted cells migrate to form LPM. Final position of LPM in the embryo depends on 




Figure 30. Contribution to DA in embryos grafted at HH5. Graft position in HH5 recipients (A); Exact grafts position shown by on PS overlay with a scale (B); Insets for Figure 31. More caudal mid-







Figure 31. Time-laps of contribution to LPM and DA in chick embryos grafted at HH5. Whole mid-streak (30-50% of full PS length) contributes to LPM. More anterior regions of mid-streak 





Figure 32. Original cell position in mid-streak does not determine its position in DA. Cell position in DA depends on its migratory trajectory in LPM. Time-laps of HH4 heterotopically 
grafted chicken embryo development. 35% of PS length wild-type chick embryo tissue stained with DiI and transplanted into 55% PS position in the recipient. Tissue from 60% PS region from GFP+ 





































































































35 60 GFP Yes Above OMA no 
55 55 DiI No OMA and above no 
2 5 
35 65 GFP Yes Above OMA no 
65 55 DiI Yes OMA and above no 
3 4 
60 45 GFP Yes OMA and above yes 






3.3.6. Not only yolk sac produces blood cells in early chick embryo  
During chimeras examination at “early chick embryo culture” (EC) day 2 and 3, we 
noticed that some of the chimeras had fluorescent cells in their blood flow. These cells were 
fluorescent only in settings for GFP excitation; hence, they were not autofluorescent, but GFP+ 
cells. Amount of GFP+ cells identified in the blood flow varied between chimeras from rare 
single cells to the dozens of cells registered per 10 seconds. Frequency of finding chimeras 
with GFP+ cells in blood flow are given in Table 8. In chimeras grafted at stage HH6 or later, 
GFP+ cells in blood were identified only in 1 chimera grafted at 70% of PS. 
Table 8. Frequencies of finding chimeras with GFP+ cells in blood flow 
Recipient stage 
at grafting 
Grafted PS region, 




Number of chimeras 
displayed GFP+ cells in 
blood flow (%) 
HH4 -5 
<35 14 0 (0) 
35-45 15 1 (6.5) 
45-55 16 4 (25) 
55-70 21 4 (19) 
>70 12 1 (8) 
 
None of the yolk sac (YS) chimeras that survived till the third day in EC on 
examination had GFP+ blood (Appendix A8). These chimeras had partial GFP+ labelling of 
YS and had blood circulation but did not have noticeable GFP+ cells contribution to the blood. 
This is an unexpected result, as the first primitive blood cells arise in the yolk sac. This could 
be explained if mesoderm progenitors of the first blood cells migrated to the YS prior to the 
grafting procedure, e.g. before HH4. Indeed, endothelial or Runx1+ cells appear in the area 
opaca (yolk sac) much earlier than those in the embryo proper [Hirakov and Himura, Jaffredo 
et al., 2005; geisha.arizona.edu ID ENG.UApct]. However, whether this is the consequence of 
differentially regulated genes expression in intra- and extraembryonic areas or time restricted 




On examination of sections of chimeras carrying GFP+ cells in blood flow, 
GFP+Runx1+ cells were identified in the vessels lumen (Figure 35.). Interestingly, embryos 
that displayed GFP+ cells in blood had contribution to the DA, intermediate mesoderm and to 
some extent to the vasculature in the area pellucida, but not to the yolk sac. Therefore, here we 
identified a not earlier appreciated source of early blood cells (or mobile cells that travel with 
blood flow) that arise not from the yolk sac, but from another embryonic region. 
In half of cases GFP+ cells were already identifiable the in blood flow at EC day 2, 
e.g. before DA fusion and intra-aortic clusters (IAC) appearance. Simultaneously, these cells 
were still present at EC day 3 (when DA fuse and IAC start to appear). Additional experiments 
are required to establish if there is a link between IAC and GFP+ cells at day 3 in EC. A possible 
source of these cells could be area pellucida vessels (AP). At least in some embryos, AP vessels 




3.3.7. Dorsal aorta and intra-aortic clusters are mosaic structures formed by 
descendants of multiple regions of primitive streak 
A region of the dorsal aorta (DA) that bears intra-aortic clusters (IAC) contains 
precursors of definitive HSC. One of the methods to trace IAC’s progeny would be to label 
them and to trace their contribution to the hematopoietic system in an adult chick. According 
to the current opinion on IAC ontogeny, clusters arise from the DA endothelial lining or from 
this lining and the cells underlining the DA. Therefore, DA labelling would enable tracing 
progeny of IAC clusters. In this chapter, we show for the first time that the mesoderm 
contributing to the DA originates from a wide region of the PS during multiple stages of chick 
embryo development. Hence, we have encountered a question: whether portions of the 
mesoderm derived from different parts of the PS have equal ability to produce IAC. To answer 
this question, chimeras with contribution to the IAC bearing part of DA were sectioned and 
immunostained for GFP and hematopoietic markers Runx1 and CD45. 
Prior reports show that in chicken embryos IAC bearing portion of the DA is located 
around the 15th somite pair [Drevon et al., 2010; Lassila et al., 1999]. In the chapter above, we 
show that region of the PS from 45% to 65% of its length contributes to the DA portion 
spanning from 1st to 20th somite, or the portion of the DA located anterior to the OMA. Hence, 
the portion of the DA formed by descendants of cells ingressed through the PS at 45-65% of 
its length shall be IAC progenitors. 
To establish whether IAC were formed by PS descendants regardless of the stage 
when grafting was carried out, in total 8 chimeras were analysed for IAC presence and their 




























cells in a 
cluster 
(+/-) 
1 45 (4) Good + + + +** 
2 50 (4) Good + + + + 
3 50 (4) Poor + + - - 
4 50 (5) Good + + + + 
5 35 (6) Good + - + - 
6 45 (6) Good + + + + 
7 50 (6) Poor + + - - 
*  - “Good” condition - chimera is HH17 or older and presents heartbeat and blood circulation; “Poor” 
condition – weak heartbeat is present, blood circulation is absent. Chimera did not develop further than HH16; ** 
- only one GFP+ cell; “+” indicates presence; “-“ – absence. 
 
In all examined chimeras, the DA lining was GFP+. The extent to which GFP+ cells 
contributed to the DA lining varied. The most intensive GFP+ staining was observed in the 
middle of the area having GFP+ cells contribution. In this position, GFP+ cells were also found 
in the lateral body wall, dorsal mesentery, peri-neural vascular plexus, somatic and splanchic 
lateral plate mesoderm (Figure 33.). 
Clusters were identified in all chimeras developed in EC day 3 beyond HH17 (Table 
9.). IAC clusters containing GFP+ cells were identified in all areas where grafts contributed to 
the rostral DA. If a graft did not span to the area where the IAC were formed, IAC were still 
identified, but they did not contain GFP+ cells (e.g. chimera ID5). 
In one case (from analysed chimeras), when chimera (ID1) had contribution to area 
pellucida vasculature, GFP+ blood cells were identified in blood circulation (Figure 34). When 




cells (Figure 35, B). This chimera had a GFP+ DA lining with a good number of GFP+Runx1+ 
cells in it. Clusters were mainly represented by Runx1+CD45+ cells. Identified on sections 
clusters were mainly Runx1+. In one instance, GFP+ cells were at the base of such a cluster 
(Figure 35., A) and in another case a GFP+ cell was identified inside a budding aortic cluster 
(Figure 35, D). Identification of mainly GFP- clusters suggests that in this chimera contribution 
to the DA was mainly not in IAC bearing portion. 
Embryos grafted at HH5 and HH6 at 50 and 45% of PS length had contribution of 
GFP+ cells to the DA lining and to intra-aortic clusters (IAC), (Figure 36. and 37.). IAC were 
found to contain different numbers of GFP cells: some IAC were entirely GFP positive while 
others contained just one or two GFP+ cells (Figure 35. D and 37., F). Within clusters, cells 
also had different expression of hematopoietic markers Runx1 and CD45 (Figure 37. E, F). 
Dynamics of hematopoietic markers expression within chick embryo IAC is not described and 
hence, Runx1 and CD45 markers expression migh be upregulated at later developmental 
stages. For instance, in in ovo cultured chicken embryos, cells within one cluster are uniformly 
Runx1 and CD45 positive (Figure 33.). 
As GFP is a permanent marker, occurrence of clusters with a mixture of GFP+ and 
GFP- cells indicates that IAC are not of a clonal origin. It is also possible that GFP+ cells 
migrate in and out of a cluster. Entirely GFP+ IAC were observed in chimeras with a complete 
GFP+ dorsal aorta lining. In chimeras with rare GFP+ cells in the aorta lining, IAC contained 
rare GFP+ cells. Hence, clusters originated from the mosaic (GFP+GFP-) aortic floor, and 
correspondingly had a mixture of GFP+GFP- cells. This hypothesis was also supported by our 
prior observations about DA composition. The DA is a mosaic organ built from descendants 
of a broad region of the PS arising during several stages of an embryo development. Therefore, 
complete labelling of all IAC with a single PS graft is hard to achieve. Whether a cluster is a 






Figure 33. Transverse sections through EC cultured chimera and in ovo 
cultured ED3 chick embryo. Anti-GFP alkaline peroxidise staining on cross-section 
through chimera isotopically grafted at mid-streak (45-55%) at HH4) (A); Wild-type in ovo 
cultured ED3 chick embryo cross-sectioned through dorsal aorta showing clusters of cells 
expressing CD45 and Runx1 (B). Peri-neural vascular plexus (1), DA endothelial lining (2); 







Figure 34. HH4 40-50% region of PS contributes to IAC bearing part of DA, area pellucida vasculature and blood. General 
view of grafted chimera with inset: PS overlaid with a scale to show exact graft position (A); Contribution of GFP+ cells to LPM during 
EC day 1 (B);  At EC day 2 GFP+ graft cells contributed to DA (white arrows) and area pellucida vessels (C); At EC day 3, graft cells 
contributed to some vasculature of YS. Rostrally and caudal parts of DA are labelled; area pellucida vasculature is labelled anterior and 
caudally to OMA-DA junction (D); GFP+ cells are detectable in embryo circulation. White arrowheads show positions of GFP+ cells in 








Figure 35. HH4 mid-streak gives rise to DA and early embryonic blood. Immunofluorescence on frozen sections of chimera grafted 
at 40-50% region of PS. Longitudinal section of chimera shown on Figure 33. GFP+ cells contribute to DA lining. Some GFP+ cells co-express 
Runx1 (white arrowheads). Runx1+ cluster of cells has GFP+ cells in its base. (A); Another longitudinal section showing contribution to DA 
lining (small empty arrowheads) and blood cells co-expressing GFP and Runx1 (large empty arrowhead) (B); Sagital cross-section through the 
chimera showing section through DA with GFP+ cells in blood flow (C); Chimera section through DA, showing Runx1+ cluster of cells with 1 









Figure 36. HH5 mid-streak contribution to inta-aortic clusters. HH5 chick embryo grafted at 50% of PS. Inset shows PS overlaid 
with a scale to show detailed graft (white arrowhead) position (A); GFP+ cells contribution to LPM and lateral body wall at EC day 1-3 (B). 
Close-up on GFP+ DA (wall is shown with white arrows) in the chimera at EC day 2 (C); Close-up on GFP+ DA (DA wall is shown with white 
arrows). Aortae fusion is initiated (two pointing to each other white arrows) (D); Chimera cross-section through heart region showing GFP+ DA 
lining with GFP+ cluster of cells (white arrow). GFP+ cells express Runx1. Some cells in cluster co-express CD45 (E); Chimera cross-section 









Figure 37. HH6 mid-streak contribution to intra-aortic clusters. HH6 chick embryo grafted at 50% of PS length. Inset: PS overlaid 
with a scale to show detailed graft (white arrowhead) position (A); Graft cells contribution to LPM at EC day 1-3 (B); Contribution to DA (white 
arrows pointing to aortae walls) observed at EC day 2 (C); Contribution to DA (white arrows) observed at EC day 3. DA fusion is initiated 
anterior to shown aortae walls. (D); Chimera cross-section anterior to DA-OMA fusion. DA lining is GFP+. A cluster of cells (white arrowhead) 







Figure 38. Model of primitive streak contribution to dorsal aorta. Neighboring 
regions of primitive streak (PS, shown here as grafts of differentr colour) contribute to 
adjacent stretches of lateral plate mesoderm (LPM). LPM migrate rostrally along chick 
embryo midline. When LPM cells reach their final position, secondary movement of LPM 
cells takes place. LPM cells (angioblasts) migrate towards embryo midline where they 
contribute to the brenches of primordial dorsal aortae. Since stretch of LPM producing DA 
angioblasts is formed from different PS descendants, DA is formed by descendants of 






In this chapter we discussed results of tracing progenitors of the dorsal aorta (DA) in 
chicken embryos from primitive streak stages (PS). In prior works the primitive streak was 
mapped out in detail, but dorsal aorta mapping was overlooked [Psychoyos and Stern, 1996; 
Sweetman et al., 2008; Limura et al. 2007; Sawada and Aoyama et al., 1999]. We aimed to 
establish the area of the primitive streak (PS) that contributes exclusively to the dorsal aorta, 
but not to extraembryonic tissues (yolk sac). Avoiding labelling of yolk sac tissues is important 
to eliminate marking of primitive blood cells that are generated in the yolk sac before initiation 
of blood circulation. Yolk sac cells were previously shown to seed hematopoietic organs in the 
embryo and might contribute to some obscure pool of HSC in adults [Cumano et al., 1996, 
Rhodes et al., 2008; Kieusseian et al., 2012; Lassila et al., 1979; 1982]. 
To this end, primitive streak regions in gastrulating chick embryos (from HH3+ to 
HH6, stages according to Hamburger and Hamilton) were labelled either with injections of 
lipophilic dyes or surgically [Hamburger and Hamilton, 1992]. Surgical grafting consisted of 
substitution of the region of the PS in host embryos with a portion of GFP+ PS tissue derived 
from the same position in the same stage donor embryo. 
According to obtained results, the DA is formed by descendants of a long stretch of 
the PS: mid-streak (30-60% of full PS length) over the number of stages of chick embryo 
development (HH3-6). Neighbouring regions of the PS contribute to overlapping portions of 
the DA. Yet, the anterior mid-streak contributes mainly to the rostral DA portion, while caudal 
mid-streak – to the caudal DA. Therefore, we can conclude that the dorsal aorta is a mosaic 
organ formed by several descendants of the primitive streak generated during different stages 
of chick embryo development. This shall be a result of a compensatory mechanism of embryo 




embryo body plan. In this way, cells derived from adjacent regions of the PS intermix and form 
one stretch of DA (Appendix A11). 
Only rostral part of the DA bears intra-aortic clusters (IAC). All grafts that contributed 
to the rostral aorta regardless of their original position, gave rise to IAC. Therefore, formation 
of the IAC is position dependent and cell fate is not determined in the primitive streak. This 
corellates with prior works showing that the dorsal aorta hemogenic endothelium is formed in 
response to molecular signalling coming from neighbouring tissues: endoderm and ectoderm 
[Pardanaud L, Dieterlen-Lièvre F., 1999; Jaffredo et al., 1998; 2005; Bollerot 2005]. According 
to our data, the most promising position to label DA and IAC to trace their progeny in adult 
chicks is Hmaburger and Hamilton stage 5 of chick embryo development - 50-60% of primitive 
streak length. 
Intensity of GFP+ DA endothelium labelling varied. Some labelled regions had the 
whole DA endothelium marked while in other regios, the DA endothelium was not completely 
labelled. Accoding to our observations, DA formed by rostral and caudal PS grafts were not 
entirely labelled. In contrast the central portion of the graft was labelled more intensively. This 
can be explained by a mosaic mode of DA assembly: descendants of adjacent PS regions - 
overlap. On the other hand, the middle of the graft can be considered as a composition of 
narrow adjacent grafts. It is important to notice here, that depending on the position in the PS, 
grafts have different migratory routs. E.g., PS regios situated lower will have wide migration 
trajectory and hence cover shorter caudal-rostral distance. Nevertheless, in the lateral plate 
mesoderm, PS descendants line up and then start their movement towards the midline. During 
this movement PS descendants completely intermix. 
Similarly, on examination, not all cells in intra-aortic clusters were GFP+. This is the 




If they were, clusters would be formed of GFP+ or GFP- cells only. Hence, the clusters are 
formed by adjacent endothelial cells that initiated the program of budding into the DA lumen.  
Interestingly, up to 25% of grafts did not have GFP+ cells contribution to the yolk sac 
(YS), but had this contribution to the area pellucida vasculature, generated small number of 
GFP+ cells in the blood flow. GFP+ cells in blood flow were observed before DA fusion, 
meaning that they were not aortic HSC or their precursors. This gives rise to the possibility that 
the YS is not the only source of primitive erythroblasts in the chicken embryo, but also the area 
pellucida vasculature. What the hematopoietic potential of these GFP+ cells is, do they seed 
hematopoietic organs, or they migrate towards hemogenic endothelium, requires further 
investigation. 
Recording the position of labelled PS cells in the lateral plate mesoderm (LPM) allows 
us to establish chick embryo stages, and LPM position for labelling DA at later stages. This is 
a valuable source of information, as chick embryos grafted at early stages have very limited 


























The first transplantable hematopoietic stem cells (HSC) arise in the aorta-gonad 
mesonephros region (AGM) during early stages of embryo development [Medvinsky et al., 
1996; 2011; Muller et al., 2004; Cumano et al., 1996; 2001; Kieusseian et al., 2012; Eaves et 
al., 2015; Ivanovs et al., 2014]. To date, it is widely accepted that HSC mature in so-called 
intra-aortic clusters (IAC), which arise at the aorta floor shortly after primordial aortae fusion 
[Babovic and Eaves, 2014; Bhatia 2007; Boisset et al., 2010, 2011; Bollerot et al., 2005; de 
Bruijin et al., 2002; Bertrand et al., 2010]. Yet, it is unclear whether these HSC arise and mature 
exclusively in the DA, its subluminal space or in IAC, or if HSC precursors migrate into the 
DA from other parts of the embryo, and what their maturation status is. 
To elucidate ontogeny of early HSC precursors (pro-HSC), we mapped potential pro-
HSC based on expression of transcription factor Runx1which is critical for HSC maturation. 
Runx1 expressing cells were mapped before in mouse embryos with established blood 
circulation and in early haploinsufficient AML1+/LacZ mouse embryos. Runx1 immunostaining 
on wild type mouse embryos was not reported before [Yokomizo and Dzierzak, 2010; Lam et 
al., 2010; Liakhovitskaia et al., 2014; Bee et al., 2009; Swiers et al., 2010(b); Cai et al., 2011; 
Chen et al., 2011]. 
The yolk sac generates the first wave of Runx1+ hematopoietic cells. To exclude 
migration of Runx1+ yolk sac cells into embryo proper we performed Runx1+ cells mapping 
in pre-circulation mouse embryos (E6-E8.5). 
Our mapping of Runx1+ cells revealed that in pre-somitic mouse embryos the majority 
of Runx1+ cells are localized to the yolk sac blood islands and chorionic plate. In the chorionic 
plate, Runx1+ cells not only line its surface, but also form cell clusters. Additionally, rare 




of amalgamation of extra- and intraembryonic vasculature - the vessel of confluence (VOC). 
The VOC connects the omphalomesenteric artery (OMA), umbilical artery and dorsal aorta 
[Zeigler et al., 2006; Daane et al., 2011]. A half of day later in development (headfold stage) 
Runx1+ cells were often found in clusters positioned in the VOC. We envision that Runx1+ 
cell clusters are the same clusters found in older embryos (E9-E12) in the omphalomesenteric 
artery, allantois and in placenta [Rhodes et al., 2008; Gekas et al., 2005; Godin et al., 1995; 
Palis et al., 1999; Kumaravelu et al., 2003]. Identified clusters could contain pre-HCS. To 
assess HSC potential of tissues containing prospective HSC, cells were isolated from 
embryonic day 8 (E8) mouse embryos and, after a culture step, tested in transplantation assays. 
In our work, we utilized a powerful pro-HSC maturation system that allowed us to 
mature E9 pro-HSC to be transplantable into the immunocompetent mouse recipients [Sheridan 
et al., 2009; Rybtsov et al., 2014, 2016].  Regions containing potential pro-HSC (for example, 
VOC region, allantois, yolk sac; head and heart) were isolated from embryonic day 8 (E8) 
mouse embryos, cultured and transplanted into sub-lethally irradiated recipients. From 82 
recipients transplanted with E8 derived cells one transplant (head and heart region) repopulated 
the recipient hematopoietic system at the level of 1.2%. The level of blood chimerism in this 
mouse dropped to 0.3% after 3.5 months. 19 recipients demonstrated low levels (0.1-0.3%) of 
blood chimerism with the majority of these grafts (46%) derived from the rostral part of the 
embryo (head, heart, upper somites). The level of recipients’ blood chimerism was low, but 
above the background level (0.1%) of blood chimersim in mice injected with carrier cells only. 
Therefore, we propose that we identified a low repopulating multilineage precursors and/or 
early proHSC. To validate HSC nature of these cells further tests are required, for example 




 If we compare this repopulation activity of E8 derived cells to that of cells derived 
from 22-26 sp (E9) embryos, it would become evident these cells repopulation activity is 
similar [Rybtsov et al., 2014]. In contrast, the repopulation capacity of cells derived from 
caudal parts of slightly older E9 embryos (embryos with more than 26 somite pairs, sp) is 
comparable to that of definitive embryonic HSC. To explain this, we investigated the events 
that take place in 21-29 sp mouse embryos.  
When we examined early E9 embryos, we found that Runx1 expression patterns 
essentially are not changed from E8 to early E9 embryos. Intensive Runx1 expression is 
observed in the area of the vessel of confluence (VOC). In addition, according to our results, 
Runx1 is specifically expressed in the section of the DA adjacent to the VOC. We also found 
that the area reported by Rybtsov et al. (2014) to bear the pre-HSC is in fact the site where the 
paired aortae first fuse. According to our data and prior reports, the aortae fusion takes place 
immediately before transplantable HSCs cells appear in the embryo [Resse et al., 2004; 
Garriock et al., 2010; Nagase et al., 2006]. We envision that intimate connection between the 
DA fusion events and induction of pro-HSCs maturation exists.  
Therefore, future studies in the direction of development of pro-HSC maturation 
systems shall also involve cultures treatment with BMP signalling mediators. For instance, by 
means of co-culture with Bmp4-expressing (and/or Shh, VEGF) stromal cell lines [Lee at al., 
2014; Clements and Traver, 2013; Leung et al., 2013; Lawson et al., 2002]. 
As it is described above, pro-HSC maturation methods established to date are not 
efficient for the maturation of early embryonic pro-HSC, and another approach to study HSC 
ontogeny had to be applied. For example, the labelling of the dorsal aorta (DA) and intra-aortic 
clusters (IAC) will provide a direct answer on the involvement of the DA in definitive 




approach would be to label the embryonic DA by grafting with tissues that express a specific 
marker, for example GFP. Chicken embryo develops ex utero and tolerates surgical operations 
and is an excellent animal model to apply this approach [Stern, 2004]. The first task in 
developing this approach was to identify cells giving rise to the DA and IAC. We have selected 
gastrulating chick embryos to identify these cells.  
To trace cells giving rise to the DA, regions of the primitive streak (PS) were labelled 
with lipophilic dyes or GFP+ regions of PS were isotopically grafted into stage matched chick 
embryo recipients [Psychoyos and Stern, 1996; Hatada and Stern CD, 1994]. Recipients were 
cultured in “early chick” (EC) embryo culture for 1-3 days, during which cells migration was 
recorded. On day 3 chimeras were collected and processed for detailed contribution analysis 
by immuno- and histochemistry. 
According to our results, cells giving rise to the DA ingress through the long stretch of 
PS (35-60%, referred as mid-streak here) during several stages of chick embryo development 
(HH3-6). Neighbouring regions of mid-streak contribute to overlapping portions of the DA. 
Cells' position in the mid-streak does not determine their position in the dorsal aorta. Position 
in the DA is defined by the final cells' position in the lateral plate mesoderm (LPM), which in 
turn depends on the cells' migratory route. For example, cells situated more caudally in mid-
streak migrate by a more lateral trajectory than the cells positioned in the anterior mid-streak. 
In this way, cells positioned to the anterior mid-streak cover shorter distance in the LPM, while 
those in the caudal mid-streak cover longer distance. As the time of travel for all cells is the 
same, cells emigrated from different regions of mid-streak end up at different levels in the 
LPM. In about 20h after cells left mid-streak, the LPM is compacted and LPM cells now form 
one uninterrupted stretch of LPM with ordered portions of PS descendants: anterior mid-streak 




that, secondary movement of cells takes place. Some LPM cells start migration towards 
embryonic midline contributing to the DA, while other LPM cells migrate laterally contributing 
to the area pellucida and yolk sac vasculature. Substantial number of LPM cells stays in place. 
In turn, this explains the requirement to label a substantial number of cells in the PS to achieve 
visible labelling of the DA. According to our observations, portions of LPM formed by HH4 
PS descendants have higher tendency to contribute to extraembryonic vasculature than mid-
streak descendants from older embryos. Similar epiblast migration patterns were recorded by 
Yang et al., (2002 and 2008). 
Mid-streak contributes to LPM and so to the DA over the whole gastrulation period 
[Garcia-Martinez and Schoenwolf, 1992; Stern, 2004]. Our results show that in older embryos 
the mid-streak contributes to the DA portions, which are positioned slightly more caudally than 
the DA portion formed by PS in younger embryos. Yet, DA portions formed by PS descendants 
from younger and older embryos significantly overlap. Therefore, the DA is a mosaic organ, 
each section of which is formed by descendants of several PS regions at several stages of 
embryo development. In HH4-6 embryos, mid-streak below 50% of its length contributes 
mainly to the DA portion caudally to DA-omphalomesenteric artery (OMA) junction. The mid-
streak region above 45% of its length contributes to DA portion above DA-OMA junction. This 
portion of DA (to the anterior of DA-OMA junction) bears IAC [Drevon et al., 2010; Lassila 
et al., 1999]. When we examined embryos that had contribution to IAC bearing portion of DA, 
we have found that regardless of the stage of the grafted embryo all grafts contributed to IAC. 
An interesting observation is that not all IAC were uniformly GFP+ formations. This could 
suggest that IAC are not of the clonal origin and/or the cells in the cluster are mobile. On the 
other hand, to date it is not known whether a cluster is a niche of HSC that carries single HSCs, 
or a whole cluster is a site of maturation of equally potent HSC. To answer this question, further 




embryo chimeras with light sheet fluorescence microscopy. Another method would be to trace 
descendants of GFP+ IAC in adult chicks. This could be achieved either by creating chimeras 
in ovo with consequent chick hatching or with cells suspension transplantations into irradiated 
chicken embryos or adult chicks [Lassila et al., 1982; Toivanen et al., 1982].  
In this work we have developed a method to construct chimeras with labelled DA that 
bears IAC. Utilization of this method will allow to clarify the role of DA and IAC in definitive 
haematopoiesis and to answer whether precursors of HSCs arise in DA or in other embryonic 
areas. We also show that the main embryonic vessel, the dorsal aorta, is a mosaic structure. 
The same is true for the enigmatic structures, the intra-aortic clusters, which are believed to be 
the niche for the hematopoietic stem cell. Reported here clusters mosaicity rise the number of 
questions as for the process of HSC maturation. In particular, are other cells in the clusters 
serve as the microenvironment for maturing HSC or all cells of the cluster possess the same 
HSC potential as other cells. Our observations necessitate further cell tracing studies to shed 
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Appendix A1. Primary Runx1 antibody control on Runx1 KO mouse embryos. Anti-Runx1/anti-CD31 staining on AML1LacZ/LacZ pre-somitic mouse 








Appendix A2. Immuno-fluorescent staining for Runx1 on E8 AML+/LacZ mouse embryos. Neural plate 
mouse embryo showing typical pattern for Runx1 staining (in YS); Headfold stage mouse embryo showing Runx1 
staining in YS and chorionic plate (B); 5 sp mouse embryo showing Runx1 staining in YS and ChP. Yolk sac (YS); 









Appendix A3. Beta-galactosidase staining on E8 Runx1+/LacZ embryos. Whole mount anti-beta-
galactosidase stained 5 sp mouse embryo (A); Scheme of connection of extra-and intra-embryonic vessels 
(B); Clusters of Runx1+ cells in nascent DA. Section C shown in A (C); Runx1+ cells in allantois and yolk 







Appendix A4. Neural plate stage mouse embryos exhibiting no CD31, CD41 or c-kit staining outside 
























Appendix A7.  Flow cytometric analysis of co-aggregates prepared from E8.5 caudal 
tissues of stromal cells. Markers used: hematopoietic CD45, endothelial Ve_cad and GFP for 
E8.5 isolated cells. CP/AL – E8.5 mouse embryis caudal parts and allantoid. Culture duration: 







A8. Flow cytometric analysis of E8.5 yolk sac tissues from co-aggregate culture using 
surface expression markers for hematopoietic (CD45) and endothelial (Ve_Cad) markers. 
GFP+ E8.5 yolk sac (YS) co-cultured for two days with E9.5 stroma cells and consequent 
seven-day co-aggregate culture with E10.5 stroma cells (A). Repeated experiment as in A, (B). 
GFP+ E8.5 YS co-cultured for two days with E9.5 stroma cells and consequent seven-day co-








A9. Flow cytometric analysis of E9 tissues from co-aggregate culture using surface 
expression markers for hematopoietic (CD45) and endothelial (Ve_Cad) markers. GFP+ 
E9 (22-26sp) caudal part and allantois (CP/AL) co-cultured for seven days with OP9 stromal 
cell line (A). GFP+ E9 (22-26sp) yolk sac (YS) co-cultured for seven days with OP9 stromal 







A10. Hematopoietic potential assessment of cultured E8 and E9 cells in 
methylcellulose media. After E8 or E9 cells co-aggregate culture, cell suspension was plated 
into methylcellulose. Cells were recovered from methylcellulose and analysed by flow 
cytometry (A). In seven days in methylcellulose no GFP+ hematopoietic colonies (cut off level 






A11. Flow cytometric blood chimerism assessment six weeks after transplantation. 
Blood chimerism in mice injected with cells derived from GFP+ E8 caudal parts and allantois 
(CP/AL), co-cultured with E9 and E10 fresh stroma cells(A). Blood chimersim in mice 
transplanted with cells derived from GFP+ E8 yolk sac (YS) co-cultured with E9 stroma and 
OP9 line(B). The same as in (A) for yolk sac tissues (C). The same as in (B) for yolk sac tissues 
(D). GFP+ content of donor cell population for (A), (E). GFP+ content of donor cell population 
in (B), (F). GFP+ population in donor cells for (C), (G). GFP+ cell content for donor population 







A12. Blood chimerism in mice transplanted with cells derived from E8 (3-8sp) tissues 
cultured as explants with consequent co-aggregation with OP9 stromal cell line. Blood 
chimerism six weeks after transplantation (A, C, E). Blood chimerism 3.5 months after 
transplantation (B, D, F). Yolk sac tissues (YS), caudal part and allantois tissues (CP+AL), 
head and heart tissues (HH). 
 
A13. Multilineage blood repopulation in mice engrafted at level higher than 0.1% 















































































































































































A15. Blood chimerism in mice transplanted with cells derived from E8.5 air-liquid 
interface explants. Blood chimerism (donor – Ly5.2 homo) six weeks after injection (A). 
Blood chimerism 3.5 months after injection (B). Multilineage analysis of donor cell population 








A16. Blood chimerism in mice transplanted with cell suspensions derived from 
embryonic (0-5sp) tissues cultured as submerged explants for four days. Short term 







A17. Blood chimerism in mice transplanted with cell suspensions derived from 
embryonic (6-13sp) tissues cultured as submerged explants for four days. Short term 
















































































































































































































































































































































































































































































































































































































Table A20. Results of transplantation of cells from E8 mouse tissues cultured as explants 
on air-liquid interface with subsequent co-aggregation with OP9 
 Yolk sac 




# of injected mice 5 5 5 
# STR repopulated  





 (0.108, 0.13) 
2 
(0.12, 0.21*) 
# LTR repopulated 




 (0.124, 0.128*) 
1 
 (0.14*) 
Multilineage repopulation for LTR 
Myeloid cells, % donor popul. 5.62 4.55 18.4 
B cells, % donor popul. 9.09 0 26.5 
T cells, % donor popul. 86.4 88.8 55.1 
* - multilineage analysis was done for these samples; STR – short term repopulation; LTR 





Table A21.  Results of transplantation of cells from E8 mouse tissues cultured as explants 
 Yolk sac 
Caudal part and 
allantois 
# of injected mice 1 1 
# STR repopulated 





# LTR repopulated 
(blood chimerism, %) 
0 0 
Multilineage repopulation for STR 
Myeloid cells, 
% donor population 
5.13 18.2 
B cells, 
% donor population 
12.8 27.7 
T cells, 







Table A22. Transplantations results done with cells derived from E8 mouse tissues 
cultured as explants in submerged culture 






# of injected mice 8 8 14 4 
# STR repopulated 











# LTR repopulated 










Multilineage repopulation for STR 
Myeloid cells, 
% donor population 
8.33 x 3.95/2.08/73.9 x 
B cells, % donor 
population 
0 x 1.32/1.04/12 x 
T cells, % donor 
population 
91.7 x 85.5/88.5/0 x 
Multilineage repopulation for STR 
Myeloid cells, % donor 
population 
x x 18.3/70.4 x 
B cells, % donor 
population 
x x 0/11.1 x 
T cells, % donor 
population 
x x 79.1/0 x 



















Frequency of contribution 
(contributed/grafted at given position) 
Tissues 
DA LPM/IM APV Somites AOV Ht Hd 
3 16 
10-20 0/3 0/3 3/3 0/3 3/3 0/3 0/3 
30-40 1/2 0/2 2/2 0/2 1/2 0/2 0/2 
40-50 2/3 1/3 2/3 0/3 2/3 1/3 0/3 
50-60 2/2 0/2 2/2 0/2 1/2 1/2 0/2 
60-70 4/5 2/5 2/5 1/5 0/5 3/5 0/5 
90-100 0/1 0/1 0/1 0/1 0/1 0/1 1/1 
4 32 
0-10 0/1 0/1 0/1 0/1 1/1 0/1 0/1 
10-20 0/3 0/3 0/3 0/3 3/3 0/3 0/3 
20-30 3/4 1/4 3/4 0/4 4/4 0/4 0/4 
30-40 2/4 1/4 4/4 0/4 3/4 0/4 0/4 
40-50 4/5 5/5 4/5 0/5 2/5 0/5 0/5 
50-60 5/7 5/7 5/7 0/7 2/7 0/7 0/7 
60-70 3/4 4/4 2/4 1/4 0/4 0/4 0/4 
70-80 1/2 1/2 1/2 2/2 0/2 0/2 0/2 
80-90 0/2 0/2 0/2 2/2 0/2 0/2 0/2 
5 18 
20-30 1/1 1/1 1/1 0/1 0/1 0/1 0/1 
30-40 3/3 3/3 3/3 0/3 0/3 0/3 0/3 
40-50 3/3 3/3 1/3 0/3 0/3 0/3 0/3 
50-60 4/6 6/6 0/6 1/6 0/6 0/6 0/6 
60-70 1/3 3/3 0/3 1/3 0/3 0/3 0/3 
70-80 0/1 0/1 0/1 1/1 0/1 0/1 0/1 
80-90 0/1 0/1 0/1 1/1 0/1 0/1 0/1 
6-8 7 
30-40 1/1 1/1 1/1 0/1 1/1 0/1 0/1 
40-50 2/2 2/2 0/2 0/2 0/2 0/2 0/2 
50-60 2/3 2/3 0/3 1/3 0/3 0/3 0/3 
60-70 0/1 0/1 0/1 1/1 0/1 0/1 0/1 
DA – dorsal aorta; LPM – lateral plate mesoderm; IM – intermediate mesoderm; APV – area pellucida vessels; 














A25. Beta-galactosidase staining buffer recipes 
Buffer A: 
 10%FCS; 
 PBS (tissue culture grade, without Mg, Ca ions); 
 2 mM MgCl2; 
 5 mM EGTA. 
Buffer B: 
 0.1M PBS (pH 7.3); 
 2mM MgCl2; 
 5mM EGTA; 
 0.2% glutaraldehyde. 
Buffer C: 
 0.1M PBS (pH 7.3); 
 2 mM MgCl2; 
 0.1% Na desoxyholate; 
 0.02% NP40; 
 0.5 mg/mL BSA. 
Buffer D: 
 5 mM K3Fe(CN)6; 
 5 mM K4Fe(CN)6x3H2O; 
 0.24 mg/mL Spermidine; 
 0.25 mM NaCl; 
 1mg/mL X-Gal (add before incubation). 






Appendix A26. Pannett and Compton saline stock for early chick culture. 
 
Stock solution A: 
- 121 g NaCl; 
- 15.5 g KCl; 
- 10.42 g CaCl2*2H2O (or 7.7 gCaCl2); 
- 12.7 g MgCl2*6H2O. 
Dilute in 1 L of water. Solution A was autoclaved prior to storage. 
 
Stock solution B: 
- 2.365 g Na2HPO4*2H2O (or 1.886 g Na2HPO4); 
- 0.188g NaH2PO4*2H2O (or 0.166 g NaH2PO4*H2O). 
Add distilled water to 1 L. The resulting solution was autoclaved prior to storage. 
 
 Both solutions were stored at 21 oC for 2 months. After opening, solutions were stored 
at 4 oC. Pannet-Compton saline working solution was prepared by mixing 40 ml of saline A, 





Appendix A27 List of antibodies used for blood chimerism assessment  
Antibodies set A: 
Fc block (anti-CD16/32, clone 93, Abcam, 1:200; 
anti-mouse CD45.1-APC, clone A20, Abcam, 1:100; 
anti-mouse CD45.2-PE, clone 104, Abcam, 1:100. 
Antibodies set B: 
Fc block (anti-CD16/32, clone 93, Abcam), 1:200; 
anti-mouse CD45.1-V450, clone A20, BD Horizon 1:100; 
anti-mouse CD45.2-V500, clone 104, Biolegend, 1:100; 
anti-mouse CD11b-PE (Mac-1), clone M1/70, eBioscience; 1:600; 
anti-mouse GR-1 (Ly6C)-FITC, clone RB6-8C5, BD Pharmingen, 1:600; 
anti mouse CD3e-APC, clone 145-2C11, eBioscience, 1:100; 
anti mouse CD45R/220- PE-Cy7, BD Pharmingen, 1:200.  
 
 
 
